<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
  <meta charset="utf-8" />
  <meta name="generator" content="pandoc" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
  <meta name="author" content="hbaolong@vip.qq.com" />
  <title>2801癌症传 注解</title>
  <style>
    html {
      color: #1a1a1a;
      background-color: #fdfdfd;
    }
    body {
      margin: 0 auto;
      max-width: 36em;
      padding-left: 50px;
      padding-right: 50px;
      padding-top: 50px;
      padding-bottom: 50px;
      hyphens: auto;
      overflow-wrap: break-word;
      text-rendering: optimizeLegibility;
      font-kerning: normal;
    }
    @media (max-width: 600px) {
      body {
        font-size: 0.9em;
        padding: 12px;
      }
      h1 {
        font-size: 1.8em;
      }
    }
    @media print {
      html {
        background-color: white;
      }
      body {
        background-color: transparent;
        color: black;
        font-size: 12pt;
      }
      p, h2, h3 {
        orphans: 3;
        widows: 3;
      }
      h2, h3, h4 {
        page-break-after: avoid;
      }
    }
    p {
      margin: 1em 0;
    }
    a {
      color: #1a1a1a;
    }
    a:visited {
      color: #1a1a1a;
    }
    img {
      max-width: 100%;
    }
    svg {
      height: auto;
      max-width: 100%;
    }
    h1, h2, h3, h4, h5, h6 {
      margin-top: 1.4em;
    }
    h5, h6 {
      font-size: 1em;
      font-style: italic;
    }
    h6 {
      font-weight: normal;
    }
    ol, ul {
      padding-left: 1.7em;
      margin-top: 1em;
    }
    li > ol, li > ul {
      margin-top: 0;
    }
    blockquote {
      margin: 1em 0 1em 1.7em;
      padding-left: 1em;
      border-left: 2px solid #e6e6e6;
      color: #606060;
    }
    code {
      font-family: Menlo, Monaco, Consolas, 'Lucida Console', monospace;
      font-size: 85%;
      margin: 0;
      hyphens: manual;
    }
    pre {
      margin: 1em 0;
      overflow: auto;
    }
    pre code {
      padding: 0;
      overflow: visible;
      overflow-wrap: normal;
    }
    .sourceCode {
     background-color: transparent;
     overflow: visible;
    }
    hr {
      background-color: #1a1a1a;
      border: none;
      height: 1px;
      margin: 1em 0;
    }
    table {
      margin: 1em 0;
      border-collapse: collapse;
      width: 100%;
      overflow-x: auto;
      display: block;
      font-variant-numeric: lining-nums tabular-nums;
    }
    table caption {
      margin-bottom: 0.75em;
    }
    tbody {
      margin-top: 0.5em;
      border-top: 1px solid #1a1a1a;
      border-bottom: 1px solid #1a1a1a;
    }
    th {
      border-top: 1px solid #1a1a1a;
      padding: 0.25em 0.5em 0.25em 0.5em;
    }
    td {
      padding: 0.125em 0.5em 0.25em 0.5em;
    }
    header {
      margin-bottom: 4em;
      text-align: center;
    }
    #TOC li {
      list-style: none;
    }
    #TOC ul {
      padding-left: 1.3em;
    }
    #TOC > ul {
      padding-left: 0;
    }
    #TOC a:not(:hover) {
      text-decoration: none;
    }
    code{white-space: pre-wrap;}
    span.smallcaps{font-variant: small-caps;}
    div.columns{display: flex; gap: min(4vw, 1.5em);}
    div.column{flex: auto; overflow-x: auto;}
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
    /* The extra [class] is a hack that increases specificity enough to
       override a similar rule in reveal.js */
    ul.task-list[class]{list-style: none;}
    ul.task-list li input[type="checkbox"] {
      font-size: inherit;
      width: 0.8em;
      margin: 0 0.8em 0.2em -1.6em;
      vertical-align: middle;
    }
    .display.math{display: block; text-align: center; margin: 0.5rem auto;}
  </style>
</head>
<body>
<header id="title-block-header">
<h1 class="title">2801癌症传 注解</h1>
<p class="author">hbaolong@vip.qq.com</p>
</header>
<p><a href="./">返回目录</a></p>
<ol type="1">
<li><h4 id="肿瘤中的体液">肿瘤中的体液</h4></li>
<li><p>〔1〕 Susan Sontag, Illness as Metaphor and AIDS and Its
Metaphors (New York: Picador, 1990), 3.</p></li>
<li><p>〔1〕 Diseases desperate grown: William Shakespeare, Hamlet, Act
IV, Scene III.</p></li>
<li><p>〔2〕 Cancer begins and ends with people: June Goodfield, The
Siege of Cancer (New York: Random House, 1975), 219.</p></li>
<li><p>〔3〕 英美制重量单位，1磅约合0.45千克。——译者注</p></li>
<li><p>〔4〕 In Aleksandr Solzhenitsyn’s novel: Aleksandr Solzhenitsyn,
Cancer Ward (New York: Farrar, Straus and Giroux, 1968).</p></li>
<li><p>〔5〕 Atossa, the Persian queen: Herodotus, The Histories
(Oxford: Oxford University Press, 1998), 223.</p></li>
<li><p>〔6〕 “The universe,” the twentieth-century biologist: John
Burdon Sanderson Haldane, Possible Worlds and Other Papers (New York:
Harper ＆ Brothers, 1928), 286.</p></li>
<li><p>〔1〕 In solving a problem of this sort: Arthur Conan Doyle, A
Study in Scarlet (Whitefish, MT: Kessinger Publishing, 2004),
107.</p></li>
<li><h4 id="第一章-血液化脓">第一章 “血液化脓”</h4></li>
<li><p>〔1〕 Physicians of the Utmost Fame: Hilaire Belloc, Cautionary
Tales for Children (New York: Alfred A. Knopf, 1922), 18–19.</p></li>
<li><p>〔2〕 Its palliation is a daily task: William B. Castle,
“Advances in Knowledge concerning Diseases of the Blood, 1949–1950,” in
The 1950 Year Book of Medicine: May 1949–May 1950 (Chicago: Year Book
Publishers, 1950), 313–26.</p></li>
<li><p>〔3〕 1英尺约等于0.3米。——编者注</p></li>
<li><p>〔4〕 In a damp: Details concerning aminopterin and its arrival
in Farber’s clinic are from several sources. Sidney Farber et al., “The
Action of Pteroylglutamic Conjugates on Man,” Science, 106, no. 2764
(1947): 619–21; S. P. K. Gupta, interview with author, February 2006;
and S. P. K. Gupta, “An Indian Scientist in America: The Story of
Dr. Yellapragada SubbaRow,” Bulletin of the Indian Institute of History
of Medicine (Hyderabad) 6, no. 2 (1976): 128–43; S. P. K. Gupta and
Edgar L. Milford, In Quest of Panacea (New Delhi: Evelyn Publishers,
1987).</p></li>
<li><p>〔5〕 Farber’s specialty was pediatric pathology: John Craig,
“Sidney Farber (1903–1973),” Journal of Pediatrics 128, no. 1 (1996):
160–62. Also see “Looking Back: Sidney Farber and the First Remission of
Acute Pediatric Leukemia,” Children’s Hospital, Boston,
http://www.childrenshospital.org/gallery/index.cfm?G=49＆page=2
(accessed January 4, 2010); H. R. Wiedemann, “Sidney Farber
(1903–1973),” European Journal of Pediatrics, 153 (1994): 223.</p></li>
<li><p>〔6〕 “It gave physicians plenty to wrangle over”: John Laszlo,
The Cure of Childhood Leukemia: Into the Age of Miracles (New Brunswick,
NJ: Rutgers University Press, 1995), 19.</p></li>
<li><p>〔7〕 “diagnosed, transfused—and sent home to die”: Medical World
News, November 11, 1966.</p></li>
<li><p>〔8〕 “He is of dark complexion”: John Hughes Bennett, “Case of
Hypertrophy of the Spleen and Liver in Which Death Took Place from
Suppuration of the Blood,” Edinburgh Medical and Surgical Journal 64
(October 1, 1845): 413–23. Also see John Hughes Bennett, Clinical
Lectures on the Principles and Practice of Medicine, 3rd ed. (New York:
William Wood ＆ Company, 1866), 620.</p></li>
<li><p>〔9〕
尽管贝内特并不了解微生物与感染之间的关系，但是他已经注意到脓肿或者伤口可以导致化脓、脓毒症、发热以及死亡。——作者注</p></li>
<li><p>〔10〕 “A suppuration of blood”: Bennett, “Case of Hypertrophy of
the Spleen.” Also see Bennett, Clinical Lectures, 896.</p></li>
<li><p>〔11〕 Rudolf Virchow, independently published: Rudolf Ludwig
Karl Virchow, Cellular Pathology: As Based upon Physiological and
Pathological Histology, trans. Frank Chance (London: John Churchill,
1860), 169–71, 220. Also see Bennett, Clinical Lectures, 896.</p></li>
<li><p>〔12〕 seeking a name for this condition: Charles J. Grant,
“Weisses Blut,” Radiologic Technology 73, no. 4 (2003): 373–76.</p></li>
<li><p>〔13〕 in the early 1980s, another change in name: Randy Shilts,
And the Band Played On(New York: St. Martin’s), 171.</p></li>
<li><p>〔14〕
当人们发现艾滋病病毒（HIV）是这种在全球迅速蔓延的疾病的罪魁祸首以后，学术界不久就摒弃了早期研究中对于同性恋具有文化“歧视”色彩的病名。——作者注</p></li>
<li><p>〔15〕 Virchow’s approach to medicine: “Virchow,” British Medical
Journal, 2, no. 3171 (1921): 573–74. Also see Virchow, Cellular
Pathology.</p></li>
<li><p>〔16〕
虽然菲尔绍并不是这个名词的创造者，但是他对肿瘤的性状进行了完整描述。——作者注</p></li>
<li><p>〔17〕 Bennett’s earlier fantasy: William Seaman Bainbridge, The
Cancer Problem (New York: Macmillan Company, 1914), 117.</p></li>
<li><p>〔18〕 Michael Anton Biermer, described: Laszlo, Cure of
Childhood Leukemia, 7–9, 15.</p></li>
<li><p>〔19〕 From its first symptom to diagnosis to death: Biermer,
“Ein Fall von Leukämie,” Virchow’s Archives, 1861, S. 552, cited in
Suchannek, “Case of Leukaemia,” 255–69.</p></li>
<li><p>〔20〕 Farber completed his advanced training: Denis R. Miller,
“A Tribute to Sidney Farber—the Father of Modern Chemotherapy,” British
Journal of Haematology 134 (2006): 4, 20–26.</p></li>
<li><p>〔21〕 What is true for E. coli: This remark, attributed to Monod
(perhaps apocryphally), appears several times in the history of
molecular biology, although its precise origins remain unknown. See, for
instance, Theresa M. Wizemann and Mary-Lou Pardue, eds., Exploring the
Biological Contributions to Human Health: Does Sex Matter? (Washington,
DC: National Academy Press, 2001), 32; Herbert Claus Friedmann, “From
Butyribacterium to E. coli: An Essay on Unity in Biochemistry,”
Perspectives in Biology and Medicine 47, no. 1 (2004): 47–66.</p></li>
<li><h4 id="第二章-黑暗深渊">第二章 黑暗深渊</h4></li>
<li><p>〔1〕 The medical importance of leukemia: Jonathan B. Tucker,
Ellie: A Child’s Fight Against Leukemia (New York: Holt, Rinehart, and
Winston, 1982), 46.</p></li>
<li><p>〔2〕 There were few successes in the treatment: John Laszlo, The
Cure of Childhood Leukemia: Into the Age of Miracles (New Brunswick, NJ:
Rutgers University Press, 1995), 162.</p></li>
<li><p>〔3〕 a cornucopia of pharmaceutical discoveries: Michael B.
Shimkin, “As Memory Serves—an Informal History of the National Cancer
Institute, 1937–57,” Journal of the National Cancer Institute 59 (suppl.
2) (1977): 559–600.</p></li>
<li><p>〔4〕 the drug was reextracted: Eric Lax, The Mold in
Dr. Florey’s Coat: The Story of the Penicillin Miracle (New York: Henry
Holt and Co., 2004), 67.</p></li>
<li><p>〔5〕 1加仑（美）约等于3.79升。——译者注</p></li>
<li><p>〔6〕 In 1942, when Merck had shipped: “Milestone Moments in
Merck History,”
http://www.merck.com/about/feature_story/01062003_penicillin.html (site
is no longer available but can be accessed through
http://www.archive.org/web/web.php).</p></li>
<li><p>〔7〕 A decade later, penicillin: E. K. Marshall, “Historical
Perspectives in Chemotherapy,” Advances in Chemotherapy 13 (1974): 1–8.
Also see Science News Letter 41 (1942).</p></li>
<li><p>〔8〕 chloramphenicol in 1947: John Ehrlich et al.,
“Chloromycetin, a New Antibiotic from a Soil Actinomycete,” Science 106,
no. 2757 (1947): 417.</p></li>
<li><p>〔9〕 tetracycline in 1948: B. M. Duggar, “Aureomycin: A Product
of the Continuing Search for New Antibiotics,” Annals of the New York
Academy of Science 51 (1948): 177–81.</p></li>
<li><p>〔10〕 “The remedies are in our own backyard”: Time, November 7,
1949.</p></li>
<li><p>〔11〕 In a brick building on the far corner: John F. Enders,
Thomas H. Weller, and Frederick C. Robbins, “Cultivation of the Lansing
Strain of Poliomyelitis Virus in Cultures of Various Human Embryonic
Tissues,” Science 49 (1949): 85–87; Fred S. Rosen, “Isolation of
Poliovirus—John Enders and the Nobel Prize,” New England Journal of
Medicine 351 (2004): 1481–83.</p></li>
<li><p>〔12〕 by 1950, more than half the medicines: A. N. Richards,
“The Production of Penicillin in the United States: Extracts and
Editorial Comment,” Annals of Internal Medicine, suppl. 8 (1969): 71–73.
Also see Austin Smith and Arthur Herrick, Drug Research and Development
(New York: Revere Publishing Co., 1948).</p></li>
<li><p>〔13〕 Typhoid fever: Anand Karnad, Intrinsic Factors: William
Bosworth Castle and the Development of Hematology and Clinical
Investigation at Boston City Hospital (Boston: Harvard Medical School,
1997).</p></li>
<li><p>〔14〕 Even tuberculosis: Edgar Sydenstricker, “Health in the New
Deal,” Annals of the American Academy of Political and Social Science
176, Social Welfare in the National Recovery Program (1934):
131–37.</p></li>
<li><p>〔15〕 The life expectancy of Americans: Lester Breslow, A Life
in Public Health: An Insider’s Retrospective (New York: Springer, 2004),
69. Also see Nicholas D. Kristof, “Access, Access, Access,” New York
Times, March 17, 2010.</p></li>
<li><p>〔16〕 Hospitals proliferated: Rosemary Stevens, In Sickness and
in Wealth (New York: Basic Books, 1989), 204, 229.</p></li>
<li><p>〔17〕 As one student observed: Temple Burling, Edith Lentz, and
Robert N. Wilson, The Give and Take in Hospitals (New York: Putnum,
1956), 9.</p></li>
<li><p>〔18〕 Lulled by the idea of the durability: From Newsweek and
Time advertisements, 1946–48. Also see Ruth P. Mack, “Trends in American
Consumption,” American Economic Review 46, no. 2, (1956):55–68.</p></li>
<li><p>〔19〕 “illness” now ranked third: Herbert J. Gans, The
Levittowners: Ways of Life and Politics in a New Suburban Community (New
York: Alfred A. Knopf), 234.</p></li>
<li><p>〔20〕 Fertility rose steadily: Paul S. Boyer et al., The
Enduring Vision: A History of the American People (Florence, KY: Cengage
Learning, 2008), 980.</p></li>
<li><p>〔21〕 The “affluent society”: John Kenneth Galbraith, The
Affluent Society (New York: Houghton Mifflin, 1958).</p></li>
<li><p>〔22〕 In May 1937: “Cancer: The Great Darkness,” Fortune, May
1937.</p></li>
<li><p>〔23〕 In 1899, when Roswell Park: Robert Proctor, Cancer Wars:
How Politics Shapes What We Know and Don’t Know About Cancer (New York:
Basic Books, 1995), 20.</p></li>
<li><p>〔24〕 Smallpox was on the decline: K. A. Sepkowitz, “The 1947
Smallpox Vaccination Campaign in New York City, Revisited,” Emerging
Infectious Diseases 10, no. 5 (2004): 960–61. Also see D. E.
Hammerschmidt, “Hands: The Last Great Smallpox Outbreak in Minnesota
(1924–25),” Journal of Laboratory and Clinical Medicine 142, no. 4
(2003): 278.</p></li>
<li><p>〔25〕 Between 1900 and 1916: Lucius Duncan Bulkley, Cancer and
Its Non-Surgical Treatment (New York: W. Wood ＆ Co., 1921).</p></li>
<li><p>〔26〕 By 1926, cancer: Proctor, Cancer Wars, 66.</p></li>
<li><p>〔27〕 In May that year, Life: “U.S. Science Wars against an
Unknown Enemy: Cancer,” Life, March 1, 1937.</p></li>
<li><p>〔28〕 When cancer appeared: “Medicine: Millions for Cancer,”
Time, July 5, 1937; “Medicine: After Syphilis, Cancer,” Time, July 19,
1937.</p></li>
<li><p>〔29〕 American Association for Cancer Research: “AACR: A Brief
History,” http://www.aacr.org/home/about-us/centennial/aacr-history.aspx
(accessed January 4, 2010).</p></li>
<li><p>〔30〕 from 70,000 men and women in 1911: “A Cancer Commission,”
Los Angeles Times, March 4, 1927.</p></li>
<li><p>〔31〕 Neely asked Congress: 69th Cong., 2nd sess., Congressional
Record, 68 (1927): p3 2922.</p></li>
<li><p>〔32〕 Within a few weeks: Richard A. Rettig, Cancer Crusade: The
Story of the National Cancer Act of 1971 (Lincoln, NE: Author’s Choice
Press, 1977), 44.</p></li>
<li><p>〔33〕 In June, a joint Senate-House conference: “National Cancer
Act of 1937,” Office of Government and Congressional Relations,
Legislative History, http://legislative.cancer.gov/history/1937
(accessed November 8, 2009).</p></li>
<li><p>〔34〕
1944年，NCI成为国立卫生研究院（NIH）的下属机构。在此后的数十年里，其他专科疾病研究机构均以此为模板进行复制。——作者注</p></li>
<li><p>〔35〕 An advisory council of scientists: Shimkin, “As Memory
Serves,” 559–600.</p></li>
<li><p>〔36〕 英里，英制长度单位，1英里约等于1609米。——编者注</p></li>
<li><p>〔37〕 “The nation is marshaling its forces”: Congressional
Record, appendix 84:2991 (June 30, 1939); Margot J. Fromer, “How, After
a Decade of Public ＆ Private Wrangling, FDR Signed NCI into Law in
1937,” Oncology Times 28 (19): 65–67.</p></li>
<li><p>〔38〕 The U.S. Marine Hospital: Ora Marashino, “Administration
of the National Cancer Institute Act, August 5, 1937, to June 30, 1943,”
Journal of the National Cancer Institute 4: 429–43.</p></li>
<li><p>〔39〕 “mostly silent”: Shimkin, “As Memory Serves,”
599–600.</p></li>
<li><p>〔40〕 “programmatic response to cancer”: Ibid.</p></li>
<li><p>〔41〕 1946—1947年，尼利与参议员克劳德·佩珀（Claude
Pepper）第三次提请审议国家癌症法案。但是该法案于1947年在国会以微弱的劣势被否决。（In
1946–47,Neely and Senator Claude Pepper: See House Foreign Affairs
Committee, House Report 2565, 79th Cong., 2nd sess. Also see Report 1743
to the 79th Cong., 2nd sess., July 18, 1946; “Could a ‘Manhattan
Project’ Conquer Cancer?” Washington Post, August 4,
1946.）——作者注</p></li>
<li><p>〔42〕 “a nice quiet place out here in the country”:
Ibid.</p></li>
<li><p>〔43〕 In the early 1950s, Fanny Rosenow: Jimmie C. Holland and
Sheldon Lewis, The Human Side of Cancer (New York: Harper Collins,
2001).</p></li>
<li><p>〔44〕 “Leukemia,” as one physician put it: J. V. Pickstone,
“Contested Cumulations: Configurations of Cancer Treatments through the
Twentieth Century,” Bulletin of the History of Medicine 81, no. 1
(2007): 164–96.</p></li>
<li><p>〔45〕 If leukemia “belonged” anywhere: Grant Taylor, Pioneers in
Pediatric Oncology (Houston: University of Texas M. D. Anderson Cancer
Center, 1990).</p></li>
<li><p>〔46〕 half a pound of chicken liver: George Washington Corner,
George Hoyt Whipple and His Friends: The Life-Story of a Nobel Prize
Pathologist (Philadelphia: Lippincott, 1963), 187.</p></li>
<li><p>〔47〕 regurgitated gastric juices: Taylor, Pioneers in Pediatric
Oncology, 29; George R. Minot, “Nobel Lecture: The Development of Liver
Therapy in Pernicious Anemia,” Nobel Lectures, Physiology or Medicine,
1922–1941 (Amsterdam: Elsevier Publishing Company, 1965).</p></li>
<li><p>〔48〕 spiced up with butter, lemon, and parsley: Francis Minot
Rackemann, The Inquisitive Physician: The Life and Times of George
Richards Minot (Cambridge: Harvard University Press, 1956),
151.</p></li>
<li><p>〔49〕 Minot and his team of researchers: George R. Minot and
William P. Murphy, “Treatment of Pernicious Anemia by a Special Diet,”
Journal of the American Medical Association, 87 (7): 470–76.</p></li>
<li><p>〔50〕 conclusively demonstrated in 1926: Minot, “Nobel
Lecture.”</p></li>
<li><p>〔51〕 In 1934, Minot and two of his colleagues: Ibid.</p></li>
<li><p>〔52〕 in the cloth mills of Bombay: Lucy Wills, “A Biographical
Sketch,” Journal of Nutrition 108 (1978), 1379–83.</p></li>
<li><p>〔53〕 In 1928, a young English physician named Lucy Willis: H.
Bastian, “Lucy Wills (1888–1964): The Life and Research of an
Adventurous Independent Woman,” Journal of the Royal College of
Physicians of Edinburgh 38:89–91.</p></li>
<li><p>〔54〕 Wills factor: Janet Watson and William B. Castle,
“Nutritional Macrocytic Anemia, Especially in Pregnancy: Response to a
Substance in Liver Other Than That Effective in Pernicious Anemia,”
American Journal of the Medical Sciences 211, no. 5 (1946): 513–30; Lucy
Wills, “Treatment of ‘Pernicious Anaemia’ of Pregnancy and ‘Tropical
Anaemia,’ with Special Reference to Yeast Extract as a Curative Agent,”
British Medical Journal 1, no. 3676 (1931): 1059–64.</p></li>
<li><p>〔55〕 He called this phenomenon acceleration: Sidney Farber et
al., “The Action of Pteroylglutamic Conjugates on Man,” Science 106, no.
2764 (1947): 619–21. Also see Mills et al., “Observations on Acute
Leukemia in Children Treated with 4-Aminopteroylglutamic Acid,”
Pediatrics 5, no. 1 (1950): 52–56.</p></li>
<li><p>〔56〕 In his long walks from his laboratory: Thomas Farber,
interview with author, November 2007.</p></li>
<li><p>〔57〕 20世纪早期，威廉·B.科利（William
B.Coley）、詹姆斯·尤因（James Ewing）和欧内斯特·考德曼（Ernest
Codman）曾经在纽约使用某种细菌毒素混合物（所谓的“科利毒素”）来治疗骨肉瘤。尽管科利注意到患者偶尔也会对此类毒素应答，但是由于上述方法（可能与免疫刺激有关）的疗效飘忽不定，因此从来没有引起肿瘤学家或外科医生的关注。——作者注</p></li>
<li><p>〔58〕 He had arrived in Boston in 1923: S. P. K. Gupta, “An
Indian Scientist in America: The Story of Dr. Yellapragada SubbaRow,”
Bulletin of the Indian Institute of History of Medicine (Hyderabad), 6,
no. 2 (1976): 128–43.</p></li>
<li><p>〔59〕 In the 1920s, another drug company: Corner, George Hoyt
Whipple, 188.</p></li>
<li><p>〔60〕 But in 1946, after many failed attempts: Gupta, “Indian
Scientist in America.”</p></li>
<li><p>〔61〕
西格（D.R.Seeger）与哈钦斯（B.Hutchings）是该团队的另两位关键成员。——作者注</p></li>
<li><h4 id="第三章-凤凰涅槃">第三章 凤凰涅槃</h4></li>
<li><p>〔1〕 Throughout the centuries: William Seaman Bainbridge, The
Cancer Problem (New York: Macmillan Company, 1914), 2.</p></li>
<li><p>〔2〕 The search for a way to eradicate this scourge: “Cancer
Ignored,” Washington Post,August 5, 1946.</p></li>
<li><p>〔3〕 Robert Sandler: Biographical details were taken from an
article in the Boston Herald, April 9, 1948, referred to in S. P. K.
Gupta, “An Indian Scientist in America: The Story of Dr. Yellapragada
SubbaRow,” Bulletin of the Indian Institute of History of Medicine
(Hyderabad), 6, no. 2 (1976): 128–43; and S. P. K. Gupta, interview with
author, February 2006. Sandler’s address in Dorchester and his father’s
profession are from the Boston directory for 1946, obtained from the
Boston Public Library. Sandler’s case (R.S.) is described in detail in
Sidney Farber’s paper below.</p></li>
<li><p>〔4〕 Farber’s treatment of Robert Sandler: Sidney Farber,
“Temporary Remissions in Acute Leukemia in Children Produced by Folic
Acid Antagonist, 4-Aminopteroyl-Glutamic Acid (Aminopterin),” New
England Journal of Medicine 238 (1948): 787–93.</p></li>
<li><p>〔5〕 The hospital staff voted: Robert Cooke, Dr. Folkman’s War:
Angiogenesis and the Struggle to Defeat Cancer (New York: Random House,
2001), 113.</p></li>
<li><p>〔6〕 “tucked in the farthest recesses”: Joseph E. Murray,
Surgery of the Soul: Reflections on a Curious Career (Sagamore Beach,
MA: Science History Publications, 2001), 127.</p></li>
<li><p>〔7〕 “let them die in peace”: Robert D. Mercer, “The Team,” in
“Chronicle,” Medical and Pediatric Oncology 33 (1999): 405–10.</p></li>
<li><p>〔8〕 “By that time, the only chemical”: Thomas Farber, interview
with author.</p></li>
<li><p>〔9〕 His small staff was housed: Taylor, Pioneers in Pediatric
Oncology, 88.</p></li>
<li><p>〔10〕 Farber’s assistants sharpened their own: Mercer, “The
Team.”</p></li>
<li><p>〔11〕 Two boys treated with aminopterin: Farber, “Temporary
Remissions in Acute Leukemia,” 787–93.</p></li>
<li><p>〔12〕 Another child, a two-and-a-half-year-old: Ibid.</p></li>
<li><p>〔13〕 By April 1948, there was just enough data: Ibid</p></li>
<li><p>〔14〕 “with skepticism, disbelief, and outrage”: Denis R.
Miller, “A Tribute to Sidney Farber—the Father of Modern Chemotherapy,”
British Journal of Haematology 134 (2006): 20–26.</p></li>
<li><p>〔15〕 “The bone marrow looked so normal”: Mercer, “The
Team.”</p></li>
<li><h4 id="第四章-神秘瘟疫">第四章 神秘瘟疫</h4></li>
<li><p>〔1〕 We reveal ourselves: Stephen Jay Gould, Full House: The
Spread of Excellence from Plato to Darwin (New York: Three Rivers Press,
1996), 7.</p></li>
<li><p>〔2〕 Thus, for 3,000 years and more: “Cancer: The Great
Darkness,” Fortune, May 1937.</p></li>
<li><p>〔3〕 Now it is cancer’s turn: Susan Sontag, Illness as Metaphor
and AIDS and Its Metaphors(New York: Picador, 1990), 5.</p></li>
<li><p>〔4〕 John Keats involuting silently: “John Keats,” Annals of
Medical History 2, no. 5 (1930): 530.</p></li>
<li><p>〔5〕 “Death and disease are often beautiful”: Sontag, Illness as
Metaphor, 20.</p></li>
<li><p>〔6〕 “in every possible sense, a nonconformist”: Sherwin Nuland,
How We Die: Reflections on Life’s Final Chapter (New York: Vintage
Books, 1995), 202.</p></li>
<li><p>〔7〕 Edwin Smith papyrus: James Henry Breasted, The Edwin Smith
Papyrus: Some Preliminary Observations (Paris: Librairie Ancienne Honoré
Champion, Edward Champion, 1922); also available online at
http://www.touregypt.net/edwinsmithsurgical.htm (accessed November 8,
2009).</p></li>
<li><p>〔8〕 Imhotep case forty-five: Breasted, Edwin Smith Papyrus.
Also see F. S. Boulos. “Oncology in Egyptian Papyri,” in Paleo-oncology:
The Antiquity of Cancer, 5th ed., ed. Spyros Retsas (London: Farrand
Press, 1986), 36; and Edward Lewison, Breast Cancer and Its Diagnosis
and Treatment (Baltimore: Williams and Walkins, 1955), 3.</p></li>
<li><p>〔9〕 A furious febrile plague: Siro I. Trevisanato, “Did an
Epidemic of Tularemia in Ancient Egypt Affect the Course of World
History?” Medical Hypotheses 63, no. 5 (2004): 905–10.</p></li>
<li><p>〔10〕 leaving its telltale pockmarks: Sergio Donadoni, ed., The
Egyptians (Chicago: University of Chicago Press, 1997), 292.</p></li>
<li><p>〔11〕 Tuberculosis rose and ebbed: Reddy D. V. Subba,
“Tuberculosis in Ancient India,” Bulletin of the Institute of Medicine
(Hyderabad) 2 (1972): 156–61.</p></li>
<li><p>〔12〕 In his sprawling Histories: Herodotus, The Histories
(Oxford: Oxford University Press, 1998), pt. VIII.</p></li>
<li><p>〔13〕 At the Chiribaya site: Arthur Aufderheide, The Scientific
Study of Mummies (Cambridge: Cambridge University Press, 2003), 117;
Arthur Aufderheide, inter-view with author, March 2009. Also see
Cambridge Encyclopedia of Paleopathology(Cambridge: Cambridge University
Press, 1998), 300</p></li>
<li><p>〔14〕 In 1914, a team: J. L. Miller, “Some Diseases of Ancient
Man,” Annals of Medical History 1 (1929): 394–402.</p></li>
<li><p>〔15〕 Louis Leakey, the archaeologist: Mel Greaves, Cancer: The
Evolutionary Legacy (Oxford: Oxford University Press, 2000).</p></li>
<li><p>〔16〕 “The early history of cancer”: Aufderheide, interview with
author, 2009.</p></li>
<li><p>〔17〕 A leprosy-like illness: Boris S. Ostrer, “Leprosy: Medical
Views of Leviticus Rabba,” Early Science and Medicine 7, no. 2 (2002):
138–54.</p></li>
<li><p>〔18〕 The risk of breast cancer: See, for instance, “Risk
Factors You Can’t Control,” Breastcancer.org,
www.breastcancer.org/risk/everyone/cant_control.jsp (accessed January 4,
2010). Also see Report No. 1743, International Cancer Research Act, 79th
Cong., 2nd Sess.; and “U.S. Science Wars against an Unknown Enemy:
Cancer,” Life,March 1, 1937.</p></li>
<li><p>〔19〕 “captain of the men of death”: William Osler and Thomas
McCrae, The Principles and Practice of Medicine: Designed for the Use of
Practitioners and Students of Medicine,9th ed. (New York: D. Appleton
and Company, 1921), 156.</p></li>
<li><p>〔20〕 Cancer still lagged: Report No. 1743, International Cancer
Research Act.</p></li>
<li><p>〔21〕 By the early 1940s, cancer: Life, March 1, 1937,
11.</p></li>
<li><p>〔22〕 life expectancy among Americans: Shrestha et al., “Life
Expectancy in the United States,” CRS Report for Congress, 2006. Also
see Lewison, Breast Cancer.</p></li>
<li><h4 id="第五章-体液学说">第五章 体液学说</h4></li>
<li><p>〔1〕 Black bile without boiling: Jeremiah Reedy, “Galen on
Cancer and Related Diseases,” Clio Medica 10, no. 3 (1975):
227.</p></li>
<li><p>〔2〕 We have learned nothing: Francis Carter Wood, “Surgery Is
Sole Cure for Bad Varieties of Cancer,” New York Times, April 19,
1914.</p></li>
<li><p>〔3〕 It’s bad bile: Mel Greaves, Cancer: The Evolutionary Legacy
(Oxford: Oxford University Press, 2000), 5.</p></li>
<li><p>〔4〕 In some ways disease: Charles E. Rosenberg, “Disease in
History: Frames and Framers,” Milbank Quarterly 67 (1989) (suppl. 1,
Framing Disease: The Creation and Negotiation of Explanatory Schemes):
1–2.</p></li>
<li><p>〔5〕 Later writers, both doctors and patients: See, for
instance, Henry E. Sigerist, “The Historical Development of the
Pathology and Therapy of Cancer,” Bulletin of the New York Academy of
Medicine 8, no. 11 (1932): 642–53; James A. Tobey, Cancer: What Everyone
Should Know about It (New York: Alfred A. Knopf, 1932).</p></li>
<li><p>〔6〕 “Of blacke cholor”: Claudius Galen, Methodus Medendi, with
a Brief Declaration of the Worthie Art of Medicine, the Office of a
Chirgion, and an Epitome of the Third Booke of Galen, of Naturall
Faculties, trans. T. Gale (London: Thomas East, 1586), 180–82.</p></li>
<li><p>〔7〕 “best left untreated”: Emile Littré’s translation of the
Hippocratic oath, Oeuvres complètes d’Hippocrate, bk. VI, aphorism 38.
Von Boenninghausen, Homeopathic Recorder, vol. 58, nos. 10, 11, 12
(1943). Also see http://classics.mit.edu/Hippocrates/aphorisms.6.vi.html
and
http://julianwinston.com/archives/periodicals/vb_aphorisms6.php.</p></li>
<li><p>〔8〕 “Do not be led away and offer”: George Parker, The Early
History of Surgery in Great Britain: Its Organization and Development
(London: Black, 1920), 44.</p></li>
<li><p>〔9〕 “Those who pretend”: Joseph-François Malgaigne, Surgery and
Ambroise Paré (Norman: University of Oklahoma Press, 1965), 73.</p></li>
<li><p>〔10〕 Ambroise Paré described charring tumors: See, for
instance, “The History of Hemostasis,” Annals of Medical History 1 (1):
137; Malgaigne, Surgery and Ambroise Paré, 73, 181.</p></li>
<li><p>〔11〕 “Many females can stand the operation”: See Lorenz
Heister, “Van de Kanker der boor-sten,” in H. T. Ulhoorn, ed.,
Heelkundige onderwijzingen (Amsterdam, 1718), 2: 845–856; also quoted in
James S. Olson, Bathsheba’s Breast: Women, Cancer, and History
(Baltimore: Johns Hopkins University Press, 2002), 50.</p></li>
<li><p>〔12〕 The apothecary: See, for instance, William Seaman
Bainbridge, The Cancer Problem (New York: Macmillan Company,
1914).</p></li>
<li><h4 id="第六章-走下神坛">第六章 走下神坛</h4></li>
<li><p>〔1〕 Rack’t carcasses: John Donne, “Love’s Exchange,” Poems of
John Donne, vol. 1, ed. E. K. Chambers (London: Lawrence ＆ Bullen,
1896), 35–36.</p></li>
<li><p>〔2〕 “Aside from the eight muscles”: Andreas Vesalius, The
Fabric of the Human Body 〔De Fabrica Humani Corporis〕, trans. W. P.
Hotchkiss, preface. See Sourcebook of Medical History (Mineola, NY:
Dover, 1960), 134; and The Illustrations from the Works of Andreas
Vesalius of Brussels (Mineola, NY: Dover, 1950), 11–13.</p></li>
<li><p>〔3〕 He needed his own specimens: Charles Donald O’Malley,
Andreas Vesalius of Brussels, 1514–1564 (Berkeley: University of
California Press, 1964).</p></li>
<li><p>〔4〕 “In the course of explaining the opinion”: “Andreas
Vesalius of Brussels Sends Greetings to His Master and Patron, the Most
Eminent and Illustrious Doctor Narcissus Parthenopeus, First Physician
to His Imperial Majesty,” The Illustrations from the Works of Andreas
Vesalius of Brussels, with annotations and translations by J. B. de C.
M. Saunders and Charles D. O’Malley (Cleveland, OH: World Publishing
Company, 1950), 233.</p></li>
<li><p>〔5〕 “as large as an orange”: Matthew Baillie, The Morbid
Anatomy of Some of the Most Important Parts of the Human Body, 2nd
American ed. (Walpole, NH: 1808), 54.</p></li>
<li><p>〔6〕 “a fungous appearance”: Ibid., 93.</p></li>
<li><p>〔7〕 “a foul deep ulcer”: Ibid., 209.</p></li>
<li><h4 id="第七章-遥表同情">第七章 “遥表同情”</h4></li>
<li><p>〔1〕 In treating of cancer: Samuel Cooper, A Dictionary of
Practical Surgery vol. 1 (New York: Harper ＆ Brothers, 1836),
49.</p></li>
<li><p>〔2〕 “If a tumor is not only movable”: John Hunter, Lectures on
the Principles of Surgery (Philadelphia: Haswell, Barrington, and
Haswell, 1839).</p></li>
<li><p>〔3〕
亨特使用这个短语来突出转移性肿瘤的特征（远处播散），他认为手术治疗此类肿瘤根本无效。——作者注</p></li>
<li><p>〔4〕 容积单位，在美国，1液量夸脱约等于0.946升。——译者注</p></li>
<li><p>〔5〕 “I did not experience pain”: See a history of ether at
http://www.anesthesia-nursing.com/ether.html (accessed January 5,
2010).</p></li>
<li><p>〔6〕 “It must be some subtle principle”: M. Percy, “On the
Dangers of Dissection,” New Journal of Medicine and Surgery, and
Collateral Branches of Science 8, no. 2 (1819): 192–96.</p></li>
<li><p>〔7〕 It “occurred to me”: Joseph Lister, “On the Antiseptic
Principle in the Practice of Surgery,” British Medical Journal 2, no.
351 (1867): 246.</p></li>
<li><p>〔8〕 In August 1867, a thirteen-year-old: Ibid., 247.</p></li>
<li><p>〔9〕 In 1869, Lister removed a breast tumor: James S. Olson,
Bathsheba’s Breast (Baltimore: Johns Hopkins University Press, 2002),
67.</p></li>
<li><p>〔10〕 Lister performed an extensive amputation: Edward Lewison,
Breast Cancer and Its Diagnosis and Treatment (Baltimore: Williams and
Walkins, 1955), 17.</p></li>
<li><p>〔11〕 “The course so far is already”: Harold Ellis, A History of
Surgery (Cambridge: Cambridge University Press, 2001), 104.</p></li>
<li><p>〔12〕 Billroth’s gastrectomy: See Theodor Billroth, Offenes
schreiben an Herrn Dr. L. Wittelshöfer, Wien Med Wschr (1881), 31:
161–65; also see Owen Wangensteen and Sarah Wangensteen, The Rise of
Surgery (Minneapolis: University of Minnesota Press, 1978),
149.</p></li>
<li><p>〔13〕 Surgeons returned to the operating table: Owen Pritchard,
“Notes and Remarks on Upwards of Forty Operations for Cancer with
Escharotics,” Lancet 136, no. 3504 (1890): 864.</p></li>
<li><h4 id="第八章-根治主义">第八章 根治主义</h4></li>
<li><p>〔1〕 The professor who blesses the occasion: Mary Lou McCarthy
McDonough, Poet Physicians: An Anthology of Medical Poetry Written by
Physicians (Springfield, IL: Charles C. Thomas, 1945).</p></li>
<li><p>〔2〕 It is over: John Brown, Rab and His Friends (Edinburgh:
David Douglas, 1885), 20.</p></li>
<li><p>〔3〕 William Stewart Halsted: W. G. MacCallum, William Stewart
Halsted, Surgeon(Kessinger Publishing, 2008), 106. Also see Michael
Osborne, “William Stewart Halsted: His Life and Contributions to
Surgery”; and S. J. Crowe, Halsted of Johns Hopkins: The Man and His Men
(Springfield, IL: Charles C. Thomas).</p></li>
<li><p>〔4〕 “I opened a large orifice”: W. H. Witt, “The Progress of
Internal Medicine since 1830,” in The Centennial History of the
Tennessee State Medical Association, 1830–1930, ed. Philip M. Hammer
(Nashville: Tennessee State Medical Association, 1930), 265.</p></li>
<li><p>〔5〕 “Small bleedings give temporary relief”: Walter Hayle
Walshe, A Practical Treatise on the Diseases of the Lungs including the
Principles of Physical Diagnosis, 3rd ed. (Philadelphia: Blanchard and
Lea, 1860), 416.</p></li>
<li><p>〔6〕 “pus-pails”: Lois N. Magner, A History of Medicine (New
York: Marcel Dekker, 1992), 296.</p></li>
<li><p>〔7〕 In October 1877, leaving behind: MacCallum, William Stewart
Halsted. Also see D. W. Cathell, The Physician Himself (1905),
2.</p></li>
<li><p>〔8〕 merely an “audacious step” away: Karel B. Absolon, The
Surgeon’s Surgeon: Theodor Billroth: 1829–1894, (Kansas: Coronado Press,
1979).</p></li>
<li><p>〔9〕 In 1882, he removed an infected gallbladder: John L.
Cameron, “William Stewart Halsted: Our Surgical Heritage,” Annals of
Surgery 225, no. 5 (1996): 445–58.</p></li>
<li><p>〔10〕 “clearer and clearer, with no sense of fatigue”: Donald
Fleming, William H. Welch and the Rise of Modern Medicine (Baltimore:
Johns Hopkins University Press, 1987).</p></li>
<li><p>〔11〕 “cold as stone and most unlivable”: Harvey Cushing, letter
to his mother, 1898, Harvey Cushing papers at Yale University.</p></li>
<li><p>〔12〕 “Mammary cancer requires”: Charles H. Moore, “On the
Influence of Inadequate Operations on the Theory of Cancer,”
Medico-Chirurgical Transactions 50, no. 245 (1867): 277.</p></li>
<li><p>〔13〕 “mistaken kindness”: Edward Lewison. Breast Cancer and Its
Diagnosis and Treatment (Baltimore: Williams and Walkins, 1955),
16.</p></li>
<li><p>〔14〕 “We clean out or strip”: William S. Halsted, “A Clinical
and Histological Study of Certain Adenocarcinomata of the Breast: And a
Brief Consideration of the Supraclavicular Operation and of the Results
of Operations for Cancer of the Breast from 1889 to 1898 at the Johns
Hopkins Hospital,” Annals of Surgery 28: 557–76.</p></li>
<li><p>〔15〕 At Hopkins, Halsted’s diligent students: W. M. Barclay,
“Progress of the Medical Sciences: Surgery,” Bristol Medical-Chirurgical
Journal 17, no. 1 (1899): 334–36.</p></li>
<li><p>〔16〕 “It is likely”: Halsted, “Clinical and Histological
Study.”</p></li>
<li><p>〔17〕 In Europe, one surgeon evacuated three ribs: See
Westerman, “Thoraxexcisie bij reci-dief can carcinoma mammae,” Ned
Tijdschr Geneeskd (1910): 1686.</p></li>
<li><p>〔18〕 “surgical elephantiasis,” “Good use of arm,” “Married,
Four Children”: from William Stewart Halsted, Surgical Papers
(Baltimore: Johns Hopkins, 1924), 2:17, 22, 24.</p></li>
<li><p>〔19〕 “performance of an artist”: Matas, “William Stewart
Halsted, an appreciation,” Bulletin of the Johns Hopkins Hospital 36,
no. 2 (1925).</p></li>
<li><p>〔20〕 “I find myself inclined”: Halsted, “Clinical and
Histological Study of Certain Adenocarcinomata of the Breast,” Annals of
Surgery 28: 560.</p></li>
<li><p>〔21〕 “cancer storehouse”: Ibid., 557.</p></li>
<li><p>〔22〕 On April 19, 1898: Ibid., 557–76.</p></li>
<li><p>〔23〕 A surgeon should “operate on the neck”: Ibid.,
572.</p></li>
<li><p>〔24〕 Halsted’s 1907 report to the American Surgical
Association: William Stewart Halsted, “The Results of Radical Operations
for the Cure of Carcinoma of the Breast,” Annals of Surgery 46, no. 1
(1907): 1–19.</p></li>
<li><p>〔25〕 “If the disease was so advanced”: “A Vote for Partial
Mastectomy: Radical Surgery Is Not the Best Treatment for Breast Cancer,
He Says,” Chicago Tribune, October 2, 1973.</p></li>
<li><p>〔26〕 “But even without the proof”: Halsted, “Results of Radical
Operations,” 7. Also see Halsted, “The Results of Radical Operations for
the Cure of Cancer of the Breast,” Transactions of the American Surgical
Association 25: 66.</p></li>
<li><p>〔27〕 “It is especially true of mammary cancer”: Ibid.,
61.</p></li>
<li><p>〔28〕 “With no protest from any other quarter”: Ellen Leopold, A
Darker Ribbon: Breast Cancer, Women, and Their Doctors in the Twentieth
Century (Boston: Beacon Press, 1999), 88.</p></li>
<li><p>〔29〕 “Undoubtedly, if operated upon properly”: Transactions of
the American Surgical Association 49.</p></li>
<li><p>〔30〕 “the more radical the better”: “Breast Cancer, New
Choices,” Washington Post,December 22, 1974.</p></li>
<li><p>〔31〕 Alexander Brunschwig devised an operation: Alexander
Brunschwig and Virginia K. Pierce, “Partial and Complete Pelvic
Exenteration: A Progress Report Based upon the First 100 Operations,”
Cancer 3 (1950): 927–74; Alexander Brunschwig, “Complete Excision of
Pelvic Viscera for Advanced Carcinoma: A One-Stage Abdominop Operation
with End Colostomy and Bilateral Ureteral Implantation into the Colon
above the Colostomy,” Cancer 1 (1948): 177–83.</p></li>
<li><p>〔32〕 Pack the Knife: From George T. Pack’s papers, quoted in
Barron Lerner, The Breast Cancer Wars: Hope, Fear, and the Pursuit of a
Cure in Twentieth-Century America (Oxford: Oxford University Press,
2003), 73.</p></li>
<li><p>〔33〕 “Even in its widest sense”: Stanford Cade, Radium
Treatment of Cancer (New York: William Wood, 1929), 1.</p></li>
<li><p>〔34〕 “There is an old Arabian proverb”: Urban Maes, “The
Tragedy of Gastric Carcinoma: A Study of 200 Surgical Cases,” Annals of
Surgery 98, no. 4 (1933): 629.</p></li>
<li><p>〔35〕
希波克拉底誓言：我愿以自身判断力所及，遵守这一誓约。凡教给我医术的人，我应像尊敬自己的父母一样，尊敬他……我愿在我的判断力所及的范围内，尽我的能力，遵守为病人谋利益的道德原则，并杜绝一切堕落及害人的行为……为他们谋幸福是我唯一的目的……我遵守以上誓言，目的在于让医药神阿波罗、阿斯克勒庇俄斯及天地诸神赐给我生命与医术上的无上光荣；一旦我违背了自己的誓言，请求天地诸神给我最严厉的惩罚！——译者注</p></li>
<li><p>〔36〕 “I know you didn’t know anything”: Hugh H. Young, Hugh
Young: A Surgeon’s Autobiography (New York: Harcourt, Brace and Company,
1940), 76.</p></li>
<li><p>〔37〕 In 1904, with Halsted as his assistant: Bertram M.
Bernheim, The Story of the Johns Hopkins (Surrey: World’s Work, 1949);
A. McGehee Harvey et al., A Model of Its Kind, vol. 1, A Centennial
History of Medicine at Johns Hopkins University (Baltimore: Johns
Hopkins University Press, 1989); Leonard Murphy, The History of Urology
(Springfield, IL: Charles C. Thomas, 1972), 132.</p></li>
<li><p>〔38〕 “the slow separation of brain from tumor”: Harvey Cushing,
“Original Memoirs: The Control of Bleeding in Operations for Brain
Tumors. With the Description of Silver ‘Clips’ for the Occlusion of
Vessels Inaccessible to the Ligature,” Annals of Surgery 49, no. 1
(1911): 14–15.</p></li>
<li><p>〔39〕 In 1933, at the Barnes hospital: Evarts G. Graham, “The
First Total Pneumonectomy,” Texas Cancer Bulletin 2 (1949):
2–4.</p></li>
<li><p>〔40〕 A surgical procedure: Alton Ochsner and M. DeBakey,
“Primary Pulmonary Malignancy: Treatment by Total Pneumonectomy—Analysis
of 79 Collected Cases and Presentation of 7 Personal Cases,” Surgery,
Gynecology, and Obstetrics 68 (1939): 435–51.</p></li>
<li><h4 id="第九章-隐形射线">第九章 隐形射线</h4></li>
<li><p>〔1〕 We have found in 〔X-rays〕: “X-ray in Cancer Cure,” Los
Angeles Times, April 6, 1902.</p></li>
<li><p>〔2〕 By way of illustration: “Last Judgment,” Washington Post,
August 26, 1945.</p></li>
<li><p>〔3〕 Röntgen’s discovery of X-rays: Wilhelm C. Röntgen, “On a
New Kind of Rays,” Nature 53, no. 1369 (1896): 274–76; John Maddox, “The
Sensational Discovery of X-rays,” Nature 375 (1995): 183.</p></li>
<li><p>〔4〕 One man who gave “magical” demonstrations: Robert William
Reid, Marie Curie (New York: Collins, 1974), 122.</p></li>
<li><p>〔5〕 In 1896, barely a year after Röntgen: Emil H. Grubbe,
“Priority in Therapeutic Use of X-rays,” Radiology 21 (1933): 156–62;
Emil H. Grubbe, X-ray Treatment: Its Origin, Birth and Early History
(St. Paul: Bruce Publishing, 1949).</p></li>
<li><p>〔6〕
尽管X射线偶尔也可以用于治疗肿瘤转移灶，但是这种方法所起到的作用非常有限。——作者注</p></li>
<li><p>〔7〕 “I believe this treatment is an absolute cure”: “X-rays
Used as a Remedy for Cancer,” New York Times, November 2, 1901.</p></li>
<li><p>〔8〕 advertised for sale to laypeople: “Mining: Surplus of
Radium,” Time, May 24, 1943.</p></li>
<li><p>〔9〕 “millions of tiny bullets of energy”: Oscar Carl Simonton,
Stephanie Simonton, and James Creighton, Getting Well Again: A
Step-by-Step, Self-Help Guide to Overcoming Cancer for Patients and
Their Families (Los Angeles: J. P. Tarcher, 1978), 7.</p></li>
<li><p>〔10〕 “The patient is put on a stretcher”: “Medicine: Advancing
Radiotherapy,” Time, October 6, 1961.</p></li>
<li><p>〔11〕 One woman with a brain tumor: “Atomic Medicine: The Great
Search for Cures on the New Frontier,” Time, April 7, 1952.</p></li>
<li><p>〔12〕
在某些情况下，放疗可用于控制或缓解已转移的肿瘤，但是极少能治愈。——作者注</p></li>
<li><p>〔13〕 Undark and the “Radium girls”: Claudia Clark, Radium
Girls: Women and Industrial Health Reform, 1910–1935 (Chapel Hill:
University of North Carolina Press, 1997); Ross Mullner, Deadly Glow:
The Radium Dial Worker Tragedy (Washington, DC: American Public Health
Association, 1999).</p></li>
<li><p>〔14〕 Marie Curie died of leukemia: Curie’s disease was
diagnosed as “aplastic anemia” of rapid, feverish development, but is
widely considered to have been a variant of myelodysplasia, a
preleukemic syndrome that resembles aplastic anemia and pro-gresses to a
fatal leukemia.</p></li>
<li><p>〔15〕 Grubbe’s fingers had been amputated: Otha Linton,
“Radiation Dangers,” Academic Radiology 13, no. 3 (2006): 404.</p></li>
<li><p>〔16〕 Willy Meyer’s posthumous address: Willy Meyer, “Inoperable
and Malignant Tumors,” Annals of Surgery 96, no. 5 (1932):
891–92.</p></li>
<li><p>〔1〕 原文为“Dyeing and
Dying”，有双关语的作用。“Dyeing”和“dying”两个词发音一致，拼写也极其相似，寓意二者之间的内在联系。——译者注</p></li>
<li><p>〔2〕 Those who have not been trained in chemistry: Michael B.
Shimkin, “As Memory Serves—an Informal History of the National Cancer
Institute, 1937–57,” Journal of the National Cancer Institute 59 (suppl.
2) (1977): 559–600.</p></li>
<li><p>〔3〕 Life is … a chemical incident: Martha Marquardt, Paul
Ehrlich (New York: Schuman, 1951), 11. Also see Frederick H. Kasten,
“Paul Ehrlich: Pathfinder in Cell Biology,” Biotechnic ＆ Histochemistry
71, no. 1 (1996).</p></li>
<li><p>〔4〕 Between 1851 and 1857: Phyllis Deane and William Alan Cole,
British Economic Growth, 1688–1959: Trends and Structure (Cambridge:
Cambridge University Press, 1969), 210.</p></li>
<li><p>〔5〕 By the 1850s, that proportion had peaked: Stanley D.
Chapman, The Cotton Industry: Its Growth and Impact, 1600–1935 (Bristol:
Thoemmes, 1999), v–xviii.</p></li>
<li><p>〔6〕 Cloth dyes had to be extracted: A. S. Travis, The Rainbow
Makers: The Origins of the Synthetic Dyestuffs Industry in Western
Europe (Bethlehem, PA: Lehigh University Press, 1993), 13.</p></li>
<li><p>〔7〕 ever-popular calico prints: Ibid.</p></li>
<li><p>〔8〕 “half of a small but long-shaped room”: William Cliffe,
“The Dyemaking Works of Perkin and Sons, Some Hitherto Unrecorded
Details,” Journal of the Society of Dyers and Colorists 73 (1957):
313–14.</p></li>
<li><p>〔9〕 In 1883, the German output of alizarin: Travis, Rainbow
Makers, 195.</p></li>
<li><p>〔10〕 “most impudent, ignorant, flatulent, fleshy”: H. A.
Colwell, “Gideon Harvey: Sidelights on Medical Life from the Restoration
to the End of the XVII Century,” Annals of Medical History 3, no. 3
(1921): 205–37.</p></li>
<li><p>〔11〕 “None of these compounds have, as yet”: “Researches
Conducted in the Laboratories of the Royal College of Chemistry,”
Reports of the Royal College of Chemistry and Researches Conducted in
the Laboratories in the Years 1845–6–7 (London: Royal College of
Chemistry, 1849), liv; Travis, Rainbow Makers, 35.</p></li>
<li><p>〔12〕 In 1828, a Berlin scientist named Friedrich Wöhler:
Friedrich Wöhler, “Ueber künst-liche Bildung des Harnstoffs,” Annalen
der Physik und Chemie 87, no. 2 (1828): 253–56.</p></li>
<li><p>〔13〕 In 1878, in Leipzig, a twenty-four-year-old: Paul Ehrlich,
“Über das Methylenblau und Seine Klinisch-Bakterioskopische
Verwerthung,” Zeitschrift für Klinische Medizin 2 (1882):
710–13.</p></li>
<li><p>〔14〕 In 1882, working with Robert Koch: Paul Ehrlich, “Über die
Färbung der Tuberkelbazillen,” Deutsche Medizinische Wochenschrift 8
(1882): 269.</p></li>
<li><p>〔15〕 “It has occurred to me”: Marquardt, Paul Ehrlich,
91.</p></li>
<li><p>〔16〕 His laboratory was now physically situated: Travis,
Rainbow Makers, 97.</p></li>
<li><p>〔17〕 On April 19, 1910, at the densely packed: See Felix Bosch
and Laia Rosich, “The Contributions of Paul Ehrlich to Pharmacology,”
Pharmacology (2008): 82, 171–79.</p></li>
<li><p>〔18〕 “syphilis—the “secret malady”: Linda E. Merians, ed., The
Secret Malady: Venereal Disease in Eighteenth-Century Britain and France
(Lexington: The University Press of Kentucky, 1996). Also see Ehrlich,
“A Lecture on Chemotherapeutics,” Lancet, ii, 445.</p></li>
<li><p>〔19〕 Ehrlich and Kaiser Wilhelm: M. Lawrence Podolsky, Cures
out of Chaos: How Unexpected Discoveries Led to Breakthroughs in
Medicine and Health (Amsterdam: Overseas Publishers Association, 1997),
273.</p></li>
<li><p>〔20〕 “thick, yellowish green cloud”: Richard Lodoïs Thoumin,
The First World War (New York: Putnam, 1963), 175.</p></li>
<li><p>〔21〕 In 1919, a pair of American pathologists: E. B. Krumbhaar
and Helen D. Krumbhaar, “The Blood and Bone Marrow in Yellow Cross Gas
(Mustard Gas) Poisoning: Changes Produced in the Bone Marrow of Fatal
Cases,” Journal of Medical Research 40, no. 3 (1919): 497–508.</p></li>
<li><h4 id="第十一章-巴里事件">第十一章 巴里事件</h4></li>
<li><p>〔1〕 “What if this mixture do not work at all?: William
Shakespeare, Romeo and Juliet, act 4, scene 3 (Philadelphia: J. B.
Lippincott, 1913), 229.</p></li>
<li><p>〔2〕 We shall so poison the atmosphere: Robert Nisbet,
“Knowledge Dethroned: Only a Few Years Ago, Scientists, Scholars and
Intellectuals Had Suddenly Become the New Aristocracy. What Happened?”
New York Times, September 28, 1975.</p></li>
<li><p>〔3〕 Every drug, the sixteenth-century: W. Pagel, Paracelsus: An
Introduction to Philosophical Medicine in the Era of the Renaissance,
2nd ed. (New York: Karger, 1982), 129–30.</p></li>
<li><p>〔4〕 On December 2, 1943: D. M. Saunders, “The Bari Incident,”
United States Naval Institute Proceedings (Annapolis: United States
Naval Institute, 1967).</p></li>
<li><p>〔5〕 Of the 617 men rescued: Guy B. Faguet, The War on Cancer:
An Anatomy of Failure, A Blueprint for the Future (New York: Springer,
2005), 71.</p></li>
<li><p>〔6〕 Goodman and Gilman weren’t interested: Alfred Gilman,
“Therapeutic Applications of Chemical Warfare Agents,” Federation
Proceedings 5 (1946): 285–92; Alfred Gilman and Frederick S. Philips,
“The Biological Actions and Therapeutic Applications of the
B-Chloroethyl Amines and Sulfides,” Science 103, no. 2675 (1946):
409–15; Louis Goodman et al., “Nitrogen Mustard Therapy: Use of
Methyl-Bis(Beta-Chlorethyl)amine Hydrochloride and
Tris(Beta-Chloroethyl)amine Hydrochloride for Hodgkin’s Disease,
Lymphosarcoma, Leukemia and Certain Allied and Miscellaneous Disorders,”
Journal of the American Medical Association132, no. 3 (1946):
126–32.</p></li>
<li><p>〔7〕 George Hitchings had also: Grant Taylor, Pioneers in
Pediatric Oncology (Houston: University of Texas M. D. Anderson Cancer
Center, 1990), 137. Also see Tonse N. K. Raju, “The Nobel Chronicles,”
Lancet 355, no. 9208 (1999): 1022; Len Goodwin, “George Hitchings and
Gertrude Elion—Nobel Prizewinners,” Parasitology Today 5, no. 2 (1989):
33.</p></li>
<li><p>〔8〕 “Scientists in academia stood disdainfully”: John Laszlo,
The Cure of Childhood Leukemia (New Brunswick, NJ: Rutgers University
Press, 1995), 65.</p></li>
<li><p>〔9〕 Instead of sifting through mounds: Gertrude B. Elion,
“Nobel Lecture in Physiology or Medicine—1988. The Purine Path to
Chemotherapy,” In Vitro Cellular and Developmental Biology 25, no. 4
(1989): 321–30; Gertrude B. Elion, George H. Hitchings, and Henry
Vanderwerff, “Antagonists of Nucleic Acid Derivatives: VI. Purines,”
Journal of Biological Chemistry 192 (1951): 505. Also see Tom Brokaw,
The Greatest Generation (1998; reprint, 2004), 304.</p></li>
<li><p>〔10〕 In the early 1950s, two physician-scientists: Joseph
Burchenal, Mary L. Murphy, et al., “Clinical Evaluation of a New
Antimetabolite, 6-Mercaptopurine, in the Treatment of Leukemia and
Allied Diseases,” Blood 8 no. 11 (1953): 965–99.</p></li>
<li><h4 id="第十二章-慈行善举">第十二章 慈行善举</h4></li>
<li><p>〔1〕 The name “Jimmy” is a household word in New England: George
E. Foley, The Children’s Cancer Research Foundation: The House That
“Jimmy” Built: The First Quarter-Century (Boston: Sidney Farber Cancer
Institute, 1982).</p></li>
<li><p>〔2〕 I’ve made a long voyage: Maxwell E. Perkins, “The Last
Letter of Thomas Wolfe and the Reply to It,” Harvard Library Bulletin,
Autumn 1947, 278.</p></li>
<li><p>〔3〕 artificial respirator known as the iron lung: Philip
Drinker and Charles F. McKhann III, “The Use of a New Apparatus for the
Prolonged Administration of Artificial Respiration: I. A Fatal Case of
Poliomyelitis,” Journal of the American Medical Association 92:
1658–60.</p></li>
<li><p>〔4〕 Polio research was shaken out of its torpor: For a
discussion of the early history of polio, see Naomi Rogers, Dirt and
Disease: Polio before FDR (Rutgers: Rutgers University Press, 1992).
Also see Tony Gould, A Summer Plague: Polio and Its Survivors (New
Haven: Yale University Press, 1995).</p></li>
<li><p>〔5〕 Within a few weeks, 2,680,000 dimes: Kathryn Black, In the
Shadow of Polio: A Personal and Social History (New York: Perseus Books,
307), 25; Paul A. Offit, The Cutter Incident: How America’s First Polio
Vaccine Led to the Growing Vaccine Crisis (New Haven: Yale University
Press, 2005); History of the National Foundation for Infantile Paralysis
Records; Volume II: Raising Funds to Fight Infantile Paralysis, Book 2
(March of Dimes Archives, 1957), 256–60.</p></li>
<li><p>〔6〕 Please take care of my baby. Her name is Catherine:
Variety, the Children’s Charity, “Our History,”
http://www.usvariety.org/about_history.html (accessed November 11,
2009).</p></li>
<li><p>〔7〕 “Well, I need a new microscope”: Robert Cooke,
Dr. Folkman’s War: Angiogenesis and the Struggle to Defeat Cancer (New
York: Random House, 2001), 115.</p></li>
<li><p>〔8〕 money and netted 5,456: Foley, Children’s Cancer Research
Foundation (Boston: Sidney Farber Cancer Institute, 1982).</p></li>
<li><p>〔9〕 Gustafson was quiet: Phyllis Clauson, interview with
author, July 2009; Karen Cummins, interview with author, July 2009. Also
see Foley, Children’s Cancer Research Foundation.</p></li>
<li><p>〔10〕 On May 22, 1948, on a warm Saturday night in the
Northeast: The original broadcast recording can be accessed on the Jimmy
Fund website at http://www.jimmyfund.org/abo/broad/jimmybroadcast.asp.
Also see Saul Wisnia, Images of America: The Jimmy Fund of the
Dana-Farber Cancer Institute (Charleston, SC: Arcadia, 2002),
18–19.</p></li>
<li><p>〔11〕 Jimmy’s mailbox was inundated: Foley, Children’s Cancer
Research Foundation.</p></li>
<li><p>〔12〕 the Manhattan Project spent: See “The Manhattan Project,
An Interactive History,” U.S. Department of Energy, Office of History,
2008.</p></li>
<li><p>〔13〕 In 1948, Americans spent more than 26 million: Mark
Pendergrast, For God, Country and Coca-Cola: The Definitive History of
the Great American Soft Drink and the Company That Makes It (New York:
Basic Books, 2000), 212.</p></li>
<li><h4 id="第十三章-吉米之屋">第十三章 吉米之屋</h4></li>
<li><p>〔1〕 Etymologically, patient means sufferer: Susan Sontag,
Illness as Metaphor and AIDS and Its Metaphors (New York: Picador,
1990), 125.</p></li>
<li><p>〔2〕 Sidney Farber’s entire purpose: Medical World News,
November 25, 1966.</p></li>
<li><p>〔3〕 “One assistant and ten thousand mice”: George E. Foley, The
Children’s Cancer Research Foundation: The House That “Jimmy” Built: The
First Quarter-Century (Boston: Sidney Farber Cancer Institute,
1982).</p></li>
<li><p>〔4〕 “Most of the doctors”: Name withheld, a hospital volunteer
in the 1950s to 1960s, interview with author, May 2001.</p></li>
<li><p>〔5〕 In 1953, when the Braves franchise left: “Braves Move to
Milwaukee; Majors’ First Shift since ’03,” New York Times, March 19,
1953.</p></li>
<li><p>〔6〕 the Jimmy Fund planned a “Welcome Home, Ted” party: “Dinner
Honors Williams: Cancer Fund Receives 50,000 from 00-Plate Affair,” New
York Times, August 18, 1953.</p></li>
<li><p>〔7〕 Funds poured in from: Foley, Children’s Cancer Research
Foundation.</p></li>
<li><p>〔8〕 “You can take the child out of the Depression”: Robin
Pogrebin and Timothy L. O’Brien, “A Museum of One’s Own,” New York
Times, December 5, 2004.</p></li>
<li><p>〔9〕 “If a little girl got attached to a doll”: “Medicine: On
the Track,” Time, January 21, 1952.</p></li>
<li><p>〔10〕 “Once I discover that almost all”: Jeremiah Goldstein,
“Preface to My Mother’s Diary,” Journal of Pediatric Hematology/Oncology
30, no. 7 (2008): 481–504.</p></li>
<li><p>〔11〕 “Acute leukemia,” he wrote: Sidney Farber, “Malignant
Tumors of Childhood,” CA: A Cancer Journal for Clinicians (1953): 3,
106–7.</p></li>
<li><p>〔12〕 The money that he had raised: Sidney Farber letter to Mary
Lasker, August 19, 1955.</p></li>
<li><p>〔1〕 Perhaps there is only one cardinal sin: Franz Kafka, The
Great Wall of China and Other Pieces (London: Secker and Warburg, 1946),
142.</p></li>
<li><p>〔2〕 The 325,000 patients with cancer: Sidney Farber, quoted in
Guy B. Faguet, The War on Cancer: An Anatomy of Failure, a Blueprint for
the Future (New York: Springer, 2005), 97.</p></li>
<li><h4 id="第十四章-癌症协会">第十四章 癌症协会</h4></li>
<li><p>〔1〕 All of this demonstrates why: Michael B. Shimkin, “As
Memory Serves—an Informal History of the National Cancer Institute,
1937–57,” Journal of the National Cancer Institute 59 (suppl. 2) (1977):
559–600.</p></li>
<li><p>〔2〕 I am aware of some alarm: Senator Lister Hill, “A Strong
Independent Cancer Agency,” October 5, 1971, Mary Lasker
Papers.</p></li>
<li><p>〔3〕 “Americans of all ages”: Alexis de Tocqueville, Democracy
in America (New York, Penguin), 296.</p></li>
<li><p>〔4〕 a woman who “could sell”: Mary Lasker Oral History Project,
Part 1, Session 1, p.3,
http://www.columbia.edu/cu/lweb/digital/collections/nny/laskerm/transcripts/laskerm_1_1_3.html.</p></li>
<li><p>〔5〕 In 1939, Mary Woodard met Albert Lasker: Ibid.,
p. 56.</p></li>
<li><p>〔6〕 “salesmanship in print”: Stephen R. Fox, The Mirror Makers:
A History of American Advertising and Its Creators (New York: William
Morrow, 1984), 51.</p></li>
<li><p>〔7〕 they were married just fifteen months after: Mary Lasker
Oral History Project, Part 1, Session 3, p. 80.</p></li>
<li><p>〔8〕 “I am opposed to heart attacks and cancer”: J. Michael
Bishop, “Mary Lasker and Her Prizes: An Appreciation,” Journal of the
American Medical Association 294, no. 11 (2005): 1418–19.</p></li>
<li><p>〔9〕 “If a toothpaste”: Mary Lasker Oral History Project, Part
1, Session 7.</p></li>
<li><p>〔10〕 “the fairy godmother of medical research”: “The Fairy
Godmother of Medical Research,” BusinessWeek, July 14, 1986.</p></li>
<li><p>〔11〕 In April 1943, Mary Lasker visited: Mary Lasker Oral
History Project, Part 1, Session 5, p. 136, and Session 16,
pp. 477–79.</p></li>
<li><p>〔12〕 The visit left her cold: Ibid., Session 16,
pp. 477–79.</p></li>
<li><p>〔13〕 Of its small annual budget of: Ibid. Also see Mary Lasker
interview, October 23, 1984, in Walter Ross, Crusade, the Official
History of the American Cancer Society (Westminster, MD: Arbor House,
1987), 33.</p></li>
<li><p>〔14〕 “Doctors,” she wrote, “are not administrators”: Mary
Lasker Oral History Project, Part 1, Session 7, p. 183.</p></li>
<li><p>〔15〕 In October 1943, Lasker persuaded a friend: Reader’s
Digest, October 1945.</p></li>
<li><p>〔16〕 “My mother died from cancer”: Letter from a soldier to
Mary Lasker, 1949.</p></li>
<li><p>〔17〕 Over the next months: Richard A. Rettig, Cancer Crusade:
The Story of the National Cancer Act of 1971 (Lincoln, NE: Author’s
Choice Press, 1977), 21.</p></li>
<li><p>〔18〕 “A two-pronged attack”: Letter from Cornelius A. Wood to
Mary Lasker, January 6, 1949, Mary Lasker Papers, Box 210.</p></li>
<li><p>〔19〕 Albert Lasker … recruited Emerson Foote: Ibid.</p></li>
<li><p>〔20〕 The “Lay Group”: Letter from Mary Lasker to Jim Adams, May
13, 1945, Mary Lasker Papers.</p></li>
<li><p>〔21〕 In a single year, it printed 9 million: these numbers are
culled from letters and receipts found in the Mary Lasker
Papers.</p></li>
<li><p>〔22〕 “Ladies’ Garden Club”: Charles Cameron, Cancer Control,
vol. 3, 1972.</p></li>
<li><p>〔23〕 “unjustified, troublesome and aggressive”: James T.
Patterson, The Dread Disease: Cancer and Modern American Culture
(Cambridge, MA: Harvard University Press, 1987), 173. Also see Rettig,
Cancer Crusade, 22.</p></li>
<li><p>〔24〕 The society’s bylaws and constitution were rewritten:
Letter from Frank Adair to ACS members, October 23, 1945.</p></li>
<li><p>〔25〕 “The Committee should not include”: Telegram from Jim
Adams to Mary Lasker, 1947, Mary Lasker Papers.</p></li>
<li><p>〔26〕 “You were probably the first person”: Letter from Rose
Kushner to Mary Lasker, July 22, 1988, Rose Kushner Papers, Harvard
University.</p></li>
<li><p>〔27〕 “a penicillin for cancer”: “Doctor Foresees Cancer
Penicillin,” New York Times,October 3, 1953.</p></li>
<li><p>〔28〕 By the early 1950s, she was regularly: See, for instance,
letter from John R. Heller to Mary Lasker, October 15, 1948, Mary Lasker
Papers, Box 119; and Memorandum on Conversation with Dr. Farber,
February 24, 1952, Mary Lasker Papers, Box 76.</p></li>
<li><p>〔29〕 “scientific treatises”: Letter from Sidney Farber to Mary
Lasker, August 19, 1955, Mary Lasker Papers, Box 170.</p></li>
<li><p>〔30〕 “An organizational pattern is developing”: Ibid.</p></li>
<li><p>〔31〕 a “regular on the Hill”: Robert Mayer, interview with
author, July 2008.</p></li>
<li><p>〔32〕 “Put a tambourine in 〔his〕 hands”: Rettig, Cancer
Crusade, 26.</p></li>
<li><p>〔33〕 “I have written to you so many times”: Letter from Sidney
Farber to Mary Lasker, September 5, 1958.</p></li>
<li><h4 id="第十五章-新生力量">第十五章 “新生力量”</h4></li>
<li><p>〔1〕 The death of a man: Czeslaw Milosz, New and Collected
Poems: 1931–2001 (New York: Ecco, 2001), 431.</p></li>
<li><p>〔2〕 I had recently begun to notice: K. E. Studer and Daryl E.
Chubin, The Cancer Mission: Social Contexts of Biomedical Research
(Newbury Park, CA: Sage Publications, 1980).</p></li>
<li><p>〔3〕 By February 1952, Albert was confined: Mary Lasker Oral
History Project, Part 1, Session 9, p. 260.</p></li>
<li><p>〔4〕 “It seems a little unfair”: Letter from Lowel Cogeshall to
Mary Lasker, March 11, 1952, Mary Lasker Papers, Box 76.</p></li>
<li><p>〔5〕 Albert Lasker died at eight o’clock: “A. D. Lasker Dies;
Philanthropist, 72,” New York Times, May 31, 1952.</p></li>
<li><p>〔6〕 “We are at war with an insidious”: Senator Lister Hill, “A
Strong Independent Cancer Agency,” October 5, 1971, Mary Lasker Papers,
Columbia University.</p></li>
<li><p>〔7〕 “University professors who are opposed”: “Science and the
Bomb,” New York Times,August 7, 1945.</p></li>
<li><p>〔8〕 Science the Endless Frontier: Vannevar Bush, Science the
Endless Frontier: A Report to the President by Vannevar Bush, Director
of the Office of Scientific Research and Development, July 1945
(Washington, DC: United States Government Printing Office,
1945).</p></li>
<li><p>〔9〕 The National Science Foundation (NSF), founded in 1950:
Daniel S. Greenberg, Science, Money, and Politics: Political Triumph and
Ethical Erosion (Chicago: University of Chicago Press, 2001),
167.</p></li>
<li><p>〔10〕 “long term, basic scientific research”: Ibid.,
419.</p></li>
<li><p>〔11〕 “so great a co-ordination of medical scientific labor”:
Stephen Parks Strickland, Politics, Science, and the Dread Disease: A
Short History of the United States Medical Research Policy (Cambridge,
MA: Harvard University Press, 1972), 16.</p></li>
<li><p>〔12〕 “Should I refuse my dinner”: Ernest E. Sellers, “Early
Pragmatists,” Science 154, no. 3757 (1996): 1604.</p></li>
<li><p>〔13〕 The outspoken Philadelphia pathologist Stanley Reimann:
Stanley Reimann, “The Cancer Problem as It Stands Today,” Transactions
and Studies of the College of Physicians of Philadelphia 13 (1945):
21.</p></li>
<li><p>〔14〕 the Cancer Chemotherapy National Service Center: C. G.
Zubrod et al., “The Chemotherapy Program of the National Cancer Center
Institute: History, Analysis, and Plans,” Cancer Chemotherapy Reports 50
(1966): 349–540; V. T. DeVita, “The Evolution of Therapeutic Research in
Cancer,” New England Journal of Medicine 298 (1978): 907–10.</p></li>
<li><p>〔15〕 Farber was ecstatic, but impatient: Letter from Sidney
Farber to Mary Lasker, August 19, 1955, Mary Lasker Papers, Box
170.</p></li>
<li><p>〔16〕 One such antibiotic came from a rod-shaped microbe: Selman
Waksman and H. B. Woodruff, “Bacteriostatic and Bacteriocidal Substances
Produced by a Soil Actinomyces,” Proceedings of the Society for
Experimental Biology and Medicine 45 (1940): 609.</p></li>
<li><p>〔17〕 Farber and actinomycin D: Sidney Farber, Giulio D’Angio,
Audrey Evans, and Anna Mitus, “Clinical Studies of Actinomycin D with
Special Reference to Wilms’ Tumor in Children,” Annals of the New York
Academy of Science 89 (1960): 421–25.</p></li>
<li><p>〔18〕 “In about three weeks lungs previously riddled with”:
Giulio D’Angio, “Pediatric Oncology Refracted through the Prism of
Wilms’ Tumor: A Discourse,” Journal of Urology 164 (2000):
2073–77.</p></li>
<li><p>〔19〕 Sonja Goldstein’s recollections: Jeremiah Goldstein,
“Preface to My Mother’s Diary,” Journal of Pediatric Hematology/Oncology
30, no. 7 (2008): 481–504.</p></li>
<li><h4 id="第十六章-屠宰场">第十六章 “屠宰场”</h4></li>
<li><p>〔1〕 Randomised screening trials are bothersome: H. J. de
Koning, “Mammographic Screening: Evidence from Randomised Controlled
Trials,” Annals of Oncology 14 (2003): 1185–89.</p></li>
<li><p>〔2〕 The best 〔doctors〕 seem to have a sixth sense: Michael
LaCombe, “What Is Internal Medicine?” Annals of Internal Medicine 118,
no. 5 (1993): 384–88.</p></li>
<li><p>〔3〕 Emil Freireich and Emil Frei: John Laszlo, The Cure of
Childhood Leukemia: Into the Age of Miracles (New Brunswick, NJ: Rutgers
University Press, 1995), 118–20.</p></li>
<li><p>〔4〕 “I have never seen Freireich in a moderate mood”: Emil Frei
III, “Confrontation, Passion, and Personalization,” Clinical Cancer
Research 3 (1999): 2558.</p></li>
<li><p>〔5〕 Gordon Zubrod, the new director: Emil Frei III, “Gordon
Zubrod, MD,” Journal of Clinical Oncology 17 (1999): 1331. Also see
Taylor, Pioneers in Pediatric Oncology, 117.</p></li>
<li><p>〔6〕 Freireich came just a few weeks later: Grant Taylor,
Pioneers in Pediatric Oncology (Houston: University of Texas M. D.
Anderson Cancer Center, 1990), 117.</p></li>
<li><p>〔7〕 “Frei’s job,” one researcher recalled: Edward Shorter, The
Health Century (New York: Doubleday, 1987), 192.</p></li>
<li><p>〔8〕 To avert conflicts: Andrew M. Kelahan, Robert Catalano, and
Donna Marinucci, “The History, Structure, and Achievements of the Cancer
Cooperative Groups,” (May/June 2000): 28–33.</p></li>
<li><p>〔9〕 “For the first time”: Robert Mayer, interview with author,
July 2008. Also see Frei, “Gordon Zubrod,” 1331; and Taylor, Pioneers in
Pediatric Oncology, 117.</p></li>
<li><p>〔10〕 Hill and randomized trials: Austin Bradford Hill,
Principles of Medical Statistics (Oxford: Oxford University Press,
1966); A. Bradford Hill, “The Clinical Trial,” British Medical Bulletin
7, no. 4 (1951): 278–82.</p></li>
<li><p>〔11〕 “The analogy of drug resistance”: Emil Freireich,
interview with author, September 2009.</p></li>
<li><p>〔12〕 The first protocol was launched: Emil Frei III et al., “A
Comparative Study of Two Regimens of Combination Chemotherapy in Acute
Leukemia,” Blood 13, no. 12 (1958): 1126–48; Richard Schilsky et al., “A
Concise History of the Cancer and Leukemia Group B,” Clinical Cancer
Research 12, no. 11, pt. 2 (2006): 3553s–55s.</p></li>
<li><p>〔13〕 “This work is one of the first comparative studies”: Frei
et al., “Comparative Study of Two Regimens.”</p></li>
<li><p>〔14〕 “The resistance would be fierce”: Emil Freireich, personal
interview.</p></li>
<li><p>〔15〕 a “butcher shop”: Vincent T DeVita, Jr. and Edward Chu, “A
History of Cancer Chemotherapy,” Cancer Research 68, no. 21 (2008):
8643.</p></li>
<li><h4 id="第十七章-初步胜利">第十七章 初步胜利</h4></li>
<li><p>〔1〕 But I do subscribe to the view: Brian Vastag, “Samuel
Broder, MD, Reflects on the 30th Anniversary of the National Cancer
Act,” Journal of the American Medical Association 286 (2001):
2929–31.</p></li>
<li><p>〔2〕
奉天医科大学始建于1912年，位于沈阳市内，1933年改称“盛京医科大学”。1945年抗战结束后，改名“辽宁医学院”，现已并入中国医科大学。——译者注</p></li>
<li><p>〔3〕 Min Chiu Li: Emil J. Freireich, “Min Chiu Li: A Perspective
in Cancer Therapy,” Clinical Cancer Research 8 (2002): 2764–65.</p></li>
<li><p>〔4〕 Li and Ethel Longoria: Mickey Goulian, interview with
author, September 2007.</p></li>
<li><p>〔5〕 “She was bleeding so rapidly”: Ibid.</p></li>
<li><p>〔6〕 Li and Hertz rushed to publish: M. C. Li, R. Hertz, and D.
M. Bergenstal, “Therapy of Choriocarcinoma and Related Trophoblastic
Tumors with Folic Acid and Purine Antagonists,” New England Journal of
Medicine 259, no. 2 (1958): 66–74.</p></li>
<li><p>〔7〕 Li’s use of hcg level in chemotherapy: John Laszlo, The
Cure of Childhood Leukemia: Into the Age of Miracles (New Brunswick, NJ:
Rutgers University Press, 1995), 145–47.</p></li>
<li><p>〔8〕 In mid-July, the board summoned: Ibid.</p></li>
<li><p>〔9〕 “Li was accused of experimenting on people”: Emil
Freireich, interview with author, September 2009.</p></li>
<li><p>〔10〕 When Freireich heard about Li’s dismissal: Laszlo, Cure of
Childhood Leukemia, 145.</p></li>
<li><h4 id="第十八章-小鼠医生">第十八章 小鼠医生</h4></li>
<li><p>〔1〕 A model is a lie that helps: Margie Patlak, “Targeting
Leukemia: From Bench to Bedside,” FASEB Journal 16 (2002):
273E.</p></li>
<li><p>〔2〕 “Clinical research is a matter of urgency”: John Laszlo,
The Cure of Childhood Leukemia: Into the Age of Miracles (New Brunswick,
NJ: Rutgers University Press, 1995.</p></li>
<li><p>〔3〕 To test three drugs, the group insisted: Ibid.,
142.</p></li>
<li><p>〔4〕 “The wards were filling up with these terribly sick
children”: Emil Freireich, interview, September 2009.</p></li>
<li><p>〔5〕 Vincristine had been discovered in 1958: Norman R.
Farnsworth, “Screening Plants for New Medicines,” in Biodiversity,
ed. E. O. Wilson (Washington, DC: National Academy Press, 1988), 94;
Normal R. Farnsworth, “Rational Approaches Applicable to the Search for
and Discovery of New Drugs From Plants,” in Memorias del 1er Symposium
Latinoamericano y del Caribe de Farmacos Naturales, La Habana, Cuba, 21
al 28 de Junio, 1980, 27–59 (Montevideo, Uruguay: UNESCO Regional Office
Academia de Ciencias de Cuba y Comisión Nacional de Cuba ante la
UNESCO).</p></li>
<li><p>〔6〕 “Frei and Freireich were simply taking drugs”: David
Nathan, The Cancer Treatment Revolution (Hoboken, NJ: Wiley, 2007),
59.</p></li>
<li><p>〔7〕 A scientist from Alabama, Howard Skipper: Laszlo, Cure of
Childhood Leukemia,199–209.</p></li>
<li><p>〔8〕 Skipper emerged with two pivotal findings: See, for
example, Howard E. Skipper, “Cellular Kinetics Associated with
‘Curability’ of Experimental Leukemias,” in William Dameshek and Ray M.
Dutcher, eds., Perspectives in Leukemia (New York: Grune ＆ Stratton,
1968), 187–94.</p></li>
<li><p>〔9〕 “Maximal, intermittent, intensive, up-front”: Emil Frei,
“Curative Cancer Chemotherapy,” Cancer Research 45 (1985):
6523–37.</p></li>
<li><h4 id="第十九章-vamp方案">第十九章 VAMP方案</h4></li>
<li><p>〔1〕 If we didn’t kill the tumor: William C. Moloney and Sharon
Johnson, Pioneering Hematology: The Research and Treatment of Malignant
Blood Disorders—Reflections on a Life’s Work (Boston: Francis A.
Countway Library of Medicine, 1997).</p></li>
<li><p>〔2〕 “I wanted to treat them with full doses of vincristine”:
John Laszlo, The Cure of Childhood Leukemia: Into the Age of Miracles
(New Brunswick, NJ: Rutgers University Press, 1995), 141.</p></li>
<li><p>〔3〕
由于大部分早期抗癌药都具有细胞毒性（杀伤细胞），同时治疗（杀伤肿瘤）剂量与毒性剂量之间的阈值非常接近，因此许多药物在治疗时需要严格把控使用剂量，以避免患者落入这些危机四伏的毒性反应陷阱。——作者注</p></li>
<li><p>〔4〕 “poison of the month”: Edward Shorter, The Health Century
(New York: Doubleday, 1987), 189.</p></li>
<li><p>〔5〕 Farber, for one, favored giving one drug at a time: See
David Nathan, The Cancer Treatment Revolution (Hoboken, NJ: Wiley,
2007), 63.</p></li>
<li><p>〔6〕 “Oh, boy,” Freireich recalled: Emil Freireich, interview
with author, September 2009.</p></li>
<li><p>〔7〕 “You can imagine the tension”: Laszlo, Cure of Childhood
Leukemia, 143.</p></li>
<li><p>〔8〕 First VAMP trial: E. J. Freireich, M. Karon, and E. Frei
III, “Quadruple Combination Therapy (VAMP) for Acute Lymphocytic
Leukemia of Childhood,” Proceedings of the American Association for
Cancer Research 5 (1963): 20; E. Frei III, “Potential for Eliminating
Leukemic Cells in Childhood Acute Leukemia,” Proceedings of the American
Association for Cancer Research 5 (1963): 20.</p></li>
<li><p>〔9〕 “I did little things”: Laszlo, Cure of Childhood Leukemia,
143–44.</p></li>
<li><p>〔10〕 “like a drop from a cliff with a thread tied”: Mickey
Goulian, interview with author, September 2007.</p></li>
<li><p>〔11〕 The patient “is amazingly recovered”: Letter from a Boston
physician to patient K.L. (name withheld). K.L., interview with author,
September 2009.</p></li>
<li><p>〔12〕 “The mood among pediatric oncologists changed”: Jonathan
B. Tucker, Ellie: A Child’s Fight against Leukemia (New York: Holt,
Rinehart, and Winston, 1982).</p></li>
<li><p>〔13〕 In September 1963, not long after Frei and Freireich:
Freireich, interview with author.</p></li>
<li><p>〔14〕 “Some of us didn’t make much of it at first”: Goulian,
interview with author.</p></li>
<li><p>〔15〕 By October, there were more children back at the clinic:
Freireich, interview with author.</p></li>
<li><p>〔16〕 “I know the patients, I know their brothers and sisters”:
“Kids with Cancer,” Newsweek, August 15, 1977.</p></li>
<li><p>〔17〕 morale at the institute to the breaking point: Freireich,
interview with author.</p></li>
<li><p>〔18〕 A few, a small handful: Emil Frei, “Curative Cancer
Chemotherapy,” Cancer Research 45 (1985): 6523–37.</p></li>
<li><p>〔19〕 he triumphantly brought photographs of a few: Harold P.
Rusch, “The Beginnings of Cancer Research Centers in the United States,”
74 (1985): 391–403.</p></li>
<li><p>〔20〕 further proof was “anticlimactic and unnecessary”:
Ibid.</p></li>
<li><p>〔21〕 “We are attempting”: Sidney Farber, letter to Etta
Rosensohn, Mary Lasker Papers, Columbia University.</p></li>
<li><h4 id="第二十章-霍奇金病">第二十章 霍奇金病</h4></li>
<li><p>〔1〕 It took plain old courage to be a chemotherapist: Vincent
T. DeVita Jr. and Edward Chu, “A History of Cancer Chemotherapy,” Cancer
Research 68, no. 21 (2008): 8643–53.</p></li>
<li><p>〔2〕
PET指正电子发射型计算机断层显像，将某种物质标记上放射性核素注入人体，然后通过该物质的聚集情况来反映代谢活动。由于恶性肿瘤组织代谢旺盛，因此标记有核素的物质聚集较多，而这些特点能够通过图像反映出来，并且可以对病变进行诊断和分析。——译者注</p></li>
<li><p>〔3〕 Hodgkin was born in 1798 to a Quaker family: Louis
Rosenfeld, Thomas Hodgkin: Morbid Anatomist ＆ Social Activist (Lanham,
MD: Madison Books, 1993), 1. Also see Amalie M. Kass and Edward H. Kass,
Perfecting the World: The Life and Times of Dr. Thomas Hodgkin,
1798–1866 (Boston: Harcourt Brace Jovanovich, 1988).</p></li>
<li><p>〔4〕 a series of cadavers, mostly of young men: T. Hodgkin, “On
Some Morbid Appearances of the Absorbent Glands and Spleen,”
Medico-Chirurgical Transactions 17 (1832): 68–114. The paper was read to
the society by Robert Lee because Hodgkin was not a member of the
society himself.</p></li>
<li><p>〔5〕 “A pathological paper may perhaps be thought”: Hodgkin, “On
Some Morbid Appearances,” 96.</p></li>
<li><p>〔6〕 In 1837, after a rather vicious political spat: Marvin J.
Stone, “Thomas Hodgkin: Medical Immortal and Uncompromising Idealist,”
Baylor University Medical Center Proceedings 18 (2005): 368–75.</p></li>
<li><p>〔7〕 In 1898, some thirty years after Hodgkin’s death: Carl
Sternberg, “Über eine eigenartige unter dem Bilde der Pseudoleu Kamie
Verlaufende Tuberkuloses des Lymphatischen Apparates,” Ztschr Heitt 19
(1898): 21–91.</p></li>
<li><p>〔8〕 more “capricious,” as one oncologist put it: A. Aisenberg,
“Prophylactic Radiotherapy in Hodgkin’s Disease,” New England Journal of
Medicine 278, no. 13 (1968): 740; A. Aisenberg, “Management of Hodgkin’s
Disease,” New England Journal of Medicine278, no. 13 (1968): 739; A. C.
Aisenberg, “Primary Management of Hodgkin’s Disease,” New England
Journal of Medicine 278, no. 2 (1968): 92–95.</p></li>
<li><p>〔9〕 the plan to build a linear accelerator: Z. Fuks and M.
Feldman, “Henry S. Kaplan, 1918–1984: A Physician, a Scientist, a
Friend,” Cancer Surveys 4, no. 2 (1985): 294–311.</p></li>
<li><p>〔10〕 In 1953, he persuaded a team: Malcolm A. Bagshaw, Henry E.
Jones, Robert F. Kallman, and Joseph P. Kriss, “Memorial Resolution:
Henry S. Kaplan (1918–1984),” Stanford University Faculty Memorials,
Stanford Historical Society,
http://histsoc.stanford.edu/pdfmem/KaplanH.pdf (accessed November 22,
2009).</p></li>
<li><p>〔11〕 The accelerator was installed: Ibid.</p></li>
<li><p>〔12〕 “Henry Kaplan was Hodgkin’s disease”: George Canellos,
interview with author, March 2008.</p></li>
<li><p>〔13〕 Rene Gilbert had shown: R. Gilbert, “Radiology in
Hodgkin’s Disease 〔malig-nant granulomatosis〕. Anatomic and Clinical
Foundations,” American Journal of Roentgenology and Radium Therapy 41
(1939): 198–241; D. H. Cowan, “Vera Peters and the Curability of
Hodgkin’s Disease,” Current Oncology 15, no. 5 (2008): 206–10.</p></li>
<li><p>〔14〕 Peters observed that broad-field radiation could: M. V.
Peters and K. C. Middlemiss, “A Study of Hodgkin’s Disease Treated by
Irradiation,” American Journal of Roentgenology and Radium Therapy 79
(1958): 114–21.</p></li>
<li><p>〔15〕 The trials that Kaplan designed: H. S. Kaplan, “The
Radical Radiotherapy of Regionally Localized Hodgkin’s Disease,”
Radiology 78 (1962): 553–61; Richard T. Hoppe, Peter T. Mauch, James O.
Armitage, Volker Diehl, and Lawrence M. Weiss, Hodgkin Lymphoma
(Philadelphia: Lippincott Williams ＆ Wilkins, 2007), 178.</p></li>
<li><p>〔16〕 “meticulous radiotherapy”: Aisenberg, “Primary Management
of Hodgkin’s Disease,” 95.</p></li>
<li><p>〔17〕 But Kaplan knew that a diminished relapse rate was not a
cure: H. S. Kaplan, “Radical Radiation for Hodgkin’s Disease,” New
England Journal of Medicine 278, no. 25 (1968): 1404; H. S. Kaplan,
“Clinical Evaluation and Radiotherapeutic Management of Hodgkin’s
Disease and the Malignant Lymphomas,” New England Journal of Medicine
278, no. 16 (1968): 892–99.</p></li>
<li><p>〔18〕 “Fundamental to all attempts at curative treatment”:
Aisenberg, “Primary Management of Hodgkin’s Disease,” 93.</p></li>
<li><h4 id="第二十一章-整体治疗">第二十一章 整体治疗</h4></li>
<li><p>〔1〕 Now we are an army on the march: “Looking Back: Sidney
Farber and the First Remission of Acute Pediatric Leukemia,” Children’s
Hospital Boston,
http://www.chil-drenshospital.org/gallery/index.cfm?G=49＆page=1
(accessed November 22, 2009).</p></li>
<li><p>〔2〕 The next step—the complete cure: Kenneth Endicott, quoted
in the Mary Lasker Papers, “Cancer Wars,” National Library of
Medicine.</p></li>
<li><p>〔3〕 The role of aggressive multiple drug therapy: R. C. Stein
et al., “Prognosis of Childhood Leukemia,” Pediatrics 43, no. 6 (1969):
1056–58.</p></li>
<li><p>〔4〕 George Canellos, then a senior fellow at the NCI: George
Canellos, interview with author, March 2008.</p></li>
<li><p>〔5〕 “A new breed of cancer investigators in the 1960s”: V. T.
DeVita Jr., British Journal of Haematology 122, no. 5 (2003):
718–27.</p></li>
<li><p>〔6〕 “maniacs doing cancer research”: Ronald Piana, “ONI Sits
Down with Dr. Vincent DeVita,” Oncology News International 17, no. 2
(February 1, 2008),
http://www.consultantlive.com/display/article/10165/1146581?pageNumber=2＆verify=0
(accessed November 22, 2009).</p></li>
<li><p>〔7〕 As expected: See Vincent T. DeVita Jr. and Edward Chu, “A
History of Cancer Chemotherapy,” Cancer Research 21: 8643.</p></li>
<li><p>〔8〕 The MOPP trial: Vincent T. DeVita Jr. et al., “Combination
Chemotherapy in the Treatment of Advanced Hodgkin’s Disease,” Annals of
Internal Medicine 73, no. 6 (1970): 881–95.</p></li>
<li><p>〔9〕 A twelve-year-old boy: Bruce Chabner, interview with
author, July 2009.</p></li>
<li><p>〔10〕 “Some of the patients with advanced disease”: Henry
Kaplan, Hodgkin’s Disease (New York: Commonwealth Fund, 1972), 15, 458.
Also see DeVita et al., “Combination Chemotherapy in the
Treatment.”</p></li>
<li><p>〔11〕
虽然平克尔于1961年去孟菲斯之前曾经在波士顿师从法伯，但是他实际上还在纽约州布法罗的罗斯韦尔·帕克癌症研究所工作过数年。——作者注</p></li>
<li><p>〔12〕 “no track record, uncertain finances, an unfinished
building”: Joseph V. Simone, “A History of St. Jude Children’s Research
Hospital,” British Journal of Haematology 120 (2003): 549–55.</p></li>
<li><p>〔13〕
罗斯韦尔小组由纽约纪念医院的詹姆斯·霍兰德与约瑟夫·伯奇纳尔领导，他们继续与平克尔合作，共同完善了白血病的治疗方案。——作者注</p></li>
<li><p>〔14〕 “an all-out combat”: R. J. Aur and D. Pinkel, “Total
Therapy of Acute Lymphocytic Leukemia,” Progress in Clinical Cancer 5
(1973): 155–70.</p></li>
<li><p>〔15〕 “in maximum tolerated doses”: Joseph Simone et al.,
“‘Total Therapy’ Studies of Acute Lymphocytic Leukemia in Children:
Current Results and Prospects for Cure,” Cancer30, no. 6 (1972):
1488–94.</p></li>
<li><p>〔16〕 it was impossible to even dose it and monitor it
correctly: Aur and Pinkel, “Total Therapy of Acute Lymphocytic
Leukemia.”</p></li>
<li><p>〔17〕 senior researchers, knowing its risks: “This Week’s
Citations Classic: R. J. A. Aur et al., “Central Nervous System Therapy
and Combination Chemotherapy of Childhood Lymphocytic Leukemia,”
Citation Classics 28 (July 14, 1986).</p></li>
<li><p>〔18〕 “From the time of his diagnosis”: Jocelyn Demers, Suffer
the Little Children: The Battle against Childhood Cancer (Fountain
Valley, CA: Eden Press, 1986), 17.</p></li>
<li><p>〔19〕 In July 1968, the St. Jude’s team published: Donald Pinkel
et al., “Nine Years’ Experience with ‘Total Therapy’ of Childhood Acute
Lymphocytic Leukemia,” Pediatrics 50, no. 2 (1972): 246–51.</p></li>
<li><p>〔20〕 The longest remission was now in its sixth year: S. L.
George et al., “A Reappraisal of the Results of Stopping Therapy in
Childhood Leukemia,” New England Journal of Medicine 300, no. 6
(1979):269–73.</p></li>
<li><p>〔21〕 In 1979, Pinkel’s team revisited: Donald Pinkel,
“Treatment of Acute Lymphocytic Leukemia” Cancer 23 (1979):
25–33.</p></li>
<li><p>〔22〕 “ALL in children cannot be considered an incurable
disease”: Pinkel et al, “Nine Years’ Experience with ‘Total
Therapy.’”</p></li>
<li><h4 id="第二十二章-本末倒置">第二十二章 本末倒置</h4></li>
<li><p>〔1〕 I am not opposed to optimism: P. T. Cole, “Cohorts and
Conclusions,” New England Journal of Medicine 278, no. 20 (1968):
1126–27.</p></li>
<li><p>〔2〕 The iron is hot and this is the time: Letter from Sidney
Farber to Mary Lasker, September 4, 1965.</p></li>
<li><p>〔3〕 In the late fifties, as DeVita recalled: Vincent T. DeVita
Jr. and Edward Chu, “A History of Cancer Chemotherapy,” Cancer Research
68, no. 21 (2008): 8643–53.</p></li>
<li><p>〔4〕 “A revolution 〔has been〕”: Vincent T. DeVita Jr.,“A
Selective History of the Therapy of Hodgkin’s Disease,” British Journal
of Hemotology 122 (2003): 718–27.</p></li>
<li><p>〔5〕 The next step—the complete cure: Kenneth Endicott, quoted
in “Cancer Wars,” Mary Lasker Papers, Profiles in Science, National
Libraries of Medicine. Also see V. T. DeVita Jr., “A Perspective on the
War on Cancer,” Cancer Journal 8, no. 5 (2002): 352–56.</p></li>
<li><p>〔6〕
吉米基金会于1948年5月正式成立。到了1968年9月，基金会运行已经进入第21个年头。其“生日”实际上是法伯自行指定的日期。——作者注</p></li>
<li><p>〔7〕 “The chemical arsenal,” one writer noted: Ellen Leopold, A
Darker Ribbon: Breast Cancer, Women, and Their Doctors in the Twentieth
Century (Boston: Beacon Press, 1999), 269–70.</p></li>
<li><p>〔8〕 “one cause, one mechanism and one cure”: “Fanfare Fades in
the Fight against Cancer,” U.S. News and World Report, June 19,
1978.</p></li>
<li><p>〔9〕 Peyton Rous: Heather L. Van Epps, “Peyton Rous: Father of
the Tumor Virus,” Journal of Experimental Medicine 201, no. 3 (2005):
320; Peter K. Vogt, “Peyton Rous: Homage and Appraisal,” Journal of the
Federation of American Societies for Experimental Biology 10 (1996):
1559–62.</p></li>
<li><p>〔10〕 Peyton Rous’s work on sarcomas in chickens: Peyton Rous,
“A Transmissible Avian Neoplasm (Sarcoma of the Common Fowl),” Journal
of Experimental Medicine 12, no. 5 (1910): 696–705; Peyton Rous, “A
Sarcoma of the Fowl Transmissible by an Agent Separable from the Tumor
Cells,” Journal of Experimental Medicine 13, no. 4 (1911):
397–411.</p></li>
<li><p>〔11〕 “I have propagated a spindle-cell sarcoma”: Rous, “A
Transmissible Avian Neoplasm.”</p></li>
<li><p>〔12〕 Richard Schope reported a papillomavirus: Richard E.
Shope, “A Change in Rabbit Fibroma Virus Suggesting Mutation: II.
Behavior of the Varient Virus in Cottontail Rabbits,” Journal of
Experimental Medicine 63, no. 2 (1936): 173–78; Richard E. Shope, “A
Change in Rabbit Fibroma Virus Suggesting Mutation: III. Interpretation
of Findings,” Journal of Experimental Medicine 63, no. 2 (1936):
179–84.</p></li>
<li><p>〔13〕 Denis Burkitt, discovered an aggressive form of lymphoma:
Denis Burkitt, “A Sarcoma Involving the Jaws in African Children,”
British Journal of Surgery 46, no. 197 (1958): 218–23.</p></li>
<li><p>〔14〕 “Cancer may be infectious”: “New Evidence That Cancer May
Be Infectious,” Life, June 22, 1962. Also see “Virus Link Found,” Los
Angeles Times, November 30, 1964.</p></li>
<li><p>〔15〕 “Is there something I can do to kill the cancer germ?”:
Letter from Mary Kirkpatrick to Peyton Rous, June 23, 1962, Peyton Rous
papers, the American Philosophical Society, quoted in James T.
Patterson, The Dread Disease: Cancer and Modern American Culture
(Cambridge, MA: Harvard University Press, 1987), 237.</p></li>
<li><p>〔16〕 the NCI inaugurated a Special Virus Cancer Program:
Nicholas Wade, “Special Virus Cancer Program: Travails of a Biological
Moonshot,” Science 174, no. 4016(1971): 1306–11.</p></li>
<li><p>〔17〕 the cancer virus program siphoned away more than 10
percent: Ibid.</p></li>
<li><p>〔18〕 “Relatively few viruses”: Peyton Rous, “The Challenge to
Man of the Neoplastic Cell,” Nobel lecture, December 13, 1966, Nobel
Lectures, Physiology or Medicine, 1963–1970 (Amsterdam: Elsevier,
1972).</p></li>
<li><p>〔19〕 “Relatively few viruses”: Peyton Rous, “Surmise and Fact
on the Nature of Cancer,” Nature 183, no. 4672 (1959): 1357–61.</p></li>
<li><p>〔20〕 “The program directed by the National Cancer Institute”:
“Hunt Continues for Cancer Drug,” New York Times, October 13,
1963.</p></li>
<li><p>〔21〕 “The iron is hot and this is the time”: Letter from Sidney
Farber to Mary Lasker, September 4, 1965, Mary Lasker Papers, Box
171.</p></li>
<li><p>〔22〕 “No large mission or goal-directed effort”: Mary Lasker,
“Need for a Commission on the Conquest of Cancer as a National Goal by
1976,” Mary Lasker Papers, Box 111.</p></li>
<li><p>〔23〕 Solomon Garb, a little-known professor of pharmacology:
Solomon Garb, Cure for Cancer: A National Goal (New York: Springer,
1968).</p></li>
<li><p>〔24〕 “A major hindrance to the cancer effort”: Ibid.</p></li>
<li><p>〔25〕 At 4:17 p.m. EDT on July 20, 1969: “The Moon: A Giant Leap
for Mankind,” Time, July 25, 1969.</p></li>
<li><p>〔26〕 “magnificent desolation”: Buzz Aldrin, Magnificent
Desolation: The Long Journey Home from the Moon (New York: Harmony
Books, 2009).</p></li>
<li><p>〔27〕 “It suddenly struck me”: “Space: The Greening of the
Astronauts,” Time, December 11, 1972.</p></li>
<li><p>〔28〕 “It was a stunning scientific and intellectual
accomplishment”: “The Moon,” Time.</p></li>
<li><p>〔29〕 When Max Faget, the famously taciturn engineer: Glen E.
Swanson, Before This Decade Is Out: Personal Reflections on the Apollo
Program (Washington, DC: NASA History Office, 1999), 374.</p></li>
<li><p>〔30〕 In her letters, Mary Lasker began: Lasker, “Need for a
Commission.”</p></li>
<li><p>〔31〕 Lister Hill, the Alabama senator: “Two Candidates in
Primary in Alabama Count Ways They Love Wallace,” New York Times, May
27, 1968.</p></li>
<li><p>〔32〕
1969年7月，载有肯尼迪与一位助选员的车辆突然从玛莎葡萄园大桥坠入海中，导致一人溺水身亡；肯尼迪承认离开了犯罪现场并且被判处缓刑。——作者注</p></li>
<li><p>〔33〕 Edward Kennedy, Farber’s ally from Boston: “Conflicted
Ambitions, Then, Chappaquiddick,” Boston Globe, February 17,
2009.</p></li>
<li><p>〔34〕 “We’re in the worst,” Lasker recalled: Mary Lasker Oral
History Project, Part II, Session 5, p. 125.</p></li>
<li><h4 id="第二十三章-登月计划">第二十三章 “登月计划”</h4></li>
<li><p>〔1〕 The relationship of government: William Carey, “Research
Development and the Federal Budget,” Seventeenth National Conference on
the Administration of Research, September 11, 1963.</p></li>
<li><p>〔2〕 What has Santa Nixon: Robert Semple, New York Times,
December 26, 1971.</p></li>
<li><p>〔3〕 On December 9, 1969, on a chilly Sunday: Advertisement from
the American Cancer Society, New York Times, December 17, 1971.</p></li>
<li><p>〔4〕 该广告也刊登在12月17日的《纽约时报》上。——作者注</p></li>
<li><p>〔5〕 in Aleksandr Solzhenitsyn’s Cancer Ward: Aleksandr
Solzhenitsyn, Cancer Ward (New York: Farrar, Straus and Giroux,
1968).</p></li>
<li><p>〔6〕 in Love Story: Erich Segal, Love Story, DVD, directed by
Arthur Hiller, 2001.</p></li>
<li><p>〔7〕 Bang the Drum Slowly, a 1973 release: Mark Harris, Bang the
Drum Slowly, DVD, directed by John D. Hancock, 2003.</p></li>
<li><p>〔8〕 Brian’s Song, the story of the Chicago Bears star: Al
Silverman, Gale Sayers, and William Blinn, Brian’s Song, DVD, directed
by Buzz Kulik, 2000.</p></li>
<li><p>〔9〕 “plunged into numb agony”: Richard A. Rettig, Cancer
Crusade: The Story of the National Cancer Act of 1971 (Lincoln, NE:
Author’s Choice Press, 1977), 175.</p></li>
<li><p>〔10〕 “Cancer changes your life,” a patient wrote: “My Fight
against Cancer,” Chicago Tribune, May 6, 1973.</p></li>
<li><p>〔11〕 “A radical change happened to the perception”: Renata
Salecl, On Anxiety (London: Routledge, 2004), 4. Also Renata Salecl,
interview with author, April 2006.</p></li>
<li><p>〔12〕 The “Big Bomb,” a columnist wrote: Ellen Goodman, “A Fear
That Fits the Times,” September 14, 1978.</p></li>
<li><p>〔13〕 出生于第二次世界大战期间的婴儿。——译者注</p></li>
<li><p>〔14〕 “To oppose big spending against cancer”: James T.
Patterson, The Dread Disease: Cancer and Modern American Culture
(Cambridge, MA: Harvard University Press, 1987), 149.</p></li>
<li><p>〔15〕 Nixon often groused: For Nixon’s comments, see National
Archives and Records Administration, Nixon Presidential Materials
Project, 513–14, June 7, 1971, tran-scribed by Daniel Greenberg. See I.
I. Rabi, quoted in Daniel S. Greenberg, The Politics of Pure Science
(Chicago: University of Chicago Press, 1999), 3.</p></li>
<li><p>〔16〕 Mary Lasker proposed that a “neutral” committee: Rettig,
Cancer Crusade, 82.</p></li>
<li><p>〔17〕 The commission, she wrote, should “include space
scientists”: Mary Lasker, “Need for a Commission on the Conquest of
Cancer as a National Goal by 1976,” Mary Lasker Papers, Box
111.</p></li>
<li><p>〔18〕 Sidney Farber was selected as the cochairman: Rettig,
Cancer Crusade, 74–89.</p></li>
<li><p>〔19〕 Yarborough wrote to Mary Lasker in the summer of 1970:
Letter from Ralph W. Yarborough to Mary Lasker, June 2, 1970, Mary
Lasker Papers, Box 112.</p></li>
<li><p>〔20〕 The panel’s final report: The report was published in two
documents in November 1970 and reprinted in December 1970 and April
1971. See Senate Document 92–99, 1st sess., April 14, 1971. Also see
Rettig, Cancer Crusade, 105.</p></li>
<li><p>〔21〕 “Not only can we afford the effort”: Benno Schmidt, quoted
by Alan C. Davis (inter-view with Richard Rettig) in Rettig, Cancer
Crusade, 109.</p></li>
<li><p>〔22〕 On March 9, 1971, acting on the panel’s recommendations:
Ibid.</p></li>
<li><p>〔23〕 she persuaded her close friend Ann Landers: “Mary Woodard
Lasker: First Lady of Medical Research,” presentation by Neen Hunt at
the National Library of Medicine,
http://profiles.nlm.nih.gov/TL/B/B/M/P/ (accessed January 6,
2010).</p></li>
<li><p>〔24〕 Landers’s column appeared on April 20, 1971: Ask Ann
Landers, Chicago Sun-Times,April 20, 1971.</p></li>
<li><p>〔25〕 “I saw trucks arriving at the Senate”: Rick Kogan,
America’s Mom: The Life, Lessons, and Legacy of Ann Landers (New York:
Harper Collins, 2003), 104.</p></li>
<li><p>〔26〕 An exasperated secretary charged with sorting: “Ann
Landers,” Washington Post, May 18, 1971.</p></li>
<li><p>〔27〕 Stuart Symington, the senator from Missouri: Ann Landers
and Margo Howard, A Life in Letters (New York: Warner Books, 2003),
255.</p></li>
<li><p>〔28〕 “Cancer is not simply an island”: Philip Lee. Also see
Committee on Labor and Public Welfare Report No. 92–247, June 28, 1971,
p. 43. S. 1828, 92nd Cong., 1st sess.</p></li>
<li><p>〔29〕 “An all-out effort at this time”: Patterson, Dread
Disease, 152.</p></li>
<li><p>〔30〕 James Watson, who had discovered the structure of DNA: See
James Watson, “To Fight Cancer, Know the Enemy,” New York Times, August
5, 2009.</p></li>
<li><p>〔31〕 “Doing ‘relevant’ research”: James Watson, “The Growing Up
of Cancer Research,” Science Year: The Book World Science Annual, 1973;
Mary Lasker Papers.</p></li>
<li><p>〔32〕 “In a nutshell”: “Washington Rounds,” Medical World News,
March 31, 1972.</p></li>
<li><p>〔33〕 “I suspect there is trouble ahead”: Irvine H. Page, “The
Cure of Cancer 1976,” Journal of Laboratory and Clinical Medicine 77,
no. 3 (1971): 357–60.</p></li>
<li><p>〔34〕 “If Richard Milhous Nixon”: “Tower Ticker,” Chicago
Tribune, January 28, 1971.</p></li>
<li><p>〔35〕 “Don’t worry about it”: Benno Schmidt, oral history and
memoir (gift and property of Elizabeth Smith, New York).</p></li>
<li><p>〔36〕 In November 1971, Paul Rogers: For details of
Representative Rogers’s bill, see Rettig, Cancer Crusade,
250–75.</p></li>
<li><p>〔37〕 In December 1971, the House finally: Iwan W. Morgan, Nixon
(London: Arnold, 2002), 72.</p></li>
<li><p>〔38〕 On December 23, 1971, on a cold, windswept afternoon:
“Nixon Signs Cancer Bill; Cites Commitment to Cure,” New York Times,
December 24, 1971.</p></li>
<li><p>〔39〕 00 million for 1972: “The National Cancer Act of 1971,”
Senate Bill 1828, enacted December 23, 1871 (P.L. 92–218), National
Cancer Institute, http://legislative.cancer.gov/history/phsa/1971
(accessed December 2, 2009). Frank Rauscher, the director of the
National Cancer Program, estimated the real numbers to have been 33
million in 1971, 78 million in 1972, 32 million in 1973, and 00 million
in 1974. Frank Rauscher, “Budget and the National Cancer Program (NCP),”
Cancer Research 34, no. 7 (1974): 1743–48.</p></li>
<li><p>〔40〕 If money was “frozen energy”: Mary Lasker Oral History
Project, Part 1, Session 7, p. 185.</p></li>
<li><p>〔41〕 The new bill, she told a reporter, “contained nothing”:
Ibid., Part 2, Session 10, p. 334.</p></li>
<li><p>〔42〕 Lasker and Sidney Farber withdrew: Ibid., Part 1, Session
7, p. 185; and Thomas Farber, interview with author, December
2007.</p></li>
<li><p>〔43〕 “Powerful? I don’t know”: “Mary Lasker: Still Determined
to Beautify the City and Nation,” New York Times, April 28,
1974.</p></li>
<li><p>〔44〕 “A crash program can produce only one result”: Chicago
Tribune, June 23, 1971, p. 16.</p></li>
<li><p>〔45〕 On March 30, 1973, in the late afternoon: Denis R. Miller,
“A Tribute to Sidney Farber—the Father of Modern Chemotherapy,” British
Journal of Haematology 134 (2006): 20–26; “Dr. Sidney Farber, a Pioneer
in Children’s Cancer Research; Won Lasker Award,” New York Times, March
31, 1973. Also see Mary Lasker, “A Personal Tribute to Sidney Farber,
M.D. (1903–1973),” CA: A Cancer Journal for Clinicians 23, no. 4 (1973):
256–57.</p></li>
<li><p>〔46〕 “Surely,” she wrote, “the world will never be the same”:
Lasker, “A Personal Tribute.</p></li>
<li><p>〔1〕 Oft expectation fails: William Shakespeare, All’s Well That
Ends Well (New York: Macmillan, 1912), act 2, scene 1, lines 145–47,
p. 34.</p></li>
<li><p>〔2〕 I have seen the moment of my greatness flicker: T. S.
Eliot, “The Love Song of J. Alfred Prufrock,” lines 84–86, The Norton
Anthology of Poetry, 4th ed. (New York: Norton, 1996), 1232.</p></li>
<li><p>〔3〕 You are absolutely correct: Frank Rauscher, letter to Mary
Lasker, March 18, 1974, Mary Lasker Papers, Box 118.</p></li>
<li><h4 id="第二十四章-我们信仰上帝其他必须源自数据">第二十四章
“我们信仰上帝，其他（必须）源自数据”</h4></li>
<li><p>〔1〕 In science, ideology tends to corrupt: “Knowledge
Dethroned,” New York Times,September 28, 1975.</p></li>
<li><p>〔2〕 Orthodoxy in surgery is like orthodoxy in other
departments: G. Keynes, “Carcinoma of the Breast, the Unorthodox View,”
Proceedings of the Cardiff Medical Society, April 1954, 40–49.</p></li>
<li><p>〔3〕 You mean I had a mastectomy for nothing?: Untitled
document, 1981, Rose Kushner Papers, 1953–90, Box 43, Harvard
University.</p></li>
<li><p>〔4〕 “In my own surgical attack on carcinoma”: Cushman Davis
Haagensen, Diseases of the Breast (New York: Saunders, 1971),
674.</p></li>
<li><p>〔5〕 Halsted’s “centrifugal theory”: W. S. Halsted, “The Results
of Operations for the Cure of the Cancer of Breast Performed at the
Johns Hopkins Hospital from June 1889 to January 1894,” Johns Hopkins
Hospital Bulletin 4 (1894): 497–555.</p></li>
<li><p>〔6〕 “To some extent,” he wrote: Haagensen, Diseases of the
Breast, 674.</p></li>
<li><p>〔7〕 “operated on cancer of the breast solely”: D. Hayes Agnew,
The Principles and Practice of Surgery, Being a Treatise on Surgical
Diseases and Injuries, 2nd ed. (Philadelphia: J. B. Lippincott Company,
1889), 3: 711.</p></li>
<li><p>〔8〕 “I do not despair of carcinoma being cured”: Ibid.</p></li>
<li><p>〔9〕 at St. Bartholomew’s Hospital in London: G. Keynes, “The
Treatment of Primary Carcinoma of the Breast with Radium,” Acta
Radiologica 10 (1929): 393–401; G. Keynes, “The Place of Radium in the
Treatment of Cancer of the Breast,” Annals of Surgery 106 (1937):
619–30. For biographical details, see W. LeFanu, “Sir Geoffrey Keynes
(1887–1982),” Bulletin of the History of Medicine 56, no. 4 (1982):
571–73.</p></li>
<li><p>〔10〕 In August 1924, Keynes examined a patient: “The Radiation
Treatment of Carcinoma of the Breast,” St. Bartholomew’s Hospital
Reports, vol. 60, ed. W. McAdam Eccles et al. (London: John Murray,
1927), 91–93.</p></li>
<li><p>〔11〕 “The ulcer rapidly heal〔ed〕”: Ibid.</p></li>
<li><p>〔12〕 “extension of 〔the〕 operation beyond a local removal”:
Ibid., 94.</p></li>
<li><p>〔13〕 the lumpectomy: Roger S. Foster Jr., “Breast Cancer
Detection and Treatment: A Personal and Historical Perspective,”
Archives of Surgery 138, no. 4 (2003): 397–408.</p></li>
<li><p>〔14〕 George Barney Crile: Ibid.; G. Crile Jr., “The Evolution
of the Treatment of Breast Cancer,” Breast Cancer: Controversies in
Management, ed. L. Wise and H. Johnson Jr. (Armonk, NY: Futura
Publishing Co., 1994).</p></li>
<li><p>〔15〕 Crile’s father. George Crile Sr.: Narendra Nathoo,
Frederick K. Lautzenheiser, and Gene H. Barnett, “The First Direct Human
Blood Transfusion: the Forgotten Legacy of George W. Crile,”
Neurosurgery 64 (2009): 20–26; G. W. Crile, Hemorrhage and Transfusion:
An Experimental and Clinical Research (New York: D. Appleton,
1909).</p></li>
<li><p>〔16〕 Political revolutions, the writer Amitav Ghosh writes:
Amitav Ghosh, Dancing in Cambodia, at Large in Burma (New Delhi: Ravi
Dayal, 1998), 25.</p></li>
<li><p>〔17〕 Crile Jr. was beginning to have his own doubts: Foster,
“Breast Cancer Detection and Treatment”; George Crile, The Way It Was:
Sex, Surgery, Treasure and Travel (Kent, OH: Kent University Press,
1992), 391–400.</p></li>
<li><p>〔18〕 Crile soon gave up on the radical mastectomy: George Crile
Jr., “Treatment of Breast Cancer by Local Excision,” American Journal of
Surgery 109 (1965): 400–403; George Crile Jr., “The Smaller the Cancer
the Bigger the Operation? Rational of Small Operations for Small Tumors
and Large Operations for Large Tumors,” Journal of the American Medical
Association 199 (1967): 736–38; George Crile Jr., A Biologic
Consideration of Treatment of Breast Cancer (Springfield, IL: Charles C.
Thomas, 1967); G. Crile Jr. and S. O. Hoerr, “Results of Treatment of
Carcinoma of the Breast by Local Excision,” Surgery, Gynecology, and
Obstetrics 132 (1971): 780–82.</p></li>
<li><p>〔19〕 two statisticians, Jerzy Neyman and Egon Pearson: J.
Neyman and E. S. Pearson, “On the Use and Interpretation of Certain Test
Criteria for Purposes of Statistical Inference. Part I,” Biometrika 20A,
nos. 1–2 (1928): 175–240; J. Neyman and E. S. Pearson, “On the Use and
Interpretation of Certain Test Criteria for Purposes of Statistical
Inference. Part II,” Biometrika 20A, nos. 3–4 (1928): 263–94.</p></li>
<li><p>〔20〕 “Go thou and do likewise”: Haagensen, Diseases of the
Breast, 674.</p></li>
<li><p>〔21〕 It took a Philadelphia surgeon: Kate Travis, “Bernard
Fisher Reflects on a Half-Century’s Worth of Breast Cancer Research,”
Journal of the National Cancer Institute 97, no. 22 (2005):
1636–37.</p></li>
<li><p>〔22〕 “It has become apparent”: Bernard Fisher, Karnosfky
Memorial Lecture transcript, Rose Kushner papers, Box 4, File 62,
Harvard University.</p></li>
<li><p>〔23〕 Thalidomide, prescribed widely to control: Phillip
Knightley, Suffer the Children: The Story of Thalidomide (New York:
Viking Press, 1979).</p></li>
<li><p>〔24〕 In Texas, Jane Roe: Roe v. Wade, 410 U.S. 113
(1973).</p></li>
<li><p>〔25〕 “Refuse to submit to a radical mastectomy”: “Breast
Cancer: Beware of These Danger Signals,” Chicago Tribune, October 3,
1973.</p></li>
<li><p>〔26〕 Rachel Carson, the author of Silent Spring: Ellen Leopold,
A Darker Ribbon: Breast Cancer, Women, and Their Doctors in the
Twentieth Century (Boston: Beacon Press, 1999), 199.</p></li>
<li><p>〔27〕 Betty Rollin and Rose Kushner: Betty Rollin, First, You
Cry (New York: Harper, 2000); Rose Kushner, Why Me? (Philadelphia:
Saunders Press, 1982).</p></li>
<li><p>〔28〕 “Happily for women,” Kushner wrote: Rose Kushner papers,
Box 2, File 22; Kushner, Why Me?</p></li>
<li><p>〔29〕 In 1967, bolstered by the activism: See Fisher’s NSABP
biography at http://www.nsabp.pitt.edu/BCPT_Speakers_Biographies.asp
(accessed January 11, 2010).</p></li>
<li><p>〔30〕 “The clinician, no matter how venerable”: Bernard Fisher,
“A Commentary on the Role of the Surgeon in Primary Breast Cancer,”
Breast Cancer Research and Treatment 1 (1981): 17–26.</p></li>
<li><p>〔31〕 “In God we trust”: “Treating Breast Cancer: Findings
Question Need for Removal,” Washington Post, October 29, 1979.</p></li>
<li><p>〔32〕 “To get a woman to participate in a clinical trial”:
“Bernard Fisher in Conversation,” Pitt Med Magazine (University of
Pittsburgh School of Medicine magazine), July 2002.</p></li>
<li><p>〔33〕 Fisher’s NSABP mastectomy trial: Bernard Fisher et al.,
“Findings from NSABP Protocol No. B-04: Comparison of Radical Mastectomy
with Alternative Treatments. II. The Clinical and Biological
Significance of Medial-Central Breast Cancers,” Cancer 48, no. 8 (1981):
1863–72.</p></li>
<li><h4 id="第二十五章-盲目乐观">第二十五章 盲目乐观</h4></li>
<li><p>〔1〕 Few doctors in this country: Rose Kushner, “Is Aggressive
Adjuvant Chemotherapy the Halsted Radical of the ’80s?” CA: A Cancer
Journal for Clinicians 34, no. 6 (1984): 345–51.</p></li>
<li><p>〔2〕 And it is solely by risking life: Georg Wilhelm Friedrich
Hegel, The Phenomenology of Mind (New York: Humanities Press, 1971),
232.</p></li>
<li><p>〔3〕 “large-scale chemotherapeutic attack”: James D. Hardy, The
World of Surgery, 1945–1985: Memoirs of One Participant (Philadelphia:
University of Pennsylvania Press, 1986), 216.</p></li>
<li><p>〔4〕 “our trench and our bunker”: Mickey Goulian, interview with
author, December 2005.</p></li>
<li><p>〔5〕 “Wandering about the NIH clinical center”: Stewart Alsop,
Stay of Execution: A Sort of Memoir (New York: Lippincott, 1973),
218.</p></li>
<li><p>〔6〕 “Although this was a cancer ward”: Kathleen R. Gilbert,
ed. The Emotional Nature of Qualitative Research (Boca Raton, FL: CRC
Press, 2001).</p></li>
<li><p>〔7〕 “accepted roles, a predetermined outcome, constant
stimuli”: Gerda Lerner, A Death of One’s Own (New York: Simon and
Schuster, 1978), 71.</p></li>
<li><p>〔8〕 “yellow and orange walls in the corridors”: “Cancer Ward
Nurses: Where ‘C’ Means Cheerful,” Los Angeles Times, July 25,
1975.</p></li>
<li><p>〔9〕 the nurses wore uniforms with plastic yellow buttons:
Alsop, Stay of Execution, 52.</p></li>
<li><p>〔10〕 “Saving the individual patient”: Ibid., 84.</p></li>
<li><p>〔11〕 In 1965, at Michigan State University: Barnett Rosenberg,
Loretta Van Camp, and Thomas Krigas, “Inhibition of Cell Division in
Escherichia coli by Electrolysis Products from a Platinum Electrode,”
Nature 205, no. 4972 (1965): 698–99.</p></li>
<li><p>〔12〕 John Cleland: Larry Einhorn, interview with author,
November 2009; also see Cure, Winter 2004; Craig A. Almeida and Sheila
A. Barry, Cancer: Basic Science and Clinical Aspects (Hoboken, NJ:
Wiley-Blackwell, 2010), 259; “Survivor Milks Life for All It’s Worth,”
Purdue Agriculture Connections, Spring 2006; “John Cleland Carried the
Olympic Torch in 2000 When the Relay Came through Indiana,” Friends 4
Cures, http://www.friends4cures.org/cure_mag_article.shtml (accessed
January 9, 2010).</p></li>
<li><p>〔13〕 “I cannot remember what I said”: John Cleland, Cure,
Winter 2004.</p></li>
<li><p>〔14〕 By 1975, Einhorn had treated: Einhorn, interview with
author, December 2009.</p></li>
<li><p>〔15〕 “Walking up to that podium”: Ibid.</p></li>
<li><p>〔16〕 “It was unforgettable”: Ibid. Also see “Triumph of the
Cure,” Salon, July 29, 1999,
http://www.salon.com/health/feature/1999/07/29/lance/index.html
(accessed November 30, 2009).</p></li>
<li><p>〔17〕 Margaret Edson’s play Wit: Margaret Edson, Wit (New York:
Dramatists Play Service, 1999).</p></li>
<li><p>〔18〕 “You may think my vocabulary”: Ibid., 28.</p></li>
<li><p>〔19〕 “We want and need and seek better guidance”: Howard E.
Skipper, “Cancer Chemotherapy Is Many Things: G.H.A. Clowes Memorial
Lecture,” Cancer Research31, no. 9 (1971): 1173–80.</p></li>
<li><p>〔20〕 There was Taxol: Monroe E. Wall and Mansukh C. Wani,
“Camptothecin and Taxol: Discovery to Clinic—Thirteenth Bruce F. Cain
Memorial Award Lecture,” Cancer Research 55 (1995): 753–60; Jordan
Goodman and Vivien Walsh, The Story of Taxol: Nature and Politics in the
Pursuit of an Anti-Cancer Drug (Cambridge, England: Cambridge University
Press, 2001).</p></li>
<li><p>〔21〕 Adriamycin, discovered in 1969: F. Arcamone et al.,
“Adriamycin, 14-hydroxydaimo-mycin, a New Antitumor Antibiotic from S.
Peucetius var. caesius,” Biotechnology and Bioengineering 11, no. 6
(1969): 1101–10.</p></li>
<li><p>〔22〕 could irreversibly damage the heart: C. A. J. Brouwer et
al., “Long-Term Cardiac Follow-Up in Survivors of a Malignant Bone
Tumor,” Annals of Oncology 17, no. 10 (2006): 1586–91.</p></li>
<li><p>〔23〕 Etoposide came from the fruit: A. M. Arnold and J. M. A.
Whitehouse, “Etoposide: A New Anti-cancer Agent,” Lancet 318, no. 8252
(1981): 912–15.</p></li>
<li><p>〔24〕 Bleomycin, which could scar lungs without warning: H.
Umezawa et al., “New Antibiotics, Bleomycin A and B,” Journal of
Antibiotics (Tokyo) 19, no. 5 (1966): 200–209; Nuno R. Grande et al.,
“Lung Fibrosis Induced by Bleomycin: Structural Changes and Overview of
Recent Advances,” Scanning Microscopy 12, no. 3 (1996): 487–94; R. S
Thrall et al., “The Development of Bleomycin-Induced Pulmonary Fibrosis
in Neutrophil-Depleted and Complement-Depleted Rats,” American Journal
of Pathology 105 (1981): 76–81.</p></li>
<li><p>〔25〕 “Did we believe we were going to cure cancer”: George
Canellos, interview with author.</p></li>
<li><p>〔26〕 In the mid-1970s: J. Ziegler, I. T. McGrath, and C. L.
Olweny, “Cure of Burkitt’s Lymphoma—Ten-Year Follow-Up of 157 Ugandan
Patients,” Lancet 3, no. 2 (8149) (1979): 936–38. Also see Ziegler et
al., “Combined Modality Treatment of Burkitt’s Lymphoma,” Cancer
Treatment Report 62, no. 12 (1978): 2031–34.</p></li>
<li><p>〔27〕
许多此类由NCI资助的临床试验均在乌干达完成，因为伯基特淋巴瘤在当地儿童中非常常见。——作者注</p></li>
<li><p>〔28〕 “Our applications skyrocketed”: Ibid.</p></li>
<li><p>〔29〕 “There is no cancer that is not potentially curable”:
“Cancer: The Chill Is Still There,” Los Angeles Times, March 20,
1979.</p></li>
<li><p>〔30〕 the eight-in-one study: J. Russel Geyer et al., “Eight
Drugs in One Day Chemotherapy in Children with Brain Tumors: A Critical
Toxicity Appraisal,” Journal of Clinical Oncology 6, no. 6 (1988):
996–1000.</p></li>
<li><p>〔31〕 “When doctors say that the side effects are tolerable”:
“Some Chemotherapy Fails against Cancer,” New York Times, August 6,
1985.</p></li>
<li><p>〔32〕 “The smiling oncologist”: Rose Kushner, “Is Aggressive
Adjuvant Chemotherapy the Halsted Radical of the ’80s?” 1984, draft 9,
Rose Kushner papers. The phrase was deleted in the final text that
appeared in 1984.</p></li>
<li><p>〔33〕 “Hexamethophosphacil with Vinplatin to potentiate”: Edson,
Wit, 31.</p></li>
<li><h4 id="第二十六章-知己知彼">第二十六章 知己知彼</h4></li>
<li><p>〔1〕 It is said that if you know your enemies: Sun Tzu, The Art
of War (Boston: Shambhala, 1988), 82.</p></li>
<li><p>〔2〕 a urological surgeon, Charles Huggins: Luis H.
Toledo-Pereyra, “Discovery in Surgical Investigation: The Essence of
Charles Brenton Huggins,” Journal of Investigative Surgery 14 (2001):
251–52; Robert E. Forster II, “Charles Brenton Huggins (22 September
1901–12 January 1997),” Proceedings of the American Philosophical
Society143, no. 2 (1999): 327–31.</p></li>
<li><p>〔3〕
通过化学或手术等外来方式使雄性动物丧失性功能或去除其生殖系统被称为去势。——译者注</p></li>
<li><p>〔4〕 Huggins’s studies of prostatic fluid: C. Huggins et al.,
“Quantitative Studies of Prostatic Secretion: I. Characteristics of the
Normal Secretion; the Influence of Thyroid, Suprarenal, and Testis
Extirpation and Androgen Substitution on the Prostatic Output,” Journal
of Experimental Medicine 70, no. 6 (1939): 543–56; Charles Huggins,
“Endocrine-Induced Regression of Cancers.” Science 156, no. 3778 (1967):
1050–54; Tonse N. K. Raju, “The Nobel Chronicles. 1966: Francis Peyton
Rous (1879–1970) and Charles Brenton Huggins (1901–1997), Lancet 354,
no. 9177 (1999): 520.</p></li>
<li><p>〔5〕 “It was vexatious to encounter a dog”: Huggins,
“Endocrine-Induced Regression.”</p></li>
<li><p>〔6〕 “Cancer is not necessarily autonomous”: Ibid.</p></li>
<li><p>〔7〕 “Its growth can be sustained and propagated”:
Ibid.</p></li>
<li><p>〔8〕 In 1929, Edward Doisy, a biochemist: Edward A. Doisy, “An
Autobiography,” Annual Review of Biochemistry 45 (1976): 1–12.</p></li>
<li><p>〔9〕 diethylstilbestrol (or DES): E. C. Dodds et al., “Synthetic
Oestrogenic Compounds Related to Stilbene and Diphenylethane. Part I,”
Proceedings of the Royal Society of London, Series B, Biological
Sciences 127, no. 847 (1939): 140–67; E. C. Dodds et al., “Estrogenic
Activity of Certain Synthetic Compounds,” Nature 141, no. 3562 (1938):
247–48; Edward Charles Dodds, Biochemical Contributions to
Endocrinology: Experiments in Hormonal Research (Palo Alto, CA: Stanford
University Press, 1957); Robert Meyers, D.E.S., the Bitter Pill (New
York: Seaview/Putnam, 1983).</p></li>
<li><p>〔10〕 Premarin, natural estrogen purified: Barbara Seaman, The
Greatest Experiment Ever Performed on Women: Exploding the Estrogen Myth
(New York: Hyperion, 2004), 20–21.</p></li>
<li><p>〔11〕 he could inject them to “feminize” the male body: Huggins,
“Endocrine-Induced Regression”; Charles Huggins et al., “Studies on
Prostatic Cancer: II. The Effects of Castration on Advanced Carcinoma of
the Prostate Gland,” Archives of Surgery 43 (1941): 209–23.</p></li>
<li><p>〔12〕 George Beatson and breast cancer: George Thomas Beatson,
“On the Treatment of Inoperable Cases of Carcinoma of the Mamma:
Suggestions for a New Method of Treatment, with Illustrative Cases,”
Lancet 2 (1896): 104–7; Serena Stockwell, “George Thomas Beatson,
M.D. (1848–1933),” CA: A Cancer Journal for Clinicians 33 (1983):
105–7.</p></li>
<li><p>〔13〕 only about two-thirds of all women: Alexis Thomson,
“Analysis of Cases in Which Oophorectomy was Performed for Inoperable
Carcinoma of the Breast,” British Medical Journal 2, no. 2184 (1902):
1538–41.</p></li>
<li><p>〔14〕 “It is impossible to tell beforehand”: Ibid.</p></li>
<li><p>〔15〕 a young chemist in Chicago: E. R. DeSombre, “Estrogens,
Receptors and Cancer: The Scientific Contributions of Elwood Jensen,”
Progress in Clinical and Biological Research 322 (1990): 17–29; E. V.
Jensen and V. C. Jordan, “The Estrogen Receptor: A Model for Molecular
Medicine,” Clinical Cancer Research 9, no. 6 (2003): 1980–89.</p></li>
<li><p>〔16〕 Ovarian removal produced many other severe side effects:
R. Sainsbury, “Ovarian Ablation as a Treatment for Breast Cancer,”
Surgical Oncology 12, no. 4 (2003): 241–50.</p></li>
<li><p>〔17〕 “there was little enthusiasm”: Jensen and Jordan, “The
Estrogen Receptor.”</p></li>
<li><p>〔18〕 Tamoxifen: Walter Sneader, Drug Discovery: A History (New
York: John Wiley and Sons, 2005), 198–99; G. R. Bedford and D. N.
Richardson, “Preparation and Identification of cis and trans Isomers of
a Substituted Triarylethylene,” Nature 212 (1966): 733–34.</p></li>
<li><p>〔19〕 Originally invented as a birth control pill: M. J. Harper
and A. L. Walpole, “Mode of Action of I.C.I. 46,474 in Preventing
Implantation in Rats,” Journal of Endocrinology 37, no. 1 (1967):
83–92.</p></li>
<li><p>〔20〕 tamoxifen had turned out to have exactly the opposite
effect: A. Klopper and M. Hall, “New Synthetic Agent for Induction of
Ovulation: Preliminary Trials in Women,” British Medical Journal 1, no.
5741 (1971): 152–54.</p></li>
<li><p>〔21〕 Arthur Walpole and breast cancer: V. C. Jordan, “The
Development of Tamoxifen for Breast Cancer Therapy: A Tribute to the
Late Arthur L. Walpole,” Breast Cancer Research and Treatment 11, no. 3
(1988): 197–209.</p></li>
<li><p>〔22〕 Mary Cole’s tamoxifen trial: M. P. Cole et al., “A New
Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical
Appraisal of ICI46474,” British Journal of Cancer 25, no. 2 (1971):
270–75; Sneader, Drug Discovery, 199.</p></li>
<li><p>〔23〕 In 1973, V. Craig Jordan: See V. C. Jordan, Tamoxifen: A
Guide for Clinicians and Patients (Huntington, NY: PRR, 1996). Also see
V. C. Jordan, “Effects of Tamoxifen in Relation to Breast Cancer,”
British Medical Journal 6075 (June 11, 1977): 1534–35.</p></li>
<li><h4 id="第二十七章-辅助化疗">第二十七章 辅助化疗</h4></li>
<li><p>〔1〕 I would rather be ashes: Jack London, Tales of Adventure
(Fayetteville, AR: Hannover House, 1956), vii.</p></li>
<li><p>〔2〕 Will you turn me out: Cicely Saunders, Selected Writings,
1958–2004, 1st ed. (Oxford: Oxford University Press, 2006), 71.</p></li>
<li><p>〔3〕 at the NCI, Paul Carbone, had launched a trial: Vincent T.
DeVita, “Paul Carbone: 1931–2002,” Oncologist 7, no. 2 (2002):
92–93.</p></li>
<li><p>〔4〕 “Except for an occasional woman”: Paul Carbone, “Adjuvant
Therapy of Breast Cancer 1971–1981,” Breast Cancer Research and
Treatment 2 (1985): 75–84.</p></li>
<li><p>〔5〕 With his own trial, the NSABP-04: B. Fisher et al.,
“Comparison of Radical Mastectomy with Alternative Treatments for
Primary Breast Cancer. A First Report of Results from a Prospective
Randomized Clinical Trial,” Cancer 39 (1977): 2827–39.</p></li>
<li><p>〔6〕 In 1972, as the NCI was scouring the nation: G. Bonadonna
et al., “Combination Chemotherapy as an Adjuvant Treatment in Operable
Breast Cancer,” New England Journal of Medicine 294, no. 8 (1976):
405–10; Vincent T. DeVita Jr. and Edward Chu, “A History of Cancer
Chemotherapy,” Cancer Research 68, no. 21 (2008): 8643–53.</p></li>
<li><p>〔7〕 “The surgeons were not just skeptical”: Springer, European
Oncology Leaders (Berlin, 2005), 159–65.</p></li>
<li><p>〔8〕 Fisher’s tamoxifen trial: B. Fisher et al., “Adjuvant
Chemotherapy with and with-out Tamoxifen in the Treatment of Primary
Breast Cancer: 5-Year Results from the National Surgical Adjuvant Breast
and Bowel Project Trial,” Journal of Clinical Oncology 4, no. 4 (1986):
459–71.</p></li>
<li><p>〔9〕 “We were all more naive a decade ago”: “Some Chemotherapy
Fails against Cancer,” New York Times, August 6, 1985.</p></li>
<li><p>〔10〕 “We shall so poison the atmosphere of the first act”:
James Watson, New York Times,May 6, 1975.</p></li>
<li><p>〔11〕 “If there is persistent pain”: J. C. White, “Neurosurgical
Treatment of Persistent Pain,” Lancet 2, no. 5 (1950): 161–64.</p></li>
<li><p>〔12〕 “a window in 〔her〕 home”: Saunders, Selected Writings,
xiv.</p></li>
<li><p>〔13〕 care, she wrote, “is a soft word”: ibid., 255.</p></li>
<li><p>〔14〕 “The resistance to providing palliative care to patients”:
Nurse J. N. (name withheld), interview with author, June 2007.</p></li>
<li><p>〔15〕 “The provision of … terminal care: Saunders, Selected
Writings, 71.</p></li>
<li><h4 id="第二十八章-癌症统计">第二十八章 癌症统计</h4></li>
<li><p>〔1〕 We must learn to count the living: Audre Lourde, The Cancer
Journals, 2nd ed. (San Francisco: Aunt Lute, 1980), 54.</p></li>
<li><p>〔2〕 Counting is the religion of this generation: Gertrude
Stein, Everybody’s Autobiography (New York: Random House, 1937),
120.</p></li>
<li><p>〔3〕 “These registries,” Cairns wrote in an article: John
Cairns, “Treatment of Diseases and the War against Cancer,” Scientific
American 253, no. 5 (1985): 51–59.</p></li>
<li><p>〔4〕 John Bailar and Elaine Smith’s analysis: J. C. Bailar III
and E. M. Smith, “Progress against Cancer?” New England Journal of
Medicine 314, no. 19 (1986): 1226–32.</p></li>
<li><p>〔5〕 cancer mortality was not declining: This was not unique to
the United States; the sta-tistics were similarly grim across Europe. In
1985, a separate analysis of age-adjusted cancer mortality across
twenty-eight developed countries revealed an increase in cancer
mortality of about 15 percent.</p></li>
<li><p>〔6〕 There is “no evidence”: Bailar and Smith, “Progress against
Cancer?”</p></li>
<li><p>〔7〕 “a thorn in the side of the National Cancer Institute”:
Gina Kolata, “Cancer Progress Data Challenged,” Science 232, no. 4753
(1986): 932–33.</p></li>
<li><p>〔8〕 As evidence, they pointed to a survey: See E. M. Greenspan,
“Commentary on September 1985 NIH Consensus Development Conference on
Adjuvant Chemotherapy for Breast Cancer,” Cancer Investigation 4, no. 5
(1986): 471–75. Also see Ezra M. Greenspan, let-ter to the editor, New
England Journal of Medicine 315, no. 15 (1986): 964.</p></li>
<li><p>〔9〕 “The problem with reliance on a single measure”: Lester
Breslow and William G. Cumberland, “Progress and Objectives in Cancer
Control,” Journal of the American Medical Association 259, no. 11
(1988): 1690–94.</p></li>
<li><p>〔10〕 “Our purpose in making these calculations”: Ibid. The
order of the quotation has been inverted for the purpose of this
narrative.</p></li>
<li><p>〔11〕 罗夏测验由瑞士精神科医生、精神病学家罗夏（Hermann
Rorschach）创立，亦称罗夏墨迹（Inkblo）测验、罗夏技术或简称罗夏。罗夏测验因使用墨渍图版又被称为墨渍图测验，现在已经被世界各国广泛使用。罗夏墨迹测验是最著名的投射法人格测验。测试方法是让受试者通过某种媒介建立起自己想象的世界，而受试者可能会透过这种无拘无束的情景显露其个性。——译者注</p></li>
<li><p>〔12〕 prevention research received: John Bailar interviewed by
Elizabeth Farnsworth, “Treatment versus Prevention” (transcript),
NewsHour with Jim Leher, PBS, May 29, 1997; Richard M. Scheffler and
Lynn Paringer, “A Review of the Economic Evidence on Prevention,”
Medical Care 18, no. 5 (1980): 473–84.</p></li>
<li><p>〔13〕 By 1992, this number had increased: Samuel S. Epstein,
Cancer-Gate: How to Win the Losing Cancer War (Amityville, NY: Baywood
Publishing Company, 2005), 59.</p></li>
<li><p>〔14〕 In 1974, describing to Mary Lasker: Letter from Frank
Rauscher to Mary Lasker, March 18, 1974, Mary Lasker Papers, Box 118,
Columbia University.</p></li>
<li><p>〔15〕 At Memorial Sloan-Kettering in New York: Ralph W. Moss,
The Cancer Syndrome (New York: Grove Press, 1980), 221.</p></li>
<li><p>〔16〕 “not one” was able to suggest an “idea”: Edmund Cowdry,
Etiology and Prevention of Cancer in Man (New York: Appleton-Century,
1968), xvii.</p></li>
<li><p>〔17〕
这种质疑可能有其内在缺陷，因为它没有涉及预防和治疗的关系。——作者注</p></li>
<li><p>〔18〕 Prevention, he noted drily: Moss, The Cancer Syndrome,
221.</p></li>
<li><p>〔19〕 “A shift in research emphasis”: Bailar and Smith,
“Progress against Cancer?”</p></li>
<li><p>〔1〕 It should first be noted: David Cantor, “Introduction:
Cancer Control and Prevention in the Twentieth Century,” Bulletin of the
History of Medicine 81 (2007): 1–38.</p></li>
<li><p>〔2〕 The idea of preventive medicine: “False Front in War on
Cancer,” Chicago Tribune, February 13, 1975.</p></li>
<li><p>〔3〕 The same correlation could be drawn: Ernest L. Wynder
letter to Evarts A. Graham, June 20, 1950, Evarts Graham
papers.</p></li>
<li><h4 id="第二十九章-黑色棺材">第二十九章 “黑色棺材”</h4></li>
<li><p>〔1〕 When my mother died I was very young: “The Chimney
Sweeper,” William Blake, The Complete Poetry and Prose of William Blake,
ed. David V. Erdman (New York: Random House, 1982), 10.</p></li>
<li><p>〔2〕 It is a disease, he wrote: Percivall Pott and James Earles,
The Chirurgical Works of Percivall Pott, F.R.S. Surgeon to
St. Bartholomew’s Hospital, a New Edition, with His Last Corrections, to
Which Are Added, a Short Account of the Life of the Author, a Method of
Curing the Hydrocele by Injection, and Occasional Notes and
Observations, by Sir James Earle, F.R.S. Surgeon Extraordinary to the
King (London: Wood and Innes, 1808), 3: 177.</p></li>
<li><p>〔3〕 “Syphilis,” as the saying ran: Michael J. O’Dowd and Elliot
E. Philipp, The History of Obstetrics ＆ Gynaecology (New York:
Parthenon Publishing Group, 2000), 228.</p></li>
<li><p>〔4〕 In 1713, Ramazzini had published: Bernardino Ramazzini, De
Morbis Artificum Diatriba (Apud Josephum Corona, 1743).</p></li>
<li><p>〔5〕
煤烟由多种化合物混合而成，它最终被证实含有数种致癌物。——作者注</p></li>
<li><p>〔6〕 “All this makes it (at first) a very different case”: Pott
and Earles, Chirurgical Works, 3: 177.</p></li>
<li><p>〔7〕 Eighteenth-century England: See Peter Kirby, Child Labor in
Britain, 1750–1870 (Hampshire, UK: Palgrave Macmillan, 2003). For
details on chimney sweeps, see ibid., 9; and Parliamentary Papers
1852–52, 88, pt. 1, tables 25, 26.</p></li>
<li><p>〔8〕 “I wants a ’prentis”: Charles Dickens, Oliver Twist, or The
Parish Boy’s Progress (London: J. M. Dent ＆ Sons, 1920), 16.</p></li>
<li><p>〔9〕 In 1788, the Chimney Sweepers Act: Joel H. Wiener, Great
Britain: The Lion at Home: A Documentary History of Domestic Policy,
1689–1973 (New York: Chelsea House Publishers, 1974), 800.</p></li>
<li><p>〔10〕 In 1761, more than a decade before: John Hill, Cautions
against the Immoderate Use of Snuff (London: R. Baldwin and J. Jackson,
1761).</p></li>
<li><p>〔11〕 a self-professed “Bottanist, apothecary, poet”: G. S.
Rousseau, ed. The Letters and Papers of Sir John Hill, 1714–1775 (New
York: AMS Press, 1982), 4.</p></li>
<li><p>〔12〕 “close, clouded, hot, narcotic rooms”: George Crabbe, The
Poetical Works of the Rev. George Crabbe: With his Letters and Journals,
and His Life (London: John Murray, 1834), 3: 180.</p></li>
<li><p>〔13〕 By the mid-1700s, the state of Virginia: See Paul G. E.
Clemens, “From Tobacco to Grain,” Journal of Economic History 35, no. 1:
256–59.</p></li>
<li><p>〔14〕 In England the import of tobacco: Kenneth Morgan, Bristol
and the Atlantic Trade in the Eighteenth Century (Cambridge University
Press, 1993), 152.</p></li>
<li><p>〔15〕 In 1855, legend runs, a Turkish soldier: See Richard
Klein, Cigarettes Are Sublime (Durham, NC: Duke University Press, 1993),
134–35.</p></li>
<li><p>〔16〕 In 1870, the per capita consumption in America: Jack
Gottsegen, Tobacco: A Study of Its Consumption in the United States (New
York: Pittman, 1940).</p></li>
<li><p>〔17〕 A mere thirty years later, Americans: Ibid.</p></li>
<li><p>〔18〕 On average, an adult American smoked ten cigarettes:
Harold F. Dorn, “The Relationship of Cancer of the Lung and the Use of
Tobacco,” American Statistician 8, no. 5 (1954): 7–13.</p></li>
<li><p>〔19〕 By the early twentieth century, four out of five: Richard
Peto, interview with author, September 2008.</p></li>
<li><p>〔20〕 “By the early 1940s, asking about a connection”:
Ibid.</p></li>
<li><p>〔21〕 “So has the use of nylon stockings”: John Wilds and Ira
Harkey, Alton Ochsner, Surgeon of the South (Baton Rouge: Louisiana
State University Press, 1990), 180.</p></li>
<li><p>〔22〕 “the cigarette century”: Allan M. Brandt, The Cigarette
Century: The Rise, Fall, and Deadly Persistence of the Product That
Defined America (New York: Basic Books, 2007).</p></li>
<li><h4 id="第三十章-皇帝的新装">第三十章 皇帝的新装</h4></li>
<li><p>〔1〕 Whether epidemiology alone can: Sir Richard Doll, “Proof of
Causality: Deduction from Epidemiological Observation,” Perspectives in
Biology and Medicine 45 (2002): 499–515.</p></li>
<li><p>〔2〕 lung cancer morbidity had risen nearly fifteenfold: Richard
Doll and A. Bradford Hill, “Smoking and Carcinoma of the Lung,” British
Medical Journal 2, no. 4682 (1950): 739–48.</p></li>
<li><p>〔3〕 “matter that ought to be studied”: Richard Peto, “Smoking
and Death: The Past 40 Years and the Next 40,” British Medical Journal
309 (1994): 937–39.</p></li>
<li><p>〔4〕 In February 1947, in the midst of a bitterly cold:
Ibid.</p></li>
<li><p>〔5〕 One expert, having noted parenthetically: British Public
Records Office, file FD. 1, 1989, as quoted by David Pollock, Denial and
Delay (Washington, DC: Action on Smoking and Health, 1989); full text
available through Action on Smoking and Health, www.ash.org.</p></li>
<li><p>〔6〕 Yet the resources committed for the study: Medical Research
Council 1947/366 and Ibid.</p></li>
<li><p>〔7〕 In the summer of 1948: Pollock, Denial and Delay, prologue.
Also see Sir Richard Doll, “The First Report on Smoking and Lung
Cancer,” in Ashes to Ashes: The History of Smoking and Health, Stephen
Lock, Lois A. Reynolds, and E. M. Tansey, eds. (Amsterdam: Editions
Rodopi B.V., 1998), 129–37.</p></li>
<li><p>〔8〕 “The same correlation could be drawn to the intake of
milk”: Ernst L. Wynder, letter to Evarts A. Graham, June 20, 1950,
Evarts Graham papers.</p></li>
<li><p>〔9〕 Wynder and Graham’s trial: Ernst L. Wynder and Evarts A.
Graham, “Tobacco Smoking as a Possible Etiologic Factor in Bronchiogenic
Carcinoma: A Study of Six Hundred and Eighty-Four Proved Cases,” Journal
of the American Medical Association143 (1950): 329–38.</p></li>
<li><p>〔10〕 When Wynder presented his preliminary ideas: Ernst L.
Wynder, “Tobacco as a Cause of Lung Cancer: Some Reflections,” American
Journal of Epidemiology 146 (1997), 687–94. Also see Jon Harkness, “The
U.S. Public Health Service and Smoking in the 1950s: The Tale of Two
More Statements,” Journal of the History of Medicine and Allied Sciences
62, no. 2 (2007): 171–212.</p></li>
<li><p>〔11〕 Doll and Hill’s study: Doll and Hill, “Smoking and
Carcinoma of the Lung.”</p></li>
<li><p>〔12〕 When the price of cigarettes was increased: Richard Peto,
personal interview. Also see Virginia Berridge, Marketing Health:
Smoking and the Discourse of Public Health in Britain (Oxford: Oxford
University Press, 2007), 45.</p></li>
<li><p>〔13〕 By May 1, 1948, 156 interviews: David Pollock, “Denial and
Delay,” collections from the public record office files deposited in the
Action on Smoking and Health archives, UK. Also see the Action on
Smoking and Health Tobacco Chronology,
http://www.ash.org.uk/ash_669pax88_archive.htm (accessed January 21,
2010).</p></li>
<li><p>〔14〕 In the early 1940s, a similar notion had gripped: R. A.
Fisher and E. B. Ford, “The Spread of a Gene in Natural Conditions in a
Colony of the Moth Panaxia diminula L.,” Heredity 1 (1947):
143–74.</p></li>
<li><p>〔15〕 福特的学生亨利·B.D.凯特尔韦尔（Henry
B.D.Kettlewell）曾经采用这种飞蛾标记法证明黑色飞蛾（能够较好地隐藏于被污染、熏黑的树木上）可以躲避飞禽的捕食，从而展现出“自然选择”所发挥的作用。——作者注</p></li>
<li><p>〔16〕 And the notion of using a similar cohort: Stephen Lock,
Lois A. Reynolds, and E. M. Tansey, eds., Ashes to Ashes (Amsterdam:
Editions Rodopi B.V., 1998), 137.</p></li>
<li><p>〔17〕 Doll and Hill’s study of smoking habits and lung cancer in
doctors: Richard Doll and A. Bradford Hill, “The Mortality of Doctors in
Relation to Their Smoking Habits: A Preliminary Report,” British Medical
Journal 1, no. 4877 (1954): 1451–55.</p></li>
<li><h4 id="第三十一章-夜贼">第三十一章 “夜贼”</h4></li>
<li><p>〔1〕 By the way, 〔my cancer〕: Evarts Graham, letter to Ernst
Wynder, February 6, 1957, Evarts Graham papers.</p></li>
<li><p>〔2〕 We believe the products that we make: “A Frank Statement to
Cigarette Smokers,” New York Times, January 4, 1954.</p></li>
<li><p>〔3〕 Cigarette sales had climbed: See, for instance, Richard
Kluger, Ashes to Ashes (New York: Vintage Books, 1997), 104–6, 123, 125.
Also see Verner Grise, U.S. Cigarette Consumption: Past, Present and
Future, conference paper, 30th Tobacco Workers Conference, Williamsburg,
VA, 1983 (archived at http://tobaccodocuments.org).</p></li>
<li><p>〔4〕 cigarette industry poured tens, then hundreds: For a
succinct history of postwar adver-tising campaigns of cigarette makers
see Kluger, Ashes to Ashes, 80–298.</p></li>
<li><p>〔5〕 “More doctors smoke Camels”: See, for example, Life,
October 6, 1952, back cover.</p></li>
<li><p>〔6〕 At the annual conferences of the American Medical
Association: See Martha N. Gardner and Allan M. Brandt, “‘The Doctors’
Choice Is America’s Choice’: The Physician in US Cigarette
Advertisements, 1930–1953,” American Journal of Public Health 96, no. 2
(2006): 222–32.</p></li>
<li><p>〔7〕 In 1955, when Philip Morris: Katherine M. West, “The
Marlboro Man: The Making of an American Image,” American Studies at the
University of Virginia website,
http://xroads.virginia.edu/~CLASS/marlboro/mman.html (accessed December
23, 2009).</p></li>
<li><p>〔8〕 “Man-sized taste of honest tobacco”: Ibid.</p></li>
<li><p>〔9〕 By the early 1960s, the gross annual sale: Estimated from
U.S. Surgeon General’s report on per capita consumption rates for
1960–1970.</p></li>
<li><p>〔10〕 On average, Americans were consuming: Jeffrey E. Harris,
“Patterns of Cigarette Smoking,” The Health Consequences of Smoking for
Women: A Report of the Surgeon General (Washington, DC: U.S. Department
of Health and Human Services, 1980), 15–342. Also see Allan Brandt, The
Cigarette Century, 97.</p></li>
<li><p>〔11〕 On December 28, 1953, three years before: “Notes on
Minutes of the Tobacco Industry Research Committee Meeting—December 28,
1953,” John W. Hill papers, “Selected and Related Documents on the Topic
of the Hill ＆ Knowlton Public Relations Campaign Formulated on Behalf
of the Tobacco Industry Research Committee,” State Historical Society of
Wisconsin, http://www.ttlaonline.com/HKWIS/12307.pdf (accessed December
23, 2009).</p></li>
<li><p>〔12〕 The centerpiece of that counterattack: “Frank Statement,”
New York Times.</p></li>
<li><p>〔13〕 In January 1954, after a protracted search: Brandt,
Cigarette Century, 178.</p></li>
<li><p>〔14〕 In a guest editorial written for the journal: C. C.
Little, “Smoking and Lung Cancer,” Cancer Research 16, no. 3 (1956):
183–84.</p></li>
<li><p>〔15〕 In a stinging rebuttal written to the editor: Evarts A.
Graham, “To the Editor of Cancer Research,” Cancer Research 16 (1956):
816–17.</p></li>
<li><p>〔16〕 “We may subject mice, or other laboratory animals”: Sir
Austin Bradford Hill, Statistical Methods in Clinical and Preventative
Medicine (London: Livingstone, 1962), 378.</p></li>
<li><p>〔17〕 Graham had invented a “smoking machine”: Ernst L. Wynder,
Evarts A. Graham, and Adele B. Croninger, “Experimental Production of
Carcinoma with Cigarette Tar,” Cancer Research 13 (1953):
855–64.</p></li>
<li><p>〔18〕 Forbes magazine had famously spoofed the research: Forbes
72 (1953): 20.</p></li>
<li><p>〔19〕 Bradford Hill’s nine criteria for epidemiology: Sir Austin
Bradford Hill, “The Environment and Disease: Association or Causation?”
Proceedings of the Royal Society of Medicine 58, no. 5 (1965):
295–300.</p></li>
<li><p>〔20〕 “Perhaps you have heard that”: Letter from Evarts Graham
to Alton Ochsner, February 14, 1957, Evarts Graham papers.</p></li>
<li><p>〔21〕 In the winter of 1954, three years before: Alton Ochsner,
Smoking and Cancer: A Doctor’s Report (New York: J. Messner,
1954).</p></li>
<li><h4 id="第三十二章-警告声明">第三十二章 “警告声明”</h4></li>
<li><p>〔1〕 Our credulity would indeed be strained: Eva Cooper v. R. J.
Reynolds Tobacco Company,256 F.2d 464 (1st Cir., 1958).</p></li>
<li><p>〔2〕 Certainly, living in America in the last half: Burson
Marsteller (PR firm) internal document, January 1, 1988. Cipollone
postverdict document available at the UCSF Legacy Tobacco Documents
Library.</p></li>
<li><p>〔3〕 In the summer of 1963, seven years after: See Richard
Kluger, Ashes to Ashes, 254–55.</p></li>
<li><p>〔4〕 Auerbach’s paper describing the lesions: O. Auerbach and A.
P. Stout, “The Role of Carcinogens, Especially Those in Cigarette Smoke,
in the Production of Precancerous Lesions,” Proceedings of the National
Cancer Conference 4 (1960): 297–304.</p></li>
<li><p>〔5〕 Auerbach’s three visitors that morning: See Kluger, Ashes
to Ashes, 254.</p></li>
<li><p>〔6〕 与西德尼·法伯没有血缘关系。——作者注</p></li>
<li><p>〔7〕 In 1961, the American Cancer Society: “The 1964 Report on
Smoking and Health,” Reports of the Surgeon General, Profiles in
Science: National Library of Medicine,
http://profiles.nlm.nih.gov/NN/Views/Exhibit/narrative/smoking.html
(accessed December 26, 2009); U.S. Surgeon General. “Smoking and
Health,” Report of the Advisory Committee to the Surgeon General of the
Public Health Service, Public Health Service publication no. 1103
(Washington, DC: U.S. Department of Health, Education, and Welfare,
Public Health Service, 1964).</p></li>
<li><p>〔8〕 “a reluctant dragon”: Lester Breslow, A History of Cancer
Control in the United States, 1946–1971 (Bethesda, MD: U.S. National
Cancer Institute, 1979), 4: 24.</p></li>
<li><p>〔9〕 he announced that he would appoint an advisory committee:
U.S. Surgeon General’s report: Smoking and Health, 1964.</p></li>
<li><p>〔10〕 Data, interviews, opinions, and testimonies:
Ibid.</p></li>
<li><p>〔11〕 Each member of the committee: Ibid. Also see Kluger, Ashes
to Ashes, 243–45.</p></li>
<li><p>〔12〕 “The word ‘cause,’” the report read: U.S. Surgeon
General’s report: Smoking and Health.</p></li>
<li><p>〔13〕 Luther Terry’s report, a leatherbound, 387-page: “1964
Report on Smoking and Health.”</p></li>
<li><p>〔14〕 “While the propaganda blast was tremendous”: George
Weissman memo to Joseph Cullman III, January 11, 1964, Tobacco Documents
Online, http://tobaccodocuments.org/landman/1005038559–8561.html
(accessed December 26, 2009).</p></li>
<li><p>〔15〕 the commission’s shining piece of lawmaking: Annual Report
of the Federal Trade Commission (Washington DC: United States Printing
Office, 1950), 65.</p></li>
<li><p>〔16〕 In 1957, John Blatnik, a Minnesota chemistry teacher:
“Making Cigarette Ads Tell the Truth,” Harper’s, August 1958.</p></li>
<li><p>〔17〕 The FTC had been revamped: “Government: The Old Lady’s New
Look,” Time, April 16, 1965.</p></li>
<li><p>〔18〕 A week later, in January 1964: Federal Trade Commission,
“Advertising and Labeling of Cigarettes. Notice of Rule-Making
Proceeding for Establishment of Trade Regulation Rules,” Federal
Register, January 22, 1964, 29:530–32.</p></li>
<li><p>〔19〕 they voluntarily requested regulation by Congress: “The
Quiet Victory of the Cigarette Lobby: How It Found the Best Filter
Yet—Congress,” Atlantic, September 1965.</p></li>
<li><p>〔20〕 Entitled the Federal Cigarette Labeling and Advertising
Act: Cigarette Labeling and Advertising Act, Title 15, chap. 36, 1965;
“Quiet Victory of the Cigarette Lobby.”</p></li>
<li><p>〔21〕 In the early summer of 1967, Banzhaf: John F. Banzhaf III
v. Federal Communications Commission et al., 405 F.2d 1082 (D.C. Cir.
1968).</p></li>
<li><p>〔22〕 “The advertisements in question”: Ibid.</p></li>
<li><p>〔23〕 “a squadron of the best-paid lawyers in the country”: John
Banzhaf, interview with author, June 2008.</p></li>
<li><p>〔24〕 “Doubt is our product”: “Smoking and Health
Proposal,”1969, Brown ＆ Williamson Collection, Legacy Tobacco Documents
Library, University of California, San Francisco.</p></li>
<li><p>〔25〕 In 1968, a worn and skeletal-looking William Talman: A
video of the ad is available at
http://www.classictvads.com/smoke_1.shtml (accessed December 26,
2009).</p></li>
<li><p>〔26〕 The last cigarette commercial: See Brandt, Cigarette
Century, 271.</p></li>
<li><p>〔27〕 He had already died: “William Hopper, Actor, Dies;
Detective in ‘Perry Mason,’ 54,” New York Times, March 7, 1970.</p></li>
<li><p>〔28〕 cigarette consumption in America plateaued: U.S.
Department of Agriculture, Tobacco Situation and Outlook Report,
publication no. TBS-226 (Washington, DC: U.S. Department of Agriculture,
Economic Research Service, Commodity Economics Division, April 1994)
table 2; G. A. Glovino, “Surveillance for Selected Tobacco-Use
Behaviors—United States, 1900–1994,” Morbidity and Mortality Weekly
Report CDC Surveillance Summaries 43, no. 3 (1994): 1–43.</p></li>
<li><p>〔29〕 “Statistics,” the journalist Paul Brodeur once wrote: Paul
Brodeur, Outrageous Misconduct: The Asbestos Industry on Trial (New
York: Pantheon Books, 1985).</p></li>
<li><p>〔30〕 She represented the midpoint: See “Women and Smoking,”
Report of the U.S. Surgeon General 2001, and prior report from
1980.</p></li>
<li><p>〔31〕 “〔It’s〕 a game only for steady nerves”: See, for
example, Popular Mechanics, November 1942, back cover.</p></li>
<li><p>〔32〕 “never twittery, nervous or jittery”: Redd Evans and John
Jacob Loeb, “Rosie the Riveter” (New York: Paramount Music Corp.,
1942).</p></li>
<li><p>〔33〕 Marc Edell, a New Jersey attorney: For details of
Cipollone’s case see Cipollone v. Liggett Group, Inc., 505 U.S. 504
(1992).</p></li>
<li><p>〔34〕 “deaf, dumb and blind”: Ibid.</p></li>
<li><p>〔35〕 In the three decades between 1954 and 1984: Burson
Marsteller (PR firm), Position Paper, History of Tobacco Litigation
Third Draft, May 10, 1988.</p></li>
<li><p>〔36〕 “Plaintiff attorneys can read the writing”: Burson
Marsteller (PR firm), internal docu-ment, Cipollone postverdict
communication plan, January 1, 1988.</p></li>
<li><p>〔37〕 In one letter, Fred Panzer: David Michaels, Doubt Is Their
Product: How Industry’s Assault on Science Threatens Your Health
(Oxford: Oxford University Press, 2008), 11. Also see Brown and
Williamson (B ＆ W), “Smoking and Health Proposal,” B ＆ W document no.
680561778-1786, 1969, available at
http://legacy.library.ucsf.edu/tid/nvs40f00.</p></li>
<li><p>〔38〕 “In a sense, the tobacco industry may be thought”:
“Research Planning Memorandum on the Nature of the Tobacco Business and
the Crucial Role of Nicotine Therein,” April 14, 1972, Anne Landman’s
Collection, Tobacco Documents Online,
http://tobaccodocuments.org/landman/501877121–7129.html (accessed
December 26, 2009).</p></li>
<li><p>〔39〕 “Think of the cigarette pack as a storage container”:
“Motives and Incentives in Cigarette Smoking,” 1972, Anne Landman’s
Collection, Tobacco Documents Online,
http://tobaccodocuments.org/landman/2024273959–3975.html (accessed
December 26, 2009).</p></li>
<li><p>〔40〕 Edell quizzed Liggett’s president: Cipollone v. Liggett
Group, Inc., et al., transcript of proceedings 〔excerpt〕, Tobacco
Products Litigation Reporter 3, no. 3 (1988): 3.2261–3.268.</p></li>
<li><p>〔41〕 the Cipollone cancer trial appeared before the court in
1987: See Cipollone v. Liggett Group, Inc., et al., 893 F.2d 541 (1990);
Cipollone v. Liggett Group, Inc., et al., 505 U.S. 504 (1992).</p></li>
<li><p>〔42〕 By 1994, the per capita consumption of cigarettes in
America: “Trends in Tobacco Use,” American Lung Association Research and
Program Services Epidemiology and Statistics Unit, July 2008,
http://www.lungusa.org/finding-cures/for-professionals/epidemiology-and-statistics-rpts.html
(accessed December 27, 2009).</p></li>
<li><p>〔43〕 Among men, the age-adjusted incidence: “Trends in Lung
Cancer Morbidity and Mortality,” American Lung Association Epidemiology
and Statistics Unit, Research and Program Services Division, September
2008,
http://www.lungusa.org/finding-cures/for-professionals/epidemiology-and-statistics-rpts.html
(accessed December 27, 2009).</p></li>
<li><p>〔44〕 In 1994, in yet another landmark case: “Mississippi Seeks
Damages from Tobacco Companies,” New York Times, May 24, 1994.</p></li>
<li><p>〔45〕 “You caused the health crisis”: Ibid.</p></li>
<li><p>〔46〕 Several other states then followed: “Tobacco Settlement
Nets Florida 1.3B,” USA Today, August 25, 1997; “Texas Tobacco Deal Is
Approved,” New York Times, January 17, 1998.</p></li>
<li><p>〔47〕 In June 1997, facing a barrage: The Master Settlement
Agreement is available online from the Office of the Attorney General of
California, http://www.ag.ca.gov/tobacco/msa.php (accessed December 27,
2009).</p></li>
<li><p>〔48〕 Tobacco smoking is now a major preventable cause: Gu et
al., “Mortality Attributable to Smoking in China,” New England Journal
of Medicine 360, no. 2 (2009): 150–59; P. Jha et al., “A Nationally
Representative Case-Control Study of Smoking and Death in India,” New
England Journal of Medicine 358, no. 11 (2008): 1137–47.</p></li>
<li><p>〔49〕 Richard Peto, an epidemiologist at Oxford: Ibid.</p></li>
<li><p>〔50〕 In China, lung cancer is already: Gu et al., “Mortality
Attributable to Smoking in China.”</p></li>
<li><p>〔51〕 In 2004, tobacco companies signed: Samet et al., “Mexico
and the Tobacco Industry,” BMJ 3 (2006): 353–55.</p></li>
<li><p>〔52〕 In the early 1990s, a study noted, British American
Tobacco: Gilmore et al., “American Tobacco’s Erosion of Health
Legislation in Uzbekistan,” BMJ 332 (2006): 355–58.</p></li>
<li><p>〔53〕 Cigarette smoking grew by about 8 percent: Ibid.</p></li>
<li><p>〔54〕 In a recent editorial in the British Medical Journal:
Ernesto Sebrié and Stanton A. Glantz, “The Tobacco Industry in
Developing Countries,” British Medical Journal332, no. 7537 (2006):
313–14.</p></li>
<li><h4 id="第三十三章-危险因素">第三十三章 危险因素</h4></li>
<li><p>〔1〕 You’re under a lot of stress: Transcript of interview with
Barry Marshall and an anonymous interviewer, National Health and Medical
Research Council archives, Australia.</p></li>
<li><p>〔2〕 In the early 1970s, for instance, a series of studies: J.
S. Harrington, “Asbestos and Mesothelioma in Man,” Nature 232, no. 5305
(1971): 54–55; P. Enterline, P. DeCoufle, and V. Henderson, “Mortality
in Relation to Occupational Exposure in the Asbestos Industry,” Journal
of Occupational Medicine 14, no. 12 (1972): 897–903; “Asbestos, the
Saver of Lives, Has a Deadly Side,” New York Times, January 21, 1973;
“New Rules Urged For Asbestos Risk,” New York Times, October 5,
1975.</p></li>
<li><p>〔3〕 In 1971, yet another such study identified: Arthur L.
Herbst, Howard Ulfelder, and David C. Poskanzer, New England Journal of
Medicine 284, no. 15 (1971): 878–81.</p></li>
<li><p>〔4〕 In the late 1960s, a bacteriologist named Bruce Ames: Bruce
N. Ames et al., “Carcinogens Are Mutagens: A Simple Test System
Combining Liver Homogenates for Activation and Bacteria for Detection,”
Proceedings of the National Academy of Sciences of the United States of
America 70, no. 8 (1973): 2281–85; Bruce N. Ames, “An Improved Bacterial
Test System for the Detection and Classification of Mutagens and
Carcinogens,” Proceedings of the National Academy of Sciences of the
United States of America 70, no. 3 (1973): 82–786.</p></li>
<li><p>〔5〕 So did X-rays, benzene compounds, and nitrosoguanidine:
“Carcinogens as Frameshift Mutagens: Metabolites and Derivatives of
2-Acetylaminofluorene and Other Aromatic Amine Carcinogens,” Proceedings
of the National Academy of Sciences of the United States of America 69,
no. 11 (1972): 3128–32.</p></li>
<li><p>〔6〕 Not every known carcinogen scored on the test: For DES, see
Ishikawa et al., “Lack of Mutagenicity of Diethylstilbestrol Metabolite
and Analog, (±)-Indenestrols A and B, in Bacterial Assays,” Mutation
Research/Genetic Toxicology 368, nos. 3–4 (1996): 261–65; for asbestos,
see K. Szyba and A. Lange, “Presentation of Benzo(a)pyrene to Microsomal
Enzymes by Asbestos Fibers in the Salmonella/Mammalian Microsome
Mutagenicity Test,” Environmental Health Perspectives 51 (1983):
337–41.</p></li>
<li><p>〔7〕 A biochemistry student at Oxford: Marc A. Shampo and Robert
A. Kyle, “Baruch Blumberg—Work on Hepatitis B Virus,” Mayo Clinic
Proceedings 78, no. 9 (2003): 1186.</p></li>
<li><p>〔8〕 The work of Baruch Blumberg: Baruch S. Blumberg, “Australia
Antigen and the Biology of Hepatitis B,” Science 197, no. 4298 (1977):
17–25; Rolf Zetterstöm, “Nobel Prize to Baruch Blumberg for the
Discovery of the Aetiology of Hepatitis B,” Acta Paediatrica 97, no. 3
(2008): 384–87; Shampo and Kyle, “Baruch Blumberg,” 1186.</p></li>
<li><p>〔9〕 Blumberg began to scour far-flung places: A. C. Allison et
al., “Haptoglobin Types in British, Spanish, Basque and Nigerian African
Populations,” Nature 181 (1958): 824–25.</p></li>
<li><p>〔10〕 In 1964, after a brief tenure at the NIH: Zetterstöm,
“Nobel Prize to Baruch Blumberg.”</p></li>
<li><p>〔11〕 One blood antigen that intrigued him: Baruch S. Blumberg,
Harvey J. Alter, and Sam Visnich, “A ‘New’ Antigen in Leukemia Sera,”
Journal of the American Medical Association 191, no. 7 (1965):
541–46.</p></li>
<li><p>〔12〕 In 1966, Blumberg’s lab set out to characterize: Baruch S.
Blumberg et al., “A Serum Antigen (Australia Antigen) in Down’s
Syndrome, Leukemia, and Hepatitis,” Annals of Internal Medicine 66, no.
5 (1967): 924–31.</p></li>
<li><p>〔13〕 Au and hepatitis: Blumberg, “Australia Antigen and the
Biology of Hepatitis B.”</p></li>
<li><p>〔14〕 “roughly circular … about forty-two nanometers”: Baruch
Blumberg, Hepatitis B: The Hunt for a Killer Virus (Princeton: Princeton
University Press, 2002), 115.</p></li>
<li><p>〔15〕 By 1969, Japanese researchers: Baruch S. Blumberg,
“Australia Antigen and the Biology of Hepatitis B.”; K. Okochi and S.
Murakami, “Observations on Australia Antigen in Japanese,” Vox Sanguinis
15, no. 5 (1968): 374–85.</p></li>
<li><p>〔16〕 But another illness soon stood out: Blumberg, Hepatitis B,
155.</p></li>
<li><p>〔17〕 20世纪70年代，哈拉尔德·楚尔·豪森（Harald zur
Hausen）发现了另一种病毒，而这种名为HPV的病原体可以导致宫颈癌。接种某种HPV亚型的疫苗可以明显降低女性罹患宫颈癌的风险。——作者注</p></li>
<li><p>〔18〕 “discipline-determined rigidity of the constituent
institutes”: Ibid., 72.</p></li>
<li><p>〔19〕
HBV可以导致非肝硬化肝脏发生癌变。目前这种病毒也被认为具有直接致癌作用。——作者注</p></li>
<li><p>〔20〕 By 1979, his group had devised one: Ibid.,
134–46.</p></li>
<li><p>〔21〕 “Since the early days of medical bacteriology”: J. Robin
Warren, “Helicobacter: The Ease and Difficulty of a New Discovery (Nobel
Lecture),” ChemMedChem 1, no. 7 (2006): 672–85.</p></li>
<li><p>〔22〕 Barry Marshall and Robin Warren’s discovery of
ulcer-causing bacteria: J. R. Warren, “Unidentified Curved Bacteria on
Gastric Epithelium in Active Chronic Gastritis,” Lancet 321, no. 8336
(1983): 1273–75; Barry J. Marshall and J. Robin Warren, “Unidentified
Curved Bacilli in the Stomach of Patients with Gastritis and Peptic
Ulceration,” Lancet 323, no. 8390 (1984): 1311–15; Barry Marshall,
Helicobacter Pioneers: Firsthand Accounts from the Scientists Who
Discovered Helicobacters, 1892–1982 (Hoboken, NJ: Wiley-Blackwell,
2002); Warren, “Helicobacter: The Ease and Difficulty”; Barry J.
Marshall, “Heliobacter Connections,” ChemMedChem 1, no. 8 (2006):
783–802.</p></li>
<li><p>〔23〕 “On the morning of the experiment”: Marshall, “Heliobacter
Connections.”</p></li>
<li><p>〔24〕
幽门螺旋杆菌感染与胃腺癌以及黏膜相关淋巴组织淋巴瘤等数种癌症有关。——作者注</p></li>
<li><p>〔25〕
马歇尔后来使用这种方案根除了幽门螺旋杆菌感染。——作者注</p></li>
<li><p>〔26〕 The effect of antibiotic therapy on cancer: Johannes G.
Kusters, Arnoud H. M. van Vliet, and Ernst J. Kuipers, “Pathogenesis of
Helicobacter pylori Infection,” Clinical Microbiology Reviews 19, no. 3
(2006): 449–90.</p></li>
<li><h4 id="第三十四章-天罗地网">第三十四章 “天罗地网”</h4></li>
<li><p>〔1〕 It is to earlier diagnosis that we must look: J. P.
Lockhart-Mummery, “Two Hundred Cases of Cancer of the Rectum Treated by
Perineal Excision,” British Journal of Surgery 14 (1926–27):
110–24.</p></li>
<li><p>〔2〕 The greatest need we have today: Sidney Farber, letter to
Etta Rosensohn, November 1962.</p></li>
<li><p>〔3〕 Lady, have you been “Paptized”?: “Lady, Have You Been
‘Paptized’?” New York Amsterdam News, April 13, 1957.</p></li>
<li><p>〔4〕 George Papanicolaou: For an overview, see George A. Vilos,
“After Office Hours: The History of the Papanicolaou Smear and the
Odyssey of George and Andromache Papanicolaou,” Obstetrics and
Gynecology 91, no. 3 (1998): 479–83; S. Zachariadou-Veneti, “A Tribute
toGeorge Papanicolaou (1883–1962),” Cytopathology 11, no. 3 (2000):
152–57.</p></li>
<li><p>〔5〕 By the late 1920s: Zachariadou-Veneti, “Tribute to George
Papanicolaou.”</p></li>
<li><p>〔6〕 As one gynecologist archly remarked: Edgar Allen, “Abstract
of Discussion on Ovarian Follicle Hormone,” Journal of the American
Medical Association 85 (1925): 405.</p></li>
<li><p>〔7〕 Papanicolaou thus began to venture: George N. Papanicolaou,
“The Cancer-Diagnostic Potential of Uterine Exfoliative Cytology,” CA: A
Cancer Journal for Clinicians 7 (1957): 124–35.</p></li>
<li><p>〔8〕 “aberrant and bizarre forms”: Ibid.</p></li>
<li><p>〔9〕 Papanicolaou published his method: G. N. Papanicolaou, “New
Cancer Diagnosis,” Proceedings of the Third Race Betterment Conference
(1928): 528.</p></li>
<li><p>〔10〕 “I think this work will be carried”: Ibid.</p></li>
<li><p>〔11〕 Between 1928 and 1950: George A. Vilos, “After Office
Hours,” Obstetrics and Gynecology 91 (March 1998): 3.</p></li>
<li><p>〔12〕 A Japanese fish and bird painter: George N. Papanicolaou,
“The Cell Smear Method of Diagnosing Cancer,” American Journal of Public
Health and the Nation’s Health 38, no. 2 (1948): 202–5.</p></li>
<li><p>〔13〕 At a Christmas party in the winter of 1950: Irena
Koprowska, A Woman Wanders through Life and Science (Albany: State
University of New York Press, 1997), 167–68.</p></li>
<li><p>〔14〕 “It was a revelation”: Ibid.</p></li>
<li><p>〔15〕 In 1952, Papanicolaou convinced the National Cancer
Institute: Cyrus C. Erickson, “Exfoliative Cytology in Mass Screening
for Uterine Cancer: Memphis and Shelby County, Tennessee,” CA: A Cancer
Journal for Clinicians 5 (1955): 63–64.</p></li>
<li><p>〔16〕 In the initial cohort of about 150,000: Harold Speert,
“Memorable Medical Mentors: VI. Thomas S. Cullen (1868–1953),”
Obstetrical and Gynecological Survey 59, no. 8 (2004): 557–63.</p></li>
<li><p>〔17〕 557 women were found to have preinvasive cancers:
Ibid.</p></li>
<li><p>〔18〕 In 1913, a Berlin surgeon named Albert Salomon: D. J.
Dronkers et al., eds., The Practice of Mammography: Pathology,
Technique, Interpretation, Adjunct Modalities (New York: Thieme, 2001),
256.</p></li>
<li><p>〔19〕 “trabeculae as thin as a spider’s web”: H. J. Burhenne, J.
E. Youker, and R. H. Gold, eds., Mammography (symposium given on August
24, 1968, at the University of California School of Medicine, San
Francisco) (New York: S. Karger, 1969), 109.</p></li>
<li><p>〔20〕 In the winter of 1963, three men set out: Sam Shapiro,
Philip Strax, and Louis Venet, “Evaluation of Periodic Breast Cancer
Screening with Mammography: Methodology and Early Observations,” Journal
of the American Medical Association 195, no. 9 (1966): 731–38.</p></li>
<li><p>〔21〕 By the mid-1950s, a triad of forces: Thomas A. Hirschl and
Tim B. Heaton, eds., New York State in the 21st Century (Santa Barbara,
CA: Greenwood Publishing Group, 1999), 144.</p></li>
<li><p>〔22〕 By the early 1960s, the plan had enrolled: See, for
instance, Philip Strax, “Screening for breast cancer,” Clinical
Obstetrics and Gynecology 20, no. 4 (1977): 781–802.</p></li>
<li><p>〔23〕 Strax and Venet eventually outfitted a mobile van: Philip
Strax, “Female Cancer Detection Mobile Unit,” Preventive Medicine 1, no.
3 (1972): 422–25.</p></li>
<li><p>〔24〕
除了乳房摄影之外，外科医生通常还会对女性患者进行乳房检查。——作者注</p></li>
<li><p>〔25〕 “Interview … 5 stations X 12 women”: Abraham Schiff quoted
in Philip Strax, Control of Breast Cancer through Mass Screening
(Philadelphia: Mosby, 1979), 148.</p></li>
<li><p>〔26〕 In 1971, eight years after the study: S. Shapiro et al.,
“Proceedings: Changes in 5-Year Breast Cancer Mortality in a Breast
Cancer Screening Program,” Proceedings of the National Cancer Conference
7 (1972): 663–78.</p></li>
<li><p>〔27〕 “The radiologist,” he wrote: Philip Strax, “Radiologist’s
Role in Screening Mammography,” unpublished document quoted in Barron H.
Lerner, “‘To See Today with the Eyes of Tomorrow’: A History of
Screening Mammography,” Canadian Bulletin of Medical History 20, no. 2
(2003): 299–321.</p></li>
<li><p>〔28〕 “Within 5 years, mammography has moved”: G. Melvin Stevens
and John F. Weigen, “Mammography Survey for Breast Cancer Detection. A
2-Year Study of 1,223 Clinically Negative Asymptomatic Women over 40,”
Cancer 19, no. 1 (2006): 51–59.</p></li>
<li><p>〔29〕 “The time has come”: Arthur I. Holleb, “Toward Better
Control of Breast Cancer,” American Cancer Society press release,
October 4, 1971 (New York: ACS Media Division), Folder: Breast Cancer
Facts, quoted in Lerner, “ ‘To See Today with the Eyes of Tomorrow.’
”</p></li>
<li><p>〔30〕 the Breast Cancer Detection and Demonstration Project:
Myles P. Cunningham, “The Breast Cancer Detection Demonstration Project
25 Years Later,” CA: A Cancer Journal for Clinicians 47, no. 3 (1997):
131–33.</p></li>
<li><p>〔31〕 Between 1976 and 1992, enormous parallel trials: See below
for particular stud-ies. Also see Madelon Finkel, ed., Understanding the
Mammography Controversy (Westport, CT: Praeger, 2005), 101–5.</p></li>
<li><p>〔32〕 In Canada, meanwhile, researchers lurched: A. B. Miller,
G. R. Howe, and C. Wall, “The National Study of Breast Cancer Screening
Protocol for a Canadian Randomized Controlled Trial of Screening for
Breast Cancer in Women,” Clinical Investigative Medicine 4, nos. 3–4
(1981): 227–58.</p></li>
<li><p>〔33〕 Edinburgh was a disaster: A. Huggins et al., “Edinburgh
Trial of Screening for Breast Cancer: Mortality at Seven Years,” Lancet
335, no. 8684 (1990): 241–46; Denise Donovan et al., “Edinburgh Trial of
Screening for Breast Cancer,” Lancet 335, no. 8695 (1990):
968–69.</p></li>
<li><p>〔34〕 The Canadian trial, meanwhile: Miller, Howe, and Wall,
“National Study of Breast Cancer Screening Protocol.”</p></li>
<li><p>〔35〕 For a critical evaluation of the CNBSS, HIP, and Swedish
studies, see David Freedman et al., “On the Efficacy of Screening for
Breast Cancer,” International Journal of Epidemiology 33, no. 1 (2004):
43–5.</p></li>
<li><p>〔36〕 Randomization problems in the Canadian National Breast
Screening Study: Curtis J. Mettlin and Charles R. Smart, “The Canadian
National Breast Screening Study: An Appraisal and Implications for Early
Detection Policy,” Cancer 72, no. S4 (1993): 1461–65; John C. Bailar III
and Brian MacMahon, “Randomization in the Canadian National Breast
Screening Study: A Review for Evidence of Subversion,” Canadian Medical
Association Journal 156, no. 2 (1997): 193–99.</p></li>
<li><p>〔37〕 “Suspicion, like beauty”: Cornelia Baines, Canadian
Medical Association Journal 157 (August 1, 1997): 249.</p></li>
<li><p>〔38〕 “One lesson is clear”: Norman F. Boyd, “The Review of
Randomization in the Canadian National Breast Screening Study: Is the
Debate Over?” Canadian Medical Association Journal 156, no. 2 (1997):
207–9.</p></li>
<li><p>〔39〕 Migration into and out of the city: See, for instance,
Scandinavian Journal of Gastroenterology 30 (1995): 33–43.</p></li>
<li><p>〔40〕 In 1976, forty-two thousand women enrolled: Ingvar
Andersson et al., “Mammographic Screening and Mortality from Breast
Cancer: The Malmö Mammographic Screening Trial,” British Medical Journal
297, no. 6654 (1988): 943–48.</p></li>
<li><p>〔41〕 “There was only one”: Ingvar Andersson, interview with
author, March 2010.</p></li>
<li><p>〔42〕 In 1988, at the end of its twelfth year: Andersson et al.,
“Mammographic Screening and Mortality.” Also Andersson, interview with
author.</p></li>
<li><p>〔43〕 When the groups were analyzed by age: Ibid.</p></li>
<li><p>〔44〕 In 2002, twenty-six years after the launch of the
original: Lennarth Nystöm et al., “Long-Term Effects of Mammography
Screening: Updated Overview of the Swedish Randomised Trials,” Lancet
359, no. 9310 (2002): 909–19.</p></li>
<li><p>〔45〕 Its effects, as the statistician Donald Berry describes
it: Donald Berry, interview with author, November 2009.</p></li>
<li><p>〔46〕 Berry wrote, “Screening is a lottery”: “Mammograms Before
50 a Waste of Time,” Science a Go Go, October 12, 1998,
http://www.scienceagogo.com/news/19980912094305data_trunc_sys.shtml
(accessed December 29, 2009).</p></li>
<li><p>〔47〕 “This is a textbook example”: Malcolm Gladwell, “The
Picture Problem: Mammography, Air Power, and the Limits of Looking,” New
Yorker, December 13, 2004.</p></li>
<li><p>〔48〕 “All photographs are accurate”: Richard Avedon, An
Autobiography (New York: Random House, 1993); Richard Avedon, Evidence,
1944–1994 (New York: Random House, 1994).</p></li>
<li><p>〔49〕 “As the decade ended,” Bruce Chabner: Bruce Chabner,
interview with author, August 2009.</p></li>
<li><h4 id="第三十五章-stamp">第三十五章 STAMP</h4></li>
<li><p>〔1〕 Then did I beat them: 2 Samuel 22:43 (King James
Version).</p></li>
<li><p>〔2〕 Cancer therapy is like beating the dog: Anna Deveare Smith,
Let Me Down Easy, script and monologue, December 2009.</p></li>
<li><p>〔3〕 “If a man die”: William Carlos Williams, The Collected
Poems of William Carlos Williams: 1939–1962 (New York: New Directions
Publishing, 1991), 2: 334.</p></li>
<li><p>〔4〕 In his poignant memoir of his mother’s illness: David
Rieff, Swimming in a Sea of Death: A Son’s Memoir (New York: Simon ＆
Schuster, 2008), 6–10.</p></li>
<li><p>〔5〕 “Like so many doctors”: Ibid., 8.</p></li>
<li><p>〔6〕 “To say this was a time of unreal”: Abraham Verghese, My
Own Country: A Doctor’s Story of a Town and Its People in the Age of
AIDS (New York: Simon ＆ Schuster, 1994), 24.</p></li>
<li><p>〔7〕 “There seemed to be little that medicine could not do”:
Ibid., 24.</p></li>
<li><p>〔8〕 E. Donnall Thomas, had shown that bone marrow: E. Donnall
Thomas, “Bone Marrow Transplantation from the Personal Viewpoint,”
International Journal of Hematology 81 (2005): 89–93.</p></li>
<li><p>〔9〕 In Thomas’s initial trial at Seattle: E. Thomas et al.,
“Bone Marrow Transplantation,” New England Journal of Medicine 292, no.
16 (1975): 832–43.</p></li>
<li><p>〔10〕 “We have a cure for breast cancer”: Craig Henderson,
interview with Richard Rettig, quoted in Richard Rettig et al., False
Hope: Bone Marrow Transplantation for Breast Cancer (Oxford: Oxford
University Press, 2007), 29.</p></li>
<li><p>〔11〕 “It was an intensely competitive place”: Robert Mayer,
interview with author, July 2008.</p></li>
<li><p>〔12〕 In 1982, Frei recruited William Peters: Shannon Brownlee,
“Bad Science and Breast Cancer,” Discover, August 2002.</p></li>
<li><p>〔13〕 In the fall of 1983, he invited Howard Skipper: William
Peters, interview with author, May 2009.</p></li>
<li><p>〔14〕 a “seminal event”: Ibid.</p></li>
<li><p>〔15〕 George Canellos, for one, was wary: George Canellos,
interview with author, March 2008.</p></li>
<li><p>〔16〕 “We were going to swing and go for the ring”: Brownlee,
“Bad Science and Breast Cancer.”</p></li>
<li><p>〔17〕 The first patient to “change history” with STAMP: Ibid.,
and Peters, interview with author.</p></li>
<li><p>〔18〕 “The ultimate trial of chemotherapeutic intensification”:
Peters, interview with author.</p></li>
<li><p>〔19〕 “Suddenly, everything broke loose”: Ibid.</p></li>
<li><p>〔20〕 The woman was thirty-six years old: Ibid.</p></li>
<li><p>〔21〕 “the most beautiful remission you could have imagined”:
Ibid.</p></li>
<li><p>〔22〕 In March 1981, in the journal Lancet: Kenneth B. Hymes et
al., “Kaposi’s Sarcoma in Homosexual Men—a Report of Eight Cases,”
Lancet 318, no. 8247 (1981): 598–600.</p></li>
<li><p>〔23〕 “gay compromise syndrome”: Robert O. Brennan and David T.
Durack, “Gay Compromise Syndrome,” Lancet 318, no. 8259 (1981):
1338–39.</p></li>
<li><p>〔24〕 In July 1982, with an understanding of the cause: “July
27, 1982: A Name for the Plague,” Time, March 30, 2003.</p></li>
<li><p>〔25〕 In a trenchant essay written as a reply: Susan Sontag,
Illness as Metaphor and AIDS and Its Metaphors (New York: Picador,
1990).</p></li>
<li><p>〔26〕 For Volberding, and for many of his earliest: See ACT UP
Oral History Project, http://www.actuporalhistory.org/.</p></li>
<li><p>〔27〕
虽然抗艾滋病药物还需要几年才能上市，但是使用鸡尾酒疗法抗击艾滋病的概念源自肿瘤学实践。——作者注</p></li>
<li><p>〔28〕 Volberding borrowed something more ineffable: Arthur J.
Amman et al., The AIDS Epidemic in San Francisco: The Medical Response,
1981–1884, vol. 3 (Berkeley: Regional Oral History Office, the Bancroft
Library, University of California, Berkeley, 1997).</p></li>
<li><p>〔29〕 “What we did here”: Ibid.</p></li>
<li><p>〔30〕 In January 1982, as AIDS cases boomed: “Building Blocks in
the Battle on AIDS,” New York Times, March 30, 1997; Randy Shilts, And
the Band Played On (New York: St. Martin’s Press).</p></li>
<li><p>〔31〕 In January 1983, Luc Montagnier’s group: Shilts, And the
Band Played On, 219; F. Barré-Sinoussi et al. “Isolation of a
T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune
Deficiency Syndrome (AIDS),” Science 220, no. 4599 (1983):
868–71.</p></li>
<li><p>〔32〕 Gallo also found a retrovirus: Mikulas Popovic et al.,
“Detection, Isolation, and Continuous Production of Cytopathic
Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS,” Science
224, no. 4648 (1984): 497–500; Robert C. Gallo et al., “Frequent
Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from
Patients with AIDS and at Risk for AIDS,” Science 224, no. 4648 (1984):
500–503.</p></li>
<li><p>〔33〕 On April 23, 1984, Margaret Heckler: James Kinsella,
Covering the Plague: AIDS and the American Media (Piscataway, NJ:
Rutgers University Press, 1992), 84.</p></li>
<li><p>〔34〕 In the spring of 1987: Steven Epstein, Impure Science:
AIDS, Activism, and the Politics of Knowledge (Berkeley: University of
California Press, 1998), 219.</p></li>
<li><p>〔35〕 “genocide by neglect”: Ibid., 221.</p></li>
<li><p>〔36〕 “Many of us who live in daily terror”: “The F.D.A.’s
Callous Response to AIDS,” New York Times, March 23, 1987.</p></li>
<li><p>〔37〕 “Drugs into bodies”: Raymond A. Smith and Patricia D.
Siplon, Drugs into Bodies: Global AIDS Treatment Activism (Santa
Barbara, CA: Greenwood Publishing Group, 2006).</p></li>
<li><p>〔38〕 “The FDA is fucked-up”: “Acting Up: March 10, 1987,”
Ripples of Hope: Great American Civil Rights Speeches, ed. Josh
Gottheimer (New York: Basic Civitas Books, 2003), 392.</p></li>
<li><p>〔39〕 “Double-blind studies”: “F.D.A.’s Callous Response to
AIDS,” New York Times.</p></li>
<li><p>〔40〕 He concluded, “AIDS sufferers”: Ibid.</p></li>
<li><p>〔41〕 By the winter of 1984, thirty-two women: Peters, interview
with author.</p></li>
<li><p>〔42〕 “There was so much excitement within the cancer
community”: Donald Berry, inter-view with author, November
2009.</p></li>
<li><p>〔43〕 Peters flew up from Duke to Boston: Peters, interview with
author.</p></li>
<li><h4 id="第三十六章-地图与降落伞">第三十六章 地图与降落伞</h4></li>
<li><p>〔1〕 Oedipus: What is the rite of purification?: Sophocles,
Oedipus the King.</p></li>
<li><p>〔2〕 Transplanters, as one oncologist: Craig Henderson, quoted
in Brownlee, “Bad Science and Breast Cancer.”</p></li>
<li><p>〔3〕 Nelene Fox and bone marrow transplantation: See Michael S.
Lief and Harry M. Caldwell, And the Walls Came Tumbling Down: Closing
Arguments that Changed the Way We Live, from Protecting Free Speech to
Winning Women’s Sufferage to Defending the Right to Die (New York: Simon
＆ Schuster, 2004), 299–354; “9 Million Awarded Family Who Sued H.M.O.,”
New York Times, December 30, 1993.</p></li>
<li><p>〔4〕 On June 19, a retinue: Lief and Caldwell, And the Walls
Came Tumbling Down, 310.</p></li>
<li><p>〔5〕 “You marketed this coverage to her”: Ibid., 307.</p></li>
<li><p>〔6〕 In August 1992, Nelene Fox: Ibid., 309.</p></li>
<li><p>〔7〕 “The dose-limiting barrier”: S. Ariad and W. R. Bezwoda,
“High-Dose Chemotherapy: Therapeutic Potential in the Age of Growth
Factor Support,” Israel Journal of Medical Sciences 28, no. 6 (1992):
377–85.</p></li>
<li><p>〔8〕 In Johannesburg, more than 90 percent: W. R. Bezwoda, L.
Seymour, and R. D. Dansey, “High-Dose Chemotherapy with Hematopoietic
Rescue as Primary Treatment for Metastatic Breast Cancer: A Randomized
Trial,” Journal of Clinical Oncology 13, no. 10 (1995):
2483–89.</p></li>
<li><p>〔9〕 On April 22, eleven months after: Lief and Caldwell, And
the Walls Came Tumbling Down, 309.</p></li>
<li><p>〔10〕 In 1993 alone: Papers were assessed on
www.pubmed.org.</p></li>
<li><p>〔11〕 “If all you have is a cold or the flu”: Lief and Caldwell,
And the Walls Came Tumbling Down, 234.</p></li>
<li><p>〔12〕 On the morning of December 28, 1993: Ibid.</p></li>
<li><p>〔13〕 That evening, it returned a verdict: “9 Million Awarded
Family,” New York Times.</p></li>
<li><p>〔14〕 In Massachusetts, Charlotte Turner: “Cancer Patient’s Kin
Sues Fallon” and “Coverage Denied for Marrow Transplant,” Worcester (MA)
Telegram ＆ Gazette, December 7, 1995; Erin Dominique Williams and Leo
Van Der Reis, Health Care at the Abyss: Managed Care vs. the Goals of
Medicine (Buffalo, NY: William S. Hein Publishing, 1997), 3.</p></li>
<li><p>〔15〕 Between 1988 and 2002: See Richard Rettig et al., eds.,
False Hope: Bone Marrow Transplantation for Breast Cancer (New York:
Oxford University Press, 2007), 85, and Table 3.2.</p></li>
<li><p>〔16〕 “complicated, costly and potentially dangerous”: Bruce E.
Brockstein and Stephanie F. Williams, “High-Dose Chemotherapy with
Autologous Stem Cell Rescue for Breast Cancer: Yesterday, Today and
Tomorrow,” Stem Cells 14, no. 1 (1996): 79–89.</p></li>
<li><p>〔17〕 Between 1991 and 1999, roughly forty thousand: JoAnne
Zujewski, Anita Nelson, and Jeffrey Abrams, “Much Ado about Not … Enough
Data,” Journal of the National Cancer Institute 90 (1998): 200–209. Also
see Rettig et al., False Hope, 137.</p></li>
<li><p>〔18〕 “Transplants, transplants, everywhere”: Robert Mayer,
interview with author, July 2008.</p></li>
<li><p>〔19〕 As Bezwoda presented the data: W. R. Bezwoda, “High Dose
Chemotherapy with Haematopoietic Rescue in Breast Cancer,” Hematology
and Cell Therapy 41, no. 2 (1999): 58–65. Also see Werner Bezwoda,
plenary session, American Society of Clinical Oncology meeting, 1999
(video recordings available at www.asco.org).</p></li>
<li><p>〔20〕 three other trials presented that afternoon:
Ibid.</p></li>
<li><p>〔21〕 At Duke, embarrassingly enough: Ibid.</p></li>
<li><p>〔22〕 “even a modest improvement”: Ibid.</p></li>
<li><p>〔23〕 A complex and tangled trial from Sweden: Ibid.</p></li>
<li><p>〔24〕 “My goal here,” one discussant began: Ibid.</p></li>
<li><p>〔25〕 “People who like to transplant will continue to
transplant”: “Conference Divided over High-Dose Breast Cancer
Treatment,” New York Times, May 19, 1999.</p></li>
<li><p>〔26〕 Investigation of Bezwoda’s breast cancer study: Raymond B.
Weiss et al., “High-Dose Chemotherapy for High-Risk Primary Breast
Cancer: An On-Site Review of the Bezwoda Study,” Lancet 355, no. 9208
(2000): 999–1003.</p></li>
<li><p>〔27〕 Another patient record, tracked back to its origin:
“Bezwoda,” Kate Barry (producer), archived in video format at
http://beta.mnet.co.za/Carteblanche, M-Net TV Africa (March 19,
2000).</p></li>
<li><p>〔28〕 “I have committed a serious breach of scientific honesty”:
“Breast Cancer Study Results on High-Dose Chemotherapy Falsified,”
Imaginis, February 9, 2000,
http://www.imaginis.com/breasthealth/news/news2.09.00.asp (accessed
January 2, 2010).</p></li>
<li><p>〔29〕 “By the late 1990s, the romance was already over”: Robert
Mayer, interview with author.</p></li>
<li><p>〔30〕 Maggie Keswick Jencks: Maggie Keswick Jencks, A View from
the Front Line (London, 1995).</p></li>
<li><p>〔31〕 “There you are, the future patient”: Ibid., 9.</p></li>
<li><p>〔32〕 In May 1997, exactly eleven years after: John C. Bailar
and Heather L. Gornik, “Cancer Undefeated,” New England Journal of
Medicine 336, no. 22 (1997): 1569–74.</p></li>
<li><p>〔33〕 Pressed on public television, he begrudgingly conceded:
“Treatment vs. Prevention,” NewsHour with Jim Lehrer, May 29, 1997, PBS,
transcript available at
http://www.pbs.org/newshour/bb/health/may97/cancer_5–29.html (accessed
January 2, 2010).</p></li>
<li><p>〔34〕 “‘Cancer’ is, in truth, a variety of diseases”: Barnett S.
Kramer and Richard D. Klausner, “Grappling with Cancer—Defeatism versus
the Reality of Progress,” New England Journal of Medicine 337, no. 13
(1997): 931–35.</p></li>
<li><p>〔1〕 It is vain to speak of cures: Robert Burton, The Anatomy of
Melancholy (: C. Armstrong and Son, 1893), 235.</p></li>
<li><p>〔2〕 You can’t do experiments to see: Samuel S. Epstein,
Cancer-Gate: How to Win the Losing Cancer War (Amityville, NY: Baywood
Publishing Company, 2005), 57.</p></li>
<li><p>〔3〕 What can be the “why” of these happenings?: Peyton Rous,
“The Challenge to Man of the Neoplastic Cell,” Nobel Lectures,
Physiology or Medicine, 1963–1970 (Amsterdam: Elsevier Publishing
Company, 1972).</p></li>
<li><h4 id="第三十七章-共同病因">第三十七章 “共同病因”</h4></li>
<li><p>〔1〕 As early as 1858: Rudolf Virchow, Lecture XX, Cellular
Pathology as Based upon Physiological and Pathological Histology, trans.
Frank Chance (London: Churchill, 1860). The passage on irritation
appears on page 488 of the translated version: “A pathological tumor in
man forms … where any pathological irritation occurs … all of them
depend upon a proliferation of cells.”</p></li>
<li><p>〔2〕 Walther Flemming, a biologist working in Prague: Neidhard
Paweletz, “Walther Flemming: Pioneer of Mitosis Research,” Nature
Reviews Molecular Cell Biology 2 (2001): 72–75.</p></li>
<li><p>〔3〕 It was Virchow’s former assistant David Paul von Hansemann:
Leon P. Bignold, Brian L. D. Coghlan, and Hubertus P. A. Jersmann, eds.,
Contributions to Oncology: Context, Comments and Translations (Basel:
Birkhauser Verlag, 2007), 83–90.</p></li>
<li><p>〔4〕 Boveri devised a highly unnatural experiment: Theodor
Boveri, Concerning the Origin of Malignant Tumours by Theodor Boveri,
translated and annotated by Henry Harris (New York: Cold Spring Harbor
Press, 2006). This is a reprint and new translation of the original
text.</p></li>
<li><p>〔5〕 “unitary cause of carcinoma”: Ibid., 56.</p></li>
<li><p>〔6〕 not “an unnatural group of different maladies”: Ibid.,
56.</p></li>
<li><p>〔7〕 In 1910, four years before Boveri had published his theory:
Peyton Rous, “A Transmissible Avian Neoplasm (Sarcoma of the Common
Fowl),” Journal of Experimental Medicine12, no. 5 (1910): 696–705;
Peyton Rous, “A Sarcoma of the Fowl Transmissible by an Agent Separable
from the Tumor Cells,” Journal of Experimental Medicine 13, no. 4
(1911): 397–411.</p></li>
<li><p>〔8〕 In 1909, a year before: Karl Landsteiner et al., “La
transmission de la paralysie infan-tile aux singes,” Compt. Rend. Soc.
Biologie 67 (1909).</p></li>
<li><p>〔9〕 In the early 1860s, working alone: Gregor Mendel, “Versuche
über Plfanzenhybriden,” Verhandlungen des Naturforschenden Vereines in
Brünn. IV für das Jahr 1865,Abhandlungen (1866): 3–47. English
translation available at
http://www.esp.org/foundations/genetics/classical/gm-65.pdf (accessed
January 2, 2010). Also see Robin Marantz Henig, The Monk in the Garden:
The Lost and Found Genius of Gregor Mendel, the Father of Genetics
(Boston: Mariner Books, 2001), 142.</p></li>
<li><p>〔10〕 decades later, in 1909, botanists: Wilhelm Ludwig
Johannsen, Elemente der Exakten Erblichkeitlehre (1913),
http://caliban.mpiz-koeln.mpg.de/johannsen/elemente/index.html (accessed
January 2, 2010).</p></li>
<li><p>〔11〕 In 1910, Thomas Hunt Morgan: See T. H. Morgan,
“Chromosomes and Heredity,” American Naturalist 44 (1910): 449–96. Also
see Muriel Lederman, “Research Note: Genes on Chromosomes: the
Conversion of Thomas Hunt Morgan,” Journal of the History of Biology 22,
no. 1 (1989): 163–76.</p></li>
<li><p>〔12〕 The third vision of the “gene”: Oswald T. Avery et al.,
“Studies on the Chemical Nature of the Substance Inducing Transformation
of Pneumococcal Types: Induction of Transformation by a Deoxyribonucleic
Acid Fraction Isolated from Pneumococcus Type III,” Journal of
Experimental Medicine 79 (1944): 137–58.</p></li>
<li><p>〔13〕 George Beadle, Thomas Morgan’s student: See George Beadle,
“Genes and Chemical Reactions in Neurospora,” Nobel Lectures, Physiology
or Medicine, 1942–1962 (Amsterdam: Elsevier Publishing Company, 1964),
587–99.</p></li>
<li><p>〔14〕 In the mid-1950s, biologists termed: See for instance
Francis Crick, “Ideas on Protein Synthesis,” October 1956, Francis Crick
Papers, National Library of Medicine. Crick’s statement of the central
dogma proposed that RNA could be back converted as a spe-cial case, but
that proteins could never be back converted into DNA or RNA. Reverse
transcription was thus left as a possibility.</p></li>
<li><p>〔15〕 In 1872, Hilário de Gouvêa: A. N. Monteiro and R.
Waizbort, “The Accidental Cancer Geneticist: Hilário de Gouvêa and
Hereditary Retinoblastoma,” Cancer Biology and Therapy 6, no. 5 (2007):
811–13.</p></li>
<li><p>〔16〕 In 1928, Hermann Joseph Muller: See Hermann Muller, “The
Production of Mutations,” Nobel Lectures, Physiology or Medicine,
1942–1962 (Amsterdam: Elsevier Publishing Company, 1964).</p></li>
<li><p>〔17〕 “the doctor may then want to call in his geneticist
friends for consultation!”: Thomas Morgan, “The Relation of Genetics to
Physiology and Medicine,” Nobel Lectures, Physiology or Medicine
1922–1941 (Amsterdam: Elsevier Publishing Company, 1965).</p></li>
<li><h4 id="第三十八章-癌症病毒">第三十八章 “癌症病毒”</h4></li>
<li><p>〔1〕 Unidentified flying objects, abominable snowmen: Medical
World News, January 11, 1974.</p></li>
<li><p>〔2〕 The biochemist Arthur Kornberg once joked: Arthur Kornberg,
“Ten Commandments: Lessons from the Enzymology of DNA Replication,”
Journal of Bacteriology 182, no. 13 (2000): 3613–18.</p></li>
<li><p>〔3〕
其他致癌病毒，例如SV40与人乳头瘤病毒（HPV），最终分别在1960年和1983年被发现。——作者注</p></li>
<li><p>〔4〕 Temin was cooking up an unusual experiment: See Howard
Temin and Harry Rubin, “Characteristics of an Assay for Rous Sarcoma
Virus,” Virology 6 (1958): 669–83.</p></li>
<li><p>〔5〕 “The virus, in some structural as well as functional
sense”: Howard Temin, quoted in Howard M. Temin et al., The DNA
Provirus: Howard Temin’s Scientific Legacy (Washington, DC: ASM Press,
1995), xviii.</p></li>
<li><p>〔6〕
尽管特明的此番表述源自推测，但是他的生物学直觉非常敏锐。数年之后，劳斯肉瘤病毒结构性附着于细胞基因组的权威证据才浮出水面。——作者注</p></li>
<li><p>〔7〕 “Temin had an inkling”: J. Michael Bishop, interview with
author, August 2009.</p></li>
<li><p>〔8〕 “The hypothesis”: J. Michael Bishop in Temin et al., DNA
Provirus, 81.</p></li>
<li><p>〔9〕 Mizutani was a catastrophe: See Robert Weinberg, Racing to
the Beginning of the Road (New York: Bantam, 1997), 61.</p></li>
<li><p>〔10〕
病毒学家后来创造了“逆转录病毒”（retrovirus）这个术语。——作者注</p></li>
<li><p>〔11〕 At MIT, in Boston: Ibid., 61–65.</p></li>
<li><p>〔12〕 “It was all very dry biochemistry”: Ibid., 64.</p></li>
<li><p>〔13〕 In their respective papers: David Baltimore,
“RNA-Dependent DNA Polymerase in Virions of RNA Tumor Viruses,” Nature
226, no. 5252 (1970): 1209–11; and H. M Temin and S. Mizutani,
“RNA-Dependent DNA Polymerase in Virions of Rous Sarcoma Virus,” Nature
226, no. 5252 (1970): 1211–13.</p></li>
<li><p>〔14〕 Spiegelman raced off to prove: Weinberg, Racing to the
Beginning, 70.</p></li>
<li><p>〔15〕 “It became his single-minded preoccupation”: Robert
Weinberg, interview with author, January 2009.</p></li>
<li><p>〔16〕 “The hoped-for human virus”: Weinberg, Racing to the
Beginning, 83.</p></li>
<li><h4 id="第三十九章-猎杀sarc">第三十九章 “猎杀sarc”</h4></li>
<li><p>〔1〕 For the Snark was a Boojum, you see: Lewis Carroll, The
Hunting of the Snark: An Agony in Eight Fits (New York: Macmillan,
1914), 53.</p></li>
<li><p>〔2〕 By analyzing the genes altered in these mutant viruses: For
a review of Duesberg’s and Vogt’s contributions, see G. Steven Martin,
“The Hunting of the Src,” Nature Reviews Molecular Cell Biology 2, no. 6
(2001): 467–75.</p></li>
<li><p>〔3〕 1969年，来自NCI的两位科学家罗伯特·许布纳（Robert
Huebner）与乔治·托达罗（George
Todaro）在缺乏证据的情况下提出了癌基因（oncogene）的概念。——作者注</p></li>
<li><p>〔4〕 A chance discovery in Ray Erikson’s laboratory: J. S.
Brugge and R. L. Erikson, “Identification of a Transformation-Specific
Antigen Induced by an Avian Sarcoma Virus,” Nature 269, no. 5626 (1977):
346–48.</p></li>
<li><p>〔5〕
在加州大学旧金山分校迈克尔·毕晓普实验室工作的亚特·莱文森（Art
Levinson）也发现了这种磷酸化活性；我们会在后续章节讨论莱文森的发现。——作者注</p></li>
<li><p>〔6〕
虽然基因编码蛋白质，但是人们有时也会用相同的名称来标注基因（src）与其蛋白质（src激酶）。生物学家可以通过上下文来判断某个名称指的是基因还是其蛋白质。——作者注</p></li>
<li><p>〔7〕 other scientists nicknamed the project: See, for instance,
Martin, “The Hunting of the Src.”</p></li>
<li><p>〔8〕 “Src,” Varmus wrote in a letter: Harold Varmus to Dominique
Stehelin, February 3, 1976, Harold Varmus papers, National Library of
Medicine archives. Also see Stehelin et al., “DNA Related to the
Transforming Genes of Avian Sarcoma Viruses Is Present in Normal DNA,”
Nature 260, no. 5547 (March 1976): 170–73.</p></li>
<li><p>〔9〕 “Nature,” Rous wrote in 1966: Peyton Rous, “The Challenge
to Man of the Neoplastic Cell,” Nobel Lectures, Physiology or Medicine,
1963–1970 (Amsterdam: Elsevier Publishing Company, 1972).</p></li>
<li><p>〔10〕 《贝奥武甫》中半人半妖的怪兽。——译者注</p></li>
<li><p>〔11〕 “We have not slain our enemy”: Harold Varmus,
“Retroviruses and Oncogenes I,” Nobel Lectures, Physiology or Medicine,
1981–1990, ed. Jan Lindsten (Singapore: World Scientific Publishing Co.,
1993).</p></li>
<li><h4 id="第四十章-突变假说">第四十章 突变假说</h4></li>
<li><p>〔1〕 The fine, fine wind: D. H. Lawrence, “The Song of a Man Who
Has Come Through,” Penguin Book of First World War Poetry, ed. John
Silkin (New York: Penguin Classics, 1996), 213.</p></li>
<li><p>〔2〕 Rowley’s specialty was studying: Janet Rowley, “Chromosomes
in Leukemia and Lymphoma,” Seminars in Hematology 15, no. 3 (1978):
301–19.</p></li>
<li><p>〔3〕 In the late 1950s, Peter Nowell: P. C. Nowell and D.
Hungerford, Science 142 (1960): 1497.</p></li>
<li><p>〔4〕 In 1969, Knudson moved: Al Knudson, interview with author,
July 2009.</p></li>
<li><p>〔5〕 “The number two,” he recalled: Ibid.</p></li>
<li><p>〔6〕 Knudson’s two-hit theory: A. Knudson, “Mutation and Cancer:
Statistical Study of Retinoblastoma,” Proceedings of the National
Academy of Sciences of the United States of America 68, no. 4 (1971):
820–23.</p></li>
<li><p>〔7〕 “Two classes of genes are apparently critical”: A. Knudson,
“The Genetics of Childhood Cancer,” Bulletin du Cancer 75, no. 1 (1988):
135–38.</p></li>
<li><p>〔8〕 “jammed accelerators” and “missing brakes”: J. Michael
Bishop, in Howard M. Temin et al., The DNA Provirus: Howard Temin’s
Scientific Legacy (Washington, DC: ASM Press, 1995), 89.</p></li>
<li><h4 id="第四十一章-风险预测">第四十一章 风险预测</h4></li>
<li><p>〔1〕 They see only their: Plato, The Republic of Plato, Benjamin
Jowett, trans. (Oxford: Clarendon Press, 1908), 220.</p></li>
<li><p>〔2〕 “Isolating such a gene”: Robert Weinberg, interview with
author, January 2009.</p></li>
<li><p>〔3〕 “The chair of the department”: Ibid.</p></li>
<li><p>〔4〕 Clarity came to him one morning: Ibid.</p></li>
<li><p>〔5〕 In the summer of 1979, Chiaho Shih: Ibid.</p></li>
<li><p>〔6〕
事实上，温伯格使用的“正常”细胞也并非完全正常。由于它们已经出现了生长适应，因此单个激活的癌基因就能使它们进入转化生长。温伯格后来发现，真正的“正常细胞”需要数个基因突变才能发生转化。——作者注</p></li>
<li><p>〔7〕 “If we were going to trap a real oncogene”: Ibid. Also,
Cliff Tabin, interview with author, December 2009.</p></li>
<li><p>〔8〕 In 1982, Weinberg: C. Shih and R. A. Weinberg (1982),
“Isolation of a Transforming Sequence from a Human Bladder Carcinoma
Cell Line,” Cell 29: 161–169. Also see M. Goldfarb, K. Shimizu, M.
Perucho, and M. Wigler, “Isolation and Preliminary Characterization of a
Human Transforming Gene from T24 Bladder Carcinoma Cells,” Nature 296
(1982): 404–9. Also see S. Pulciani et al., “Oncogenes in Human Tumor
Cell Lines: Molecular Cloning of a Transforming Gene from Human Bladder
Carcinoma Cells,” Proceedings of the National Academy of Sciences. USA
79: 2845–49.</p></li>
<li><p>〔9〕
其实ras基因与src基因都是早年致癌病毒研究的发现。当然这也再次强调了此类病毒在揭示内源致癌基因机理方面的惊人能力。——作者注</p></li>
<li><p>〔10〕 “Once we had cloned”: Robert Weinberg, Racing to the
Beginning of the Road (New York: Bantam, 1997), 165.</p></li>
<li><p>〔11〕 Ray Erikson traveled to Washington: Ray Erikson, interview
with author, October 2009.</p></li>
<li><p>〔12〕
1971年《国家癌症法案》颁布之后，拉斯克派在很大程度上已经解散。虽然玛丽·拉斯克依然参与科学政策的制定，但是她也不再拥有20世纪60年代的影响力与气魄。——作者注</p></li>
<li><p>〔13〕 “I don’t remember any enthusiasm”: Ibid.</p></li>
<li><p>〔14〕 “How can one capture genes”: Robert Weinberg, One Renegade
Cell (New York: Basic Books, 1999), 74.</p></li>
<li><p>〔15〕 遗传学家采用了珍妮特·罗利开创的染色技术。——作者注</p></li>
<li><p>〔16〕
特别是一个只有在失活时才凸显其功能的基因。——作者注</p></li>
<li><p>〔17〕 “We knew where Rb lived”: Weinberg, interview with
author.</p></li>
<li><p>〔18〕 Dryja began his hunt for Rb: Thaddeus Dryja, interview
with author, November 2008.</p></li>
<li><p>〔19〕 “I stored the tumors obsessively”: Ibid.</p></li>
<li><p>〔20〕 “It was at that moment”: Ibid.</p></li>
<li><p>〔21〕 “We have isolated 〔a human gene〕”: Stephen H. Friend et
al., “A Human DNA Segment with Properties of the Gene that Predisposes
to Retinoblastoma and Osteosarcoma,” Nature 323, no. 6089 (1986):
643–46.</p></li>
<li><p>〔22〕 When scientists tested the gene isolated by Dryja: D. W.
Yandell et al., “Oncogenic Point Mutations in the Human Retinoblastoma
Gene: Their Application to Genetic Counseling,” New England Journal of
Medicine 321, no. 25 (1989): 1689–95.</p></li>
<li><p>〔23〕 Its chief function is to bind to several other proteins:
See for instance James A. DeCaprio, “How the Rb Tumor Suppressor
Structure and Function was Revealed by the Study of Adenovirus and
SV40,” Virology 384, no. 2 (2009): 274–84.</p></li>
<li><p>〔24〕 a horde of other oncogenes and anti-oncogenes: George
Klein, “The Approaching Era of the Tumor Suppressor Genes,” Science 238,
no. 4833 (1987): 1539–45.</p></li>
<li><p>〔25〕
尽管病毒并非癌症发生的主要原因，但是病毒的确可以引起某些特殊癌症，例如人乳头瘤病毒会导致宫颈癌。宫颈癌的发病机制在20世纪90年代被破解之后，人们才发现HPV可以使Rb基因与p53基因的信号失活，而这也强调了内源性基因在病毒致癌中的重要作用。——作者注</p></li>
<li><p>〔26〕 Philip Leder’s team at Harvard engineered: Timothy A.
Stewart, Paul K. Pattengale, and Philip Leder, “Spontaneous Mammary
Adenocarcinomas in Transgenic Mice That Carry and Express MTV/myc Fusion
Genes,” Cell 38 (1984): 627–37.</p></li>
<li><p>〔27〕 In 1988, he successfully applied for a patent: Daniel J.
Kevles, “Of Mice ＆ Money: The Story of the World’s First Animal
Patent,” Daedalus 131, no. 2 (2002): 78.</p></li>
<li><p>〔28〕 “The active myc gene does not appear to be sufficient”:
Stewart, Pattengale, and Leder, “Spontaneous Mammary Adenocarcinomas,”
627–37.</p></li>
<li><p>〔29〕 Leder created a second OncoMouse: E. Sinn et al.,
“Coexpression of MMTV/v-Ha-ras and MMTV/c-myc Genes in Transgenic Mice:
Synergistic Action of Oncogenes in Vivo,” Cell 49, no. 4 (1987):
465–75.</p></li>
<li><p>〔30〕 “Cancer genetics,” as the geneticist Cliff Tabin: Tabin,
interview with author, November 2009.</p></li>
<li><h4 id="第四十二章-癌症标志">第四十二章 癌症标志</h4></li>
<li><p>〔1〕 I do not wish to achieve immortality: Eric Lax, Woody Allen
and His Comedy (London: Elm Tree Books, 1976).</p></li>
<li><p>〔2〕
1988年，人们仅鉴别出一种基因（ras）的确切身份。尽管其他三种基因均被认为是抑癌基因，但是它们的身份直到后来才得到验证。——作者注</p></li>
<li><p>〔3〕 “The four molecular alterations accumulated”: B. Vogelstein
et al., “Genetic Alterations During Colorectal-Tumor Development,” New
England Journal of Medicine 319, no. 9 (1988): 525–32.</p></li>
<li><p>〔4〕 A tumor could thus “acquire” its own blood supply: Judah
Folkman, “Angiogenesis,” Annual Review of Medicine 57 (2006):
1–18.</p></li>
<li><p>〔5〕 Folkman’s Harvard colleague Stan Korsmeyer: W. B. Graninger
et al., “Expression of Bcl-2 and Bcl-2-Ig Fusion Transcripts in Normal
and Neoplastic Cells,” Journal of Clinical Investigation 80, no. 5
(1987): 1512–15. Also see Stanley J. Korsemeyer, “Regulators of Cell
Death,” 11, no. 3 (1995): 101–5.</p></li>
<li><p>〔6〕 In the fall of 1999, Robert Weinberg attended: Robert
Weinberg, interview with author, January 2009.</p></li>
<li><p>〔7〕 In January 2000, a few months after their walk: Douglas
Hanahan and Robert A. Weinberg, “The Hallmarks of Cancer,” Cell 100, no.
1 (2000): 57–70.</p></li>
<li><p>〔8〕 “We discuss … rules that govern”: Ibid.</p></li>
<li><p>〔9〕 “With holistic clarity of mechanism”: Ibid. Also see Bruce
Chabner, “Biological Basis for Cancer Treatment,” Annals of Internal
Medicine 118, no. 8 (1993): 633–37.</p></li>
<li><p>〔1〕 We are really reaping the fruits: Mike Gorman, letter to
Mary Lasker, September 6, 1985, Mary Lasker Papers.</p></li>
<li><p>〔2〕 The National Cancer Institute, which has overseen: “To
Fight Cancer, Know the Enemy,” New York Times, August 5, 2009.</p></li>
<li><p>〔3〕 The more perfect a power is: See for instance St. Aquinas,
Commentary on the Book of Causes, trans. Vincent Guagliardo et al. (CUA
Press, 1996), 9.</p></li>
<li><h4 id="第四十三章-努力绝非徒劳无功">第四十三章
“努力绝非徒劳无功”</h4></li>
<li><p>〔1〕 Have you met Jimmy?: Jimmy Fund solicitation pamphlet,
1963.</p></li>
<li><p>〔2〕 In the summer of 1997: “Einar Gustafson, 65, ‘Jimmy’ of
Child Cancer Fund, Dies,” New York Times, January 24, 2001; “Jimmy
Found,” People, June 8, 1998.</p></li>
<li><p>〔3〕 Only Sidney Farber had known: Phyllis Clauson, interview
with author, 2009.</p></li>
<li><p>〔4〕 “Jimmy’s story,” she recalled: Ibid.</p></li>
<li><p>〔5〕 A few weeks later, in January 1998: Karen Cummings,
interview with author, 2009.</p></li>
<li><p>〔6〕 And so it was in May 1998: Ibid.</p></li>
<li><p>〔7〕
虽然吉米于1948年在波士顿儿童医院开始化疗，但是他从1952年起就改在吉米基金会大楼接受随访与治疗。——作者注</p></li>
<li><p>〔8〕 《瑞普·范·温克尔》是美国作家华盛顿·欧文（Washington
Irving）的著名短篇小说。主人公为了躲避凶悍的妻子到附近的山上去打猎。他因为饮用魔酒睡了20年，醒来后发现已经时过境迁。——译者注</p></li>
<li><p>〔9〕 “Everything has changed”: Clauson, interview with
author.</p></li>
<li><p>〔10〕 “How to overcome him became”: Max Lerner, Wrestling with
the Angel: A Memoir of My Triumph over Illness (New York: Touchstone,
1990), 26.</p></li>
<li><p>〔11〕 The poet Jason Shinder wrote, “Cancer”: “The Lure of
Death,” New York Times,December 24, 2008.</p></li>
<li><p>〔12〕 “I’ve made a long voyage”: Maxwell E. Perkins, “The Last
Letter of Thomas Wolfe and the Reply to It,” Harvard Library Bulletin,
Autumn 1947, 278.</p></li>
<li><p>〔13〕 In 2005, an avalanche of papers: See, for example, Peter
Boyle and Jacques Ferlay, “Mortality and Survival in Breast and
Colorectal Cancer,” Nature Reviews and Clinical Oncology 2 (2005):
424–25; Itsuro Yoshimi and S. Kaneko, “Comparison of Cancer Mortality
(All Malignant Neoplasms) in Five Countries: France, Italy, Japan, UK
and USA from the WHO Mortality Database (1960–2000),” Japanese Journal
of Clinical Oncology 35, no. 1 (2005): 48–51; Alison L. Jones,
“Reduction in Mortality from Breast Cancer,” British Medical Journal
330, no. 7485 (2005): 205–6.</p></li>
<li><p>〔14〕 The mortality for nearly every major: Eric J. Kort et al.,
“The Decline in U.S. Cancer Mortality in People Born Since 1925,” Cancer
Research 69 (2009): 6500–6505.</p></li>
<li><p>〔15〕 mortality had declined by about 1 percent: Ibid. Also see
Ahmedin Jemal et al., “Cancer Statistics, 2005,” CA: A Cancer Journal
for Clinicians 55 (2005): 10–30; “Annual Report to the Nation on the
Status of Cancer, 1975–2002,” Journal of the National Cancer Institute,
October 5, 2005.</p></li>
<li><p>〔16〕 between 1990 and 2005, the cancer-specific: Ibid.</p></li>
<li><p>〔17〕 more than half a million American men and women: American
Cancer Society, Cancer Facts ＆ Figures 2008 (Atlanta: American Cancer
Society, 2008), 6.</p></li>
<li><p>〔18〕
接种人乳头瘤病毒疫苗可以使发病率进一步下降。——作者注</p></li>
<li><p>〔19〕 Donald Berry, a statistician in Houston: Donald A. Berry,
“Effect of Screening and Adjuvant Therapy on Mortality from Breast
Cancer,” New England Journal of Medicine 353, no. 17 (2005):
1784–92.</p></li>
<li><p>〔20〕
由于早在1990年之前手术就已经得到广泛应用，并且几乎所有女性患者都接受了手术治疗，因此手术的贡献无法进行评估。——作者注</p></li>
<li><p>〔21〕 “No one,” as Berry said: Donald Berry, interview with
author, November 2009.</p></li>
<li><p>〔22〕 Mary Lasker died of heart failure: “Mary W. Lasker,
Philanthropist for Medical Research, Dies at 93,” New York Times,
February 23, 1994.</p></li>
<li><p>〔23〕 the cancer geneticist Ed Harlow captured: Ed Harlow, “An
Introduction to the Puzzle,” Cold Spring Harbor Symposia on Quantitative
Biology 59 (1994): 709–23.</p></li>
<li><p>〔24〕 In the winter of 1945, Vannevar Bush: Vannevar Bush,
Science the Endless Frontier: A Report to the President by Vannevar
Bush, Director of the Office of Scientific Research and Development,
July 1945 (Washington, D.C.: U.S. Government Printing Office,
1945).</p></li>
<li><h4 id="第四十四章-旧病新药">第四十四章 旧病新药</h4></li>
<li><p>〔1〕
帕特洛克罗斯（Patroclus，也名Patroklos）是阿喀琉斯的挚友，他穿上阿喀琉斯的铠甲假扮成其模样出战，但是最后被特洛伊军队的赫克托耳杀死。——译者注</p></li>
<li><p>〔2〕 In the story of Patroclus: Louise Gluck, The Triumph of
Achilles (New York: Ecco Press, 1985), 16.</p></li>
<li><p>〔3〕 The perfect therapy has not been developed: Bruce Chabner
letter to Rose Kushner, Rose Kushner Papers, Box 50.</p></li>
<li><p>〔4〕
并非所有癌细胞都具有生长迅速的特点。生长缓慢的癌症往往更难被针对细胞生长的药物杀伤。——作者注</p></li>
<li><p>〔5〕 In the summer of 1985: Laurent Degos, “The History of Acute
Promyelocytic Leukaemia,” British Journal of Haematology 122, no. 4
(2003): 539–53; Raymond P. Warrell et al., “Acute Promyelocytic
Leukemia,” New England Journal of Medicine 329, no. 3 (1993): 177–89;
Huang Meng-er et al., “Use of All-Trans Retinoic Acid in the Treatment
of Acute Promyelocytic Leukemia,” Blood 72 (1988): 567–72.</p></li>
<li><p>〔6〕 “The nucleus became larger”: Meng-er et al., “Use of
All-Trans Retinoic Acid.”</p></li>
<li><p>〔7〕 In 1982, a postdoctoral scientist: Robert Bazell, Her-2:
The Making of Herceptin, a Revolutionary Treatment for Breast Cancer
(New York: Random House, 1998), 17.</p></li>
<li><p>〔8〕 “It would have been an overnight test”: Ibid.</p></li>
<li><p>〔9〕 although Padhy’s discovery was published: Lakshmi Charon
Padhy et al., “Identification of a Phosphoprotein Specifically Induced
by the Transforming DNA of Rat Neuroblastomas,” Cell 28, no. 4 (1982):
865–71.</p></li>
<li><p>〔10〕 1986年，杰弗里·德瑞宾（Jeffrey Drebin）和马克·格林（Mark
Greene）证实使用抗neu抗体治疗可以抑制癌细胞生长。但是所有研究团队均忽略了将这种抗体作为研发人类抗癌药物的前景。——作者注</p></li>
<li><h4 id="第四十五章-万缕之城">第四十五章 万缕之城</h4></li>
<li><p>〔1〕 In Ersilia, to establish the relationships: Italo Calvino,
Invisible Cities (Boston: Houghton Mifflin Harcourt, 1978), 76.</p></li>
<li><p>〔2〕 In his book Invisible Cities: Ibid.</p></li>
<li><p>〔3〕 In the summer of 1984: Robert Bazell, Her-2: The Making of
Herceptin, a Revolutionary Treatment for Breast Cancer (New York: Random
House, 1998).</p></li>
<li><p>〔4〕 In 1982, Genentech unveiled the first: “A New Insulin Given
Approval for Use in U.S.,” New York Times, October 30, 1982.</p></li>
<li><p>〔5〕 in 1984, it produced a clotting factor: “Genentech
Corporate Chronology,”
http://www.gene.com/gene/about/corporate/history/timeline.html (accessed
January 30, 2010).</p></li>
<li><p>〔6〕 in 1985, it created a recombinant version: Ibid.</p></li>
<li><p>〔7〕
［1］其实乌尔里希发现的是与大鼠neu基因同源的人类基因。此外，其他两个研究小组也独立地发现了相同的基因。——作者注</p></li>
<li><p>〔8〕 It was under the aegis: L. Coussens et al., “3 Groups
Discovered the Neu Homolog (Her-2, Also Called Erb-b2),” Science 230
(1985): 1132–39. Also see T. Yamamoto et al., Nature 319 (1986): 230–34,
and C. King et al., Science 229 (1985): 974–76.</p></li>
<li><p>〔9〕 In the summer of 1986: Bazell, Her-2, and Dennis Slamon,
interview with author, April 2010.</p></li>
<li><p>〔10〕 Dennis Slamon, a UCLA oncologist: Ibid.</p></li>
<li><p>〔11〕 a “velvet jackhammer”: Eli Dansky, “Dennis Slamon: From
New Castle to New Science,” SU2C Mag,
http://www.standup2cancer.org/node/194 (accessed January 24,
2010).</p></li>
<li><p>〔12〕 “a murderous resolve”: Ibid.</p></li>
<li><p>〔13〕 In Chicago, Slamon had performed a series: See, for
example, I. S. Chen et al., “The x Gene Is Essential for HTLV
Replication,” Science 229, no. 4708 (1985): 54–58; W. Wachsman et al.,
“HTLV x Gene Mutants Exhibit Novel Transcription Regulatory Phenotypes,”
Science 235, no. 4789 (1987): 647–77; C. T. Fang et al., “Detection of
Antibodies to Human T-Lymphotropic Virus Type 1 (HTLV-1),” Transfusion
28, no. 2 (1988): 179–83.</p></li>
<li><p>〔14〕 If Ullrich sent him the DNA probes: Details of the Ullrich
and Slamon collaboration are outlined in Bazell, Her-2, and from Slamon,
interview with author.</p></li>
<li><p>〔15〕 In a few months: D. Slamon et al., “Human Breast Cancer:
Correlation of Relapse and Survival with Amplification of the Her-2/Neu
Oncogene,” Science 235 (1987): 177–82.</p></li>
<li><p>〔16〕 In the mid-1970s, two immunologists at Cambridge
University: See Nobel Lectures, Physiology or Medicine, 1981–1990,
ed. Jan Lindsten (Singapore: World Scientific Publishing,
1993).</p></li>
<li><p>〔17〕 “allergic to cancer”: Merrill Goozner, The 00 Million
Pill: The Truth Behind the Cost of New Drugs (Berkeley: University of
California Press, 2004), 195.</p></li>
<li><p>〔18〕 Drained and dejected: Ibid.</p></li>
<li><p>〔19〕 “Nobody gave a shit”: Bazell, Her-2, 49.</p></li>
<li><p>〔20〕
这种药物也被称作曲妥珠单抗（Trastuzumab），后缀“ab”表示这是一种抗体。——作者注</p></li>
<li><p>〔21〕 “When I was finished with all that”: Ibid. Also Barbara
Bradfield, interview with author, July 2008.</p></li>
<li><p>〔22〕 But there was more river to ford: Ibid.</p></li>
<li><p>〔23〕 “His tone changed,” she recalled: Ibid.</p></li>
<li><p>〔24〕 “I was at the end of my road”: Ibid</p></li>
<li><p>〔25〕 “Survivors look back and see omens”: Joan Didion, The Year
of Magical Thinking (New York: Vintage, 2006), 152.</p></li>
<li><p>〔26〕 On a warm August morning in 1992: Bradfield, interview
with author. Details of the trial and the treatment are from Bradfield’s
interview, from Bazell’s Her-2, and from Slamon, interview with author,
April 2010.</p></li>
<li><h4 id="第四十六章-同情用药">第四十六章 同情用药</h4></li>
<li><p>〔1〕 Dying people don’t have time or energy: “Dying for
Compassion,” Breast Cancer Action Newsletter 31 (August 1995).</p></li>
<li><p>〔2〕 It seemed as if we had: Musa Mayer, Breast Cancer Action
Newsletter 80 (February/March 2004).</p></li>
<li><p>〔3〕
同情用药（拓展性同情使用临床试验用药物）是指在一些情况下，患者不能通过参加临床试验来获得临床试验用药物时，可以允许在开展临床试验的机构内使用尚未得到批准上市的药物给急需的患者。——译者注</p></li>
<li><p>〔4〕 “True success happens”: Breast Cancer Action Newsletter 32
(October 1995).</p></li>
<li><p>〔5〕 The number of women enrolled in these trials: Robert
Bazell, Her-2: The Making of Herceptin, a Revolutionary Treatment for
Breast Cancer (New York: Random House, 1998), 160–80.</p></li>
<li><p>〔6〕 “We do not provide … compassionate use”: Ibid.,
117.</p></li>
<li><p>〔7〕 “If you start making exceptions”: Ibid., 127.</p></li>
<li><p>〔8〕 “Why do women dying of breast cancer”: “Dying for
Compassion,” Breast Cancer Action Newsletter.</p></li>
<li><p>〔9〕 “Scientific uncertainty is no excuse”: Charlotte Brody et
al., “Rachel’s Daughters, Searching for the Causes of Breast Cancer: A
Light-Saraf-Evans Production Community Action ＆ Resource Guide,”
http://www.wmm.com/filmCatalog/study/rachelsdaughters.pdf (accessed
January 31, 2010).</p></li>
<li><p>〔10〕 Marti Nelson, for one, certainly could not: Marti Nelson’s
case and its aftermath are described in Bazell, Her-2.</p></li>
<li><p>〔11〕 On Sunday, May 17: Bruce A. Chabner, “ASCO 1998: A
Commentary,” Oncologist 3, no. 4 (1998): 263–66; D. J. Slamon et al.,
“Addition of Herceptin to First-Line Chemotherapy for HER-2
Overexpressing Metastatic Breast Cancer Markedly Increases Anti-Cancer
Activity: A Randomized, Multinational Controlled Phase III Trial
(abstract 377),” Proceedings of the American Society of Clinical
Oncology 16 (1998): 377.</p></li>
<li><p>〔12〕 In the pivotal 648 study: Slamon et al., “Addition of
Herceptin to First-Line Chemotherapy,” 377.</p></li>
<li><p>〔13〕 In 2003, two enormous multinational studies: Romond et
al. and Piccart-Gebhart et al., New England Journal of Medicine 353
(2005): 1659–84.</p></li>
<li><p>〔14〕 “The results,” one oncologist wrote: Gabriel Hortobagyi,
“Trastuzumab in the treat-ment of breast cancer,” editorial, New England
Journal of Medicine, 353, no. 16 (2005): 1734.</p></li>
<li><p>〔15〕 “The company,” Robert Bazell, the journalist: Bazell,
Her-2, 180–82.</p></li>
<li><h4 id="第四十七章-乘胜追击">第四十七章 乘胜追击</h4></li>
<li><p>〔1〕 The nontoxic curative compound: James F. Holland, “Hopes
for Tomorrow ver-sus Realities of Today: Therapy and Prognosis in Acute
Lymphocytic Leukemia of Childhood,” Pediatrics 45:191–93.</p></li>
<li><p>〔2〕 Why, it is asked, does the supply of new miracle drugs:
Lewis Thomas, The Lives of a Cell (New York: Penguin, 1978),
115.</p></li>
<li><p>〔3〕 This abnormality, the so-called Philadelphia chromosome:
John M. Goldman and Junia V. Melo, “Targeting the BCR-ABL Tyrosine
Kinase in Chronic Myeloid Leukemia,” New England Journal of Medicine
344, no. 14 (2001): 1084–86.</p></li>
<li><p>〔4〕 The identity of the gene: Annelies de Klein et al., “A
Cellular Oncogene Is Translocated to the Philadelphia Chromosome in
Chronic Myelocitic Leukemia,” Nature 300, no. 5894 (1982):
765–67.</p></li>
<li><p>〔5〕
其实abl基因最早见于病毒，后来研究人员才发现人类细胞中也存在该基因（重现了ras与src的故事）。逆转录病毒也再次“盗用”人类癌基因的身份成为致癌病毒。——作者注</p></li>
<li><p>〔6〕 The mouse developed the fatal spleen-choking: E. Fainstein
et al., “A New Fused Transcript in Philadelphia Chromosome Positive
Acute Lymphocytic Leukaemia,” Nature 330, no. 6146 (1987): 386–88; Nora
Heisterkamp et al., “Structural Organization of the Bcr Gene and Its
Role in the Ph’ Translocation,” Nature 315, no. 6022 (1985): 758–61; de
Klein et al., “Cellular Oncogene Is Translocated”; Nora Heisterkamp et
al., “Chromosomal Localization of Human Cellular Homologues of Two Viral
Oncogenes,” Nature 299, no. 5885 (1982): 747–49.</p></li>
<li><p>〔7〕 In the mid-1980s: Daniel Vasella and Robert Slater, Magic
Cancer Bullet: How a Tiny Orange Pill Is Rewriting Medical History (New
York: HarperCollins, 2003), 40–48; Elisabeth Buchdunger and Jürg
Zimmermann, “The Story of Gleevec,” innovation.org,
http://www.innovation.org/index.cfm/StoriesofInnovation/InnovatorStories/The_Story_of_Gleevec
(accessed January 31, 2010).</p></li>
<li><p>〔8〕 马耳他十字（Maltese
Cross）由四个“V”字或是箭头样的凹四边形组成，是医院骑士团以及马耳他骑士团所使用的符号。——译者注</p></li>
<li><p>〔9〕 Jürg Zimmermann, a talented chemist: Howard Brody, Hooked:
Ethics, the Medical Profession, and the Pharmaceutical Industry (Lanham,
MD: Rowman ＆ Littlefield, 2007), 14–15; Buchdunger and Zimmermann,
“Story of Gleevec.”</p></li>
<li><p>〔10〕 “〔It was〕 what a locksmith does”: Buchdunger and
Zimmermann, “Story of Gleevec.”</p></li>
<li><p>〔11〕 “I was drawn to oncology as a medical student”: Brian
Druker, interview with author, November 2009.</p></li>
<li><p>〔12〕 In 1993, he left Boston: Ibid.</p></li>
<li><p>〔13〕 “Everyone just humored me”: Ibid.</p></li>
<li><p>〔14〕 In October 1992, just a few months: Ibid.</p></li>
<li><p>〔15〕 “Although freedom from leukemia”: S. Tura et al.,
“Evaluating Survival After Allogeneic Bone Marrow Transplant for Chronic
Myeloid Leukaemia in Chronic Phase: A Comparison of Transplant Versus
No-Transplant in a Cohort of 258 Patients First Seen in Italy Between
1984 and 1986,” British Journal of Haematology 85 (1993):
292–99.</p></li>
<li><p>〔16〕 “Cancer is complicated”: Druker, interview with
author.</p></li>
<li><p>〔17〕 In the summer of 1993, when Lydon’s drug: Ibid.</p></li>
<li><p>〔18〕 Druker described the findings in the journal: Brian J.
Druker, “Effects of a Selective Inhibitor of the Abl Tyrosine Kinase on
the Growth of Bcr-Abl Positive Cells,” Nature Medicine 2, no. 5 (1996):
561–66.</p></li>
<li><p>〔19〕 “The drug … would never work”: The story of Gleevec’s
development is from Druker, interview with author.</p></li>
<li><p>〔20〕 In early 1998, Novartis finally relented: Lauren
Sompayrac, How Cancer Works(Sudbury, MA: Jones and Bartlett, 2004),
21.</p></li>
<li><p>〔21〕
之所以在此使用商品名，是因为它对于患者来说更为熟悉。CGP57148的学名是伊马替尼（imatinib）。此外，这种药物也被称为STI571。——作者注</p></li>
<li><p>〔22〕 红细胞、血小板与白细胞。——作者注</p></li>
<li><p>〔23〕 Druker edged into higher and higher: Brian J. Druker et
al., “Efficacy and Safety of a Specific Inhibitor of the BCR-ABL
Tyrosine Kinase in Chronic Myeloid Leukemia,” New England Journal of
Medicine 344, no. 14 (2001): 1031–37.</p></li>
<li><p>〔24〕 Of the fifty-four patients: Ibid.</p></li>
<li><p>〔25〕 “Before the year 2000”: Hagop Kantarjian, Georgetown
Oncology Board Review Lectures, 2008.</p></li>
<li><p>〔26〕 “When I was a youngster in Illinois”: Bruce A. Chabner,
“The Oncologic Four-Minute Mile,” Oncologist 6, no. 3 (2001):
230–32.</p></li>
<li><p>〔27〕 “It proves a principle”: Ibid.</p></li>
<li><h4 id="第四十八章-红桃皇后">第四十八章 红桃皇后</h4></li>
<li><p>〔1〕 “Well, in our country,” said Alice: Lewis Carroll, Alice in
Wonderland and Through the Looking Glass (Boston: Lothrop, 1898),
125.</p></li>
<li><p>〔2〕 In August 2000: Details of Jerry Mayfield’s case are from
the CML blog newcmldrug.com. This website is run by Mayfield to provide
information to patients about CML and targeted therapy.</p></li>
<li><p>〔3〕 CML cells, Sawyers discovered: See for instance M. E. Gorre
et al., “Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL
Gene Mutation or Amplification,” Science 293, no. 5531 (2001): 876–80;
Neil P. Shah et al., “Multiple BCR-ABL Kinase Domain Mutations Confer
Polyclonal Resistance to the Tyrosine Kinase Inhibitor Imatinib (STI571)
in Chronic Phase and Blast Crisis Chronic Myeloid Leukemia,” Cancer Cell
2, no. 2 (2002): 117–25.</p></li>
<li><p>〔4〕 “an arrow pierced through the center of the protein’s
heart”: Attributed to John Kuriyan; quoted by George Dmitri to the
author at a Columbia University seminar, November 2009.</p></li>
<li><p>〔5〕 In 2005, working with chemists: Jagabandhu Das et al.,
“2-Aminothiazole as a Novel Kinase Inhibitor Template.
Structure-Activity Relationship Studies toward the Discovery of
N-(2-Chloro-6-methylphenyl)-2-〔〔6-〔4-(2-hydroxyethyl)-1-(piperazinyl)〕-2-methyl-4-pyrimidinyl〕(amino)〕-1,3-thiazole-5-carboxamide
(Dasatinib, BMS-354825) as a Potent pan-Src Kinase Inhibitor,” Journal
of Medicinal Chemistry 49, no. 23 (2006): 6819–32; Neil P. Shah et al.,
“Overriding Imatinib Resistance with a Novel ABL Kinase Inhibitor,”
Science 305, no. 5682 (2004): 399–401; Moshe Talpaz et al., “Dasatinib
in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias,” New
England Journal of Medicine 354, no. 24 (2006): 2531–41.</p></li>
<li><p>〔6〕 twenty-four novel drugs: For a full list, see National
Cancer Institute, targeted ther-apies list,
http://www.cancer.gov/cancertopics/factsheet/Therapy/targeted (accessed
February 23, 2010). This website also details the role of such drugs as
Avastin and bortezomib.</p></li>
<li><p>〔7〕 Over a decade: “Velcade (Bortezomib) Is Approved for
Initial Treatment of Patients with Multiple Myeloma,” U.S. Food and Drug
Administration,
http://www.fda.gov/AboutFDA/CentersOffices/CDER/ucm094633.htm (accessed
January 31, 2010); “FDA Approval for Lenalidomide,” National Cancer
Institute, U.S. National Institutes of Health,
http://www.cancer.gov/cancertopics/druginfo/fda-lenalidomide (accessed
January 31, 2010).</p></li>
<li><p>〔8〕 In 1948, epidemiologists identified a cohort: Framingham
Heart Study, the National Heart, Lung and Blood Institute and Boston
University, http://www.framingham-heartstudy.org/ (accessed January 31,
2010).</p></li>
<li><p>〔9〕 In May 2008, two Harvard epidemiologists: Nicholas A.
Christakis, “The Collective Dynamics of Smoking in a Large Social
Network,” New England Journal of Medicine 358, no. 21 (2008):
2249–58.</p></li>
<li><p>〔10〕 “Cancer at the fin de siècle”: Harold J. Burstein, “Cancer
at the Fin de Siècle,” Medscape Today, February 1, 2000,
http://www.medscape.com/viewarticle/408448 (accessed January 31,
2010).</p></li>
<li><h4 id="第四十九章-山外有山">第四十九章 山外有山</h4></li>
<li><p>〔1〕 “Every sickness is a musical problem”: W. H. Auden, “The
Art of Healing (In Memoriam David Protetch, M.D.),” New Yorker,
September 27, 1969.</p></li>
<li><p>〔2〕 The revolution in cancer research: Bert Vogelstein and
Kenneth Kinzler, “Cancer Genes and the Pathways They Control,” Nature
Medicine 10, no. 8 (2004): 789–99.</p></li>
<li><p>〔3〕 “The purpose of my book”: Susan Sontag, Illness as Metaphor
and AIDS and Its Metaphors (New York: Picador, 1990), 102.</p></li>
<li><p>〔4〕 The Human Genome Project: “Once Again, Scientists Say Human
Genome Is Complete,” New York Times, April 15, 2003.</p></li>
<li><p>〔5〕 the Cancer Genome Atlas: “New Genome Project to Focus on
Genetic Links in Cancer,” New York Times, December 14, 2005.</p></li>
<li><p>〔6〕 “When applied to the 50 most common”: “Mapping the Cancer
Genome,” Scientific American, March 2007.</p></li>
<li><p>〔7〕 In 2006, the Vogelstein team revealed: Tobias Sjöblom et
al., “The Consensus Coding Sequences of Human Breast and Colorectal
Cancers,” Science 314, no. 5797 (2006): 268–74.</p></li>
<li><p>〔8〕 In 2008, both Vogelstein’s group and the Cancer Genome
Atlas: Roger McLendon et al., “Comprehensive Genomic Characterization
Defines Human Glioblastoma Genes and Core Pathways,” Nature 455, no.
7216 (2008): 1061–68. Also see D. Williams Parsons et al., “An
Integrated Genomic Analysis of Human Glioblastoma Multiforme,” Science
321, no. 5897 (2008): 1807–12; and Roger McLendon et al., “Comprehensive
Genomic Characterization.”</p></li>
<li><p>〔9〕 Only a few cancers are notable exceptions: C. G. Mullighan
et al., “Genome-Wide Analysis of Genetic Alterations in Acute
Lymphoblastic Leukemia,” Nature 446, no. 7137 (2007): 758–64.</p></li>
<li><p>〔10〕
到目前为止，急性淋巴细胞白血病基因组的完整测序尚未完成。这里提及的突变是指基因缺失或扩增。随着测序工作的深入，基因突变数量还可能会继续增加。——作者注</p></li>
<li><p>〔11〕 “In the end,” as Vogelstein put it: Bert Vogelstein,
comments on lecture at Massachusetts General Hospital, 2009; also see
Vogelstein and Kinzler, “Cancer Genes and the Pathways They
Control.”</p></li>
<li><p>〔12〕 Other mutations are not passive players: The distinction
between passenger and driver mutations has generated an enormous debate
in cancer genetics. Many scientists sus-pect that the initial analysis
of the breast cancer genome may have overestimated the number of driver
mutations. Currently, this remains an open question in cancer genetics.
See, for instance, Getz et al., Rubin et al., and Forrest et al.,
Science 317, no 5844: 1500, comments on Sjöblom article above.</p></li>
<li><p>〔13〕
藤壶（barnacle）是附着在海边岩石、船体上的一簇簇灰白色、有石灰质外壳的生物，风吹浪打也冲刷不掉。——译者注</p></li>
<li><p>〔14〕 In a recent series of studies, Vogelstein’s team: See, for
example, Rebecca J. Leary, “Integrated Analysis of Homozygous Deletions,
Focal Amplifications, and Sequence Alterations in Breast and Colorectal
Cancers,” Proceedings of the National Academy of Sciences of the United
States of America 105, no. 42 (2008): 16224–29; Siân Jones et al., “Core
Signaling Pathways in Human Pancreatic Cancer Revealed by Global Genomic
Analyses,” Science 321, no. 5897 (2008): 1801–6.</p></li>
<li><p>〔15〕 “Cancer,” as one scientist recently put it: Emmanuel
Petricoin, quoted in Dan Jones, “Pathways to Cancer Therapy,” Nature
Reviews Drug Discovery 7 (2008): 875–76.</p></li>
<li><p>〔16〕 In a piece published in the New York Times: “To Fight
Cancer, Know the Enemy,” New York Times, August 5, 2009.</p></li>
<li><p>〔17〕
小鼠可以过滤掉焦油中的许多致癌成分。石棉可以通过体内诱导瘢痕形成的炎症反应致癌。由于细菌不会产生这种反应，因此它们对石棉具有“免疫力”。——作者注</p></li>
<li><p>〔18〕 In 2000, the so-called Million Women Study: Valerie Beral
et al., “Breast Cancer and Hormone-Replacement Therapy in the Million
Women Study,” Lancet 362, no. 9382 (2003): 419–27.</p></li>
<li><p>〔19〕 The second controversy also has its antecedents: See, for
instance, F. J. Roe and M. C. Lancaster et al., “Natural, Metallic and
Other Substances, as Carcinogens,” British Medical Bulletin 20 (1964):
127–33; and Jan Dich et al., “Pesticides and Cancer,” Cancer Causes ＆
Control 8, no. 3 (1997): 420–43.</p></li>
<li><p>〔20〕 In 2005, the Harvard epidemiologist David Hunter:
Yen-Ching Chen and David J. Hunter, “Molecular Epidemiology of Cancer,”
CA: A Cancer Journal for Clinicians 55 (2005): 45–54.</p></li>
<li><p>〔21〕 In the mid-1990s, building on the prior decade’s advances:
Yoshio Miki et al., “A Strong Candidate for the Breast and Ovarian
Cancer Susceptibility Gene BRCA1,” Science 266, no. 5182 (1994): 66–71;
R. Wooster et al., “Localization of a Breast Cancer Susceptibility Gene,
BRCA2, to Chromosome 13q12–13,” Science 265, no. 5181 (1994): 2088–90;
J. M. Hall et al., “Linkage of Early-Onset Familial Breast Cancer to
Chromosome 17q21,” Science 250, no. 4988 (1990): 1684–89; Michael R.
Stratton et al., “Familial Male Breast Cancer Is Not Linked to the BRCA1
Locus on Chromosome 17q,” Nature Genetics 7, no. 1 (1994):
103–7.</p></li>
<li><p>〔22〕 An Israeli woman: Breast cancer patient O. B-L. (name
withheld), interview with author, December 2008.</p></li>
<li><p>〔23〕 In the mid-1990s, John Dick: Tsvee Lapidot et al., “A Cell
Initiating Human Acute Myeloid Leukaemia After Transplantation into SCID
Mice,” Nature 367, no. 6464 (1994): 645–58.</p></li>
<li><p>〔24〕 Indeed, as the fraction of those affected by cancer
creeps: “One in three” is from the recent evaluation by the National
Cancer Institute. See
http://www.cancer.gov/news-center/tip-sheet-cancer-health-disparities.
The number “one in two” comes from the NCI seer statistics,
http://seer.cancer.gov/statfacts/html/all.html, but includes all cancer
sites, summarized in Matthew Hayat et al., “Cancer Statistics, Trends
and Multiple Primary Cancer Analyses,” Oncologist 12 (2007):
20–37.</p></li>
<li><h4 id="阿托莎之战">阿托莎之战</h4></li>
<li><p>〔1〕 We aged a hundred years: Anna Akhmatova, “In Memoriam, July
19, 1914,” in The Complete Poems of Anna Akhmatova, vol. 1 (Chicago:
Zephyr Press, 1990), 449.</p></li>
<li><p>〔2〕 It is time, it is time for me too to depart: Aleksandr
Solzhenitsyn, Cancer Ward (New York: Farrar, Straus and Giroux, 1974),
476.</p></li>
<li><p>〔3〕 On May 17, 1973: “A Memorial Tribute in Honor of Dr. Sidney
Farber, 1903–1973,” Thursday, May 17, 1973. Gift of Thomas Farber to the
author.</p></li>
<li><p>〔4〕
如前所述，由于“癌症”的概念在公元前500年尚未得到阐述或明确，因此有关阿托莎所患疾病的诊断存疑。——作者注</p></li>
<li><p>〔5〕 英国作家奥斯卡·王尔德创作的小说《道林·格雷的画像》（The
Picture of Dorian
Gray）里面的主人公。天生丽质的道林·格雷为求青春永驻而出卖了自己的灵魂。——译者注</p></li>
<li><p>〔6〕 It is impossible to enumerate: Atossa’s case and her
survival numbers are speculative, but based on several sources. See, for
instance, “Effects of chemotherapy and hor-monal therapy for early
breast cancer on recurrence and 15-year survival: An over-view of the
randomised trials,” Lancet, 365, no. 9472: 1687–1717.</p></li>
<li><p>〔7〕 In 1997, the NCI director, Richard Klausner: See Barnett S.
Kramer and Richard D. Klausner, “Grappling with Cancer—Defeatism Versus
the Reality of Progress,” New England Journal of Medicine 337, no. 13
(1997): 931–35.</p></li>
<li><p>〔8〕 The new drug was none other than Gleevec: See, for example,
H. Joensuu, “Treatment of Inoperable Gastrointestinal Stromal Tumors
(GIST) with Imatinib (Glivec, Gleevec),” Medizinische Klinik (Munich)
97, suppl. 1 (2002): 28–30; M. V. Chandu de Silva and Robin Reid,
“Gastrointestinal Stromal Tumors (GIST): C-kit Mutations, CD117
Expression, Differential Diagnosis and Targeted Cancer Therapy with
Imatinib,” Pathology Oncology Research 9, no. 1 (2003): 13–19.</p></li>
<li><h4 id="致谢">致谢</h4></li>
<li><h4 id="悉达多穆克吉访谈录">悉达多·穆克吉访谈录</h4></li>
<li><h4 id="术语参考释义">术语参考释义</h4></li>
<li><h4 id="译者注记">译者注记</h4></li>
</ol>
<script src="https://giscus.app/client.js"
        data-repo="hbaolong/hbaolong.github.io"
        data-repo-id="R_kgDOLetDQg"
        data-category="General"
        data-category-id="DIC_kwDOLetDQs4CfLEl"
        data-mapping="url"
        data-strict="0"
        data-reactions-enabled="1"
        data-emit-metadata="1"
        data-input-position="top"
        data-theme="preferred_color_scheme"
        data-lang="zh-CN"
        crossorigin="anonymous"
        async>
</script>
</body>
</html>
